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 The main focus of hydrogel technology is on hydrogels in their crosslinked form. 
Although hydrogels are promising materials for cartilage tissue engineering, the clinical 
translation of these materials are hindered because they lack the ability to be molded into 
a defect site by a surgeon due to hydrogel precursors being liquid solutions that are prone 
to leaking from the implantation site during placement. Therefore, the current thesis work 
focuses on the hydrogels in their precursor form prior to crosslinking and describes the 
development of creating hydrogel pastes that have the potential to be clinically translatable. 
The current thesis first developed a platform hydrogel paste composed of methacrylated 
hyaluronic acid (MeHA), which is a more traditional hydrogel material, and hyaluronic 
acid nanoparticles. The hyaluronic acid nanoparticles were shown to impart a yield stress 
on the hydrogel precursors, allowing the precursors to be molded and shaped prior to 
crosslinking. Furthermore, the mixtures containing hyaluronic acid nanoparticles were able 
to be crosslinked and further characterized as solids and they could encapsulate bone 
marrow-derived stem cells that remained viable. The next major focus of the thesis was 
tailoring the platform system for cartilage tissue specifically, by gradually replacing each 
of the two components of the platform system with naturally derived cartilage extracellular 
matrix, to create a chondroinductive material. Devitalized (DVC) and decellularized 
cartilage (DCC) particles were found to impart paste-like behavior in MeHA gels, where 
DVC significantly upregulated chondrogenic gene expression. DCC that was solubilized 
and methacrylated (MeSDCC) was created and crosslinked, which formed hydrogels with 
a compressive modulus in the range of native cartilage tissue. Finally, DVC particles mixed 
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in with solubilized and methacrylated DVC created pastes that significantly upregulated 
chondrogenic gene expression compared to gels without DVC particles. The important next 
steps will be to further evaluate these MeSDVC and DVC particle pastes in an in vivo 
model, and further explore whether decellularization of the tissue is necessary. Ultimately, 
this thesis successfully developed a hydrogel paste that is inherently chondroinductive and 
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CHAPTER 1: INTRODUCTION TO THESIS 
 The overall objective of thesis was to develop a mechanically dynamic, “paste-like” 
hydrogel material that could retain its molded or extruded shape, would “set” after 
placement and withstand mechanical loading, and would be inherently chondroinductive. 
The overall progression was to first develop a platform hydrogel paste system and then 
tailor it specifically for cartilage tissue engineering. This platform system entailed a two 
component system that was mixed together (Figure 1.1): one component was comprised of 
particles that provided the paste-like rheological properties, and the other component was 
a photocrosslinkable linear polymer that, after crosslinking, provided the mechanical 
integrity needed to withstand mechanical loading. The two components were then replaced 
one by one to create a chondroinductive paste. Therefore, characterization and progression 
of this hydrogel paste design incorporated the following three specific aims (Figure 1.2): 
(1) characterize methacrylated hyaluronic acid (MeHA) and hyaluronic acid nanoparticle 
pastes with modulated rheological properties, (2) engineer and refine MeHA pastes 
incorporating decellularized (DCC) and devitalized cartilage (DVC) and evaluate 
chondroinductivity in vitro, and (3) Characterize solubilized and methacrylated DCC 
(MeSDCC) and solubilized and methacrylated DVC (MeSDVC) and evaluate 
chondroinductivity of DVC pastes in vitro.   
 The first aim was to develop a platform technology to create hydrogel pastes that 
were capable of encapsulating rat bone marrow-derived stem cells that remained viable. 
The second aim was to replace the hyaluronic acid nanoparticles with chondroinductive 
materials, DCC and DVC, and compare and evaluate these materials in vitro. The third aim 
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first characterized hydrogels composed only of MeSDCC and evaluated them for their 
biomechanics and for their chondroinductive potential, comparing them to methacrylated 
gelatin. The final part of the third aim was to evaluate MeSDVC and DVC particle pastes 
for their chondroinductive potential in vitro. The chapters that follow reflect the 
chronological progression of these aims, and the organization of these chapters is as 
follows:   
 Chapter 2 provides a background of the structural and functional characteristics of 
hard-soft tissue interfaces and then contains a thorough literature review on the two main 
types of nanomaterials emerging in interfacial tissue engineering strategies: nanoparticles 
and nanofibers. Additionally, the chapter provides approaches used to employ these 
nanomaterials in interfacial constructs. Although the current thesis work did not evaluate 
the hydrogel pastes as interfacial constructs, Chapter 2 addresses the entire thesis as it 
provided valuable insight on the development of materials that would be successful in 
cartilage tissue engineering strategies and it addresses the first aim by providing reasoning 
for using nanomaterials for cartilage tissue engineering. 
 Chapter 3 addresses the first aim of developing a platform hydrogel paste system. 
MeHA was mixed with hyaluronic acid nanoparticles and linear hyaluronic acid in various 
formulations, where the solutions were evaluated for their yield stress prior to crosslinking. 
Additionally, the solutions were crosslinked and characterized as solids for swelling, 
mechanical compression, and cell viability after encapsulation. This chapter therefore 
provided the foundation for the rest of the current thesis, as it validated the two-component 
hydrogel system as effectively producing hydrogel pastes. 
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 Chapter 4 addresses the second aim, by introducing DCC and DVC particles as a 
means to achieve yield stress in hydrogel precursors. DCC and DVC particles were mixed 
with MeHA in various formulations, evaluated for their yield stress, and were then 
crosslinked, where the compressive modulus, swelling, gene expression, and histology 
were compared and evaluated for chondroinductive potential in vitro. Therefore, the results 
of this chapter were crucial in designing the final portion of the third aim, where it was 
decided to focus on the use of DVC rather than DCC.  
 Chapter 5 addresses the first part of the third aim, i.e., characterizing MeSDCC 
hydrogels, and provides insight on the use of this newly developed material for future work. 
MeSDCC gels were fabricated and encapsulated with cells and were then evaluated for 
their compressive modulus, swelling, and chondroinductivity in vitro, where the MeSDCC 
gels were compared alongside methacrylated gelatin (GelMA) gels. The results of this 
chapter affirmed that MeSDCC is a potential promising material for cartilage tissue 
engineering and therefore, methacrylated extracellular matrix was chosen to be further 
evaluated in Chapter 6. 
 Chapter 6 further addresses aim 3 by evaluating chondroinductive pastes composed 
of MeSDVC and DVC. DVC was chosen from the results based on aim 2, and various 
formulations of DVC particles mixed with MeSDVC were evaluated for a yield stress prior 
to crosslinking, and after crosslinking, the compressive modulus, swelling, and 
chondroinductivity of these formulations were analyzed in vitro. The findings of this 
chapter further validated the use of the two-component hydrogel paste system and provided 
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evidence that hydrogel pastes composed entirely of cartilage ECM have potential for 
cartilage tissue engineering.   
 Chapter 7 addresses the concluding remarks of this current thesis. It summarizes 
the key findings and then describes and presents comparisons made among and between 
all three aims. Finally, recommendations are made regarding future work with these 
materials.   
 Overall, the work conducted in this current thesis proposed a potential solution to 
overcome the major drawback of traditional hydrogels, which is leaking from the defect 
site after implantation. Hydrogels are promising materials for treating arthritis. Current 
clinical treatments for arthritis include autologous chondrocyte implantation, mosiacplasty, 
and microfracture. Other treatments available are products such as Zimmer’s DeNovo® 
product, which is composed of living, human juvenile cartilage. However, not only do these 
treatments involve high risk of donor site morbidity and/or the need for multiple surgeries, 
or require living donated cartilage, of which availability of donors is a concern, but they 
all still lack the ability to regenerate fully functional cartilage tissue. Although many 
promising improvements are being made in hydrogel technology for cartilage regeneration, 
without the potential for clinical translation, it will be difficult for these advancements to 
reach commercialization. Therefore, although the work in this current thesis did not 
encompass regenerating the entire osteochondral interface, it did provide the mindset of 
clinical translation for hydrogel advancements, and it provided for the first time a 
foundation for a potential hydrogel solution that is paste-like and chondroinductive to 
regenerate damaged cartilage tissue.    
 5 




The field of interfacial tissue engineering is striving to restore the structural and 
functional characteristics of hard-soft tissue interfaces, which include osteochondral and 
bone-tendon/ligament interfaces. This chapter first discusses the structural and functional 
characteristics of these interfaces and then describes the two main types of nanomaterials 
emerging in interfacial tissue engineering strategies: nanoparticles and nanofibers. 
Additionally, the chapter discusses approaches used to employ these nanomaterials in 
interfacial constructs.  
 
INTRODUCTION 
Engineering of interfacial tissues is emerging as one of the grandest challenges of 
tissue engineering. This emergence is in part because of the complexity of the interface 
itself, but additionally because interfacial tissues are in high clinical demand. Hard-soft 
tissue interfaces (e.g., bone-cartilage, bone-tendon, bone-ligament), which are the focus of 
this chapter, are especially prone to injury. Considering the bone-tendon/ligament interface 
alone, repair methods using grafts are not necessarily focused on regenerating the tissue 
interface, which can lead to compromised graft function and poor long-term clinical 
outcome.82, 89 Therefore, the field of interfacial tissue engineering is striving to restore the 
                                               
*Published as Beck E.C. and Detamore M.S., “Nanomaterials for hard-soft tissue interfaces,” Chapter 13 in: 
Nanomaterials in Tissue Engineering: Characterization, Fabrication and Applications, eds. Gaharwar AK, 
Sant S, Hancock MJ, Hacking SA. Woodhead Publishing, Philadelphia, PA, pages 363 – 386, 2013. 
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structural and functional characteristics of the interface itself to form a seamless transition 
from hard-soft tissues. 
The structural and functional characteristics of the interfaces of bone-cartilage, and 
bone-tendon/ligament will be described here. These characteristics are highly complex 
because the interface is responsible for the transfer of mechanical loads between two 
dissimilar and heterogeneous tissues.89, 149 Therefore, the physiology and function of each 
interface must be understood prior to designing interfacial constructs. The bone-cartilage 
interface, known as the osteochondral interface, unites hyaline cartilage with subchondral 
bone and is the most extensively studied interface in tissue engineering. Cartilage can be 
further divided into three zones (Figure 2.1). The superficial zone at the articular surface is 
characterized by flattened chondrocytes and thin collagen II fibrils that run parallel to the 
joint surface.138 The middle zone contains more rounded chondrocytes and slightly larger 
and less parallel collagen II fibers.99 The deep zone contains chondrocytes and collagen II 
fibrils that run perpendicular to the articular surface.138 Underlying the three cartilage zones 
is a wavy tidemark that marks the beginning of the calcified cartilage zone, which extends 
the collagen fibrils from the deep zone to the subchondral bone. Finally, the subchondral 
bone is composed of primarily collagen I and hydroxyapatite crystals.154 The subchondral 
bone is secured to the calcified cartilage by interdigitation at the interface of these two 
zones. In addition to providing a secure attachment, this interdigitation reduces stress 
concentrations at the bone-cartilage interface to allow for efficient transfer of mechanical 
loading.82 
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Although osteochondral constructs are more widely explored in interfacial tissue 
engineering, the bone-tendon/ligament interfaces are gaining attention as well. Tendons 
transfer loads from muscle to bone, while ligaments link bone to bone and help ensure joint 
stability.86 The insertions of tendons and ligaments to bones can vary drastically, but they 
can generally be classified as direct or indirect.86 Direct insertions are characterized by four 
transition zones (Figure 2.1). The first zone is fibrous connective tissue that contains 
fibroblasts with aligned collagen fibrils. These collagen fibrils extend to the next zone, the 
uncalcified fibrocartilage zone, which contains larger collagen fibrils that are less parallel 
than the previous region. A wavy tidemark separates the uncalcified fibrocartilage zone 
from the calcified cartilage zone. Finally, interdigitation secures the calcified cartilage zone 
to the fourth zone, which is the underlying bone.7 Indirect insertions do not contain the 
fibrocartilage zones, but instead the tendon is directly secured to the bone through 
Sharpey’s fibers, which are collagen fibers that extend directly into the underlying bone.86 
Primarily, tissue engineering strategies to regenerate osteochondral and bone-
tendon/ligament interfacial tissues are stratified in nature. These stratified designs are 
considered “graded” designs, as they combine two or more distinct layers that aim to hone 
in on the characteristics of the various interfacial zones. More recently, continuously 
graded approaches have been considered, where instead of containing discrete layers, the 
constructs provide a more gradual tissue interface transition, similar to the native interface 
itself.27 These interfacial tissue engineering approaches and strategies have been 
thoroughly reviewed in the literature,24, 27, 45, 75, 82-84, 89, 90, 98, 112, 117, 118, 124, 154, 160 however 
the quest for the best approach continues. 
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  An emerging trend in interfacial tissue engineering is the incorporation of 
nanomaterials in the interfacial design. Prior to 2009, few publications existed that 
incorporated nanomaterials for interfacial constructs. However, the number of publications 
in this area continues to increase steadily each year, with just over five publications in 2009 
alone and doubling to more than ten publications in 2011 alone. Additionally, the number 
of publications in this area so far for 2012 are on a similar pace to that of 2011, emphasizing 
that nanomaterials are rapidly gaining attention and generating interest in the field of 
interfacial tissue engineering. Nanomaterials are typically classified as materials that are 
1-100 nm in size, although many groups consider materials smaller than 1 μm to be 
nanoscale. Nanomaterials can take many forms, including nanoparticles, nanofibers, 
nanocrystals, nanorods, nanotubes, etc. In a relatively short period, nanomaterials have 
exhibited extraordinary potential to advance medical therapies. In the field of tissue 
engineering, nanomaterials have become of growing interest recently because the 
extracellular matrices of tissues are composed of hierarchically nanostructured materials 
that can regulate cellular functions such as differentiation, morphogenesis, adhesion, 
proliferation, and migration.137 Thus, nanomaterials have the potential to advance current 
strategies for interfacial tissue engineering.  
The following sections review the two nanomaterial components currently being 
used in hard-soft tissue engineering: nanoparticles and nanofibers. In addition, a section is 
included that discusses strategies incorporating nanomaterials in hard-soft tissue interfaces. 
Although this text is organized by nanomaterial component, because of overlap in 
nanomaterial use in some strategies, the tables are arranged by interface type. Table 2.1 
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provides the nanomaterials employed in osteochondral strategies and Table 2.2 provides 
the nanomaterials used in bone-tendon/ligament strategies.  
 
NANOPARTICLES 
Recent interfacial tissue engineering constructs have incorporated nanoparticles of 
various types of materials. Because all hard-soft tissues include bone, it is not surprising 
that the majority of nanoparticles used in interfacial tissue engineering constructs are 
ceramic. Not only are ceramics part of the native extracellular matrix (ECM) of bone, they 
can additionally increase the mechanical strength, biocompatibility, and osteoconductivity 
of tissue engineered scaffolds.21, 31 In the following sections, we will discuss interfacial 
constructs that incorporate ceramic nanoparticles of hydroxyapatite (HAp), the most 
commonly incorporated ceramic nanoparticle, β-tricalcium phosphate (β-TCP), and other 
mineral-based materials. Although most of the nanoparticle materials in the following 
sections are mineral-based, newly emerging nanoparticle materials, including magnetic 
and fluorescent nanoparticles, will be discussed in the following sections. 
 
Hydroxyapatite (HAp) Nanoparticles 
It is well known that the nanostructure of bone, including HAp, plays an important 
role in the overall mechanical properties of bone.106 HAp nanocrystals constitute 
approximately 70% of native bone matrix.58 These HAp nanocrystals are roughly 50 nm 
long, 25 nm wide, and 2-5 nm thick.56, 107 One method used in interfacial tissue engineering 
is to directly incorporate synthetic HAp in the constructs.18, 19, 62, 91, 102, 113, 152 Samavedi et 
 10 
al.113 fabricated a continuously graded mesh by co-electrospinning nano-
HAp/polycaprolactone (PCL) with poly(ester urethane). This approach for the bone-
ligament/tendon interface resulted in a continuous mineral gradient as well as a gradient in 
tensile moduli throughout the scaffold.113 Mohan et al.91 additionally constructed a 
continuous mineral gradient for the osteochondral interface by incorporating nano-HAp 
into poly(D,L-lactic-co-glycolic acid) (PLGA) microspheres. The gradient was formed by 
filling a mold with opposing types of microspheres, PLGA with or without nano-HAp, and 
microspheres loaded with transforming growth factor-β1 for chondrogenesis. Scaffolds 
containing both mineral and signal gradients were found to promote the greatest extent of 
regeneration.91 Another group used a bi-layered approach, composed of a poly vinyl 
alcohol (PVA)/gelatin/nano-HAp layer and a polyamide6 layer.102 Osteogenically induced 
bone marrow stem cells (BMSCs) were seeded onto the HAp layer and chondrogenically 
induced BMSCs were seeded onto the polyamide6 layer, and the constructs were implanted 
intramuscularly. After 12 weeks, the layers retained the corresponding osteogenic and 
chondrogenic gene expression.102 Other groups have used non-stratified nanocomposites 
that have shown promise for osteochondral tissue engineering. These nanocomposites 
incorporated HAp and synthetic polymers, including PLGA152 and poly(1,8-octanediol-co-
citrate) (POC).18, 19 Xue et al.152 implanted PLGA constructs containing HAp into rat 
osteochondral defects and observed superior osteochondral regeneration in the scaffolds 
incorporating HAp compared to PLGA control scaffolds.  
In addition to solely incorporating nano-HAp, some groups compared both HAp 
microparticle and nanoparticle incorporation.19, 62 For bone tissue engineering, a debate 
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currently exists on the use of HAp microparticles versus nanoparticles.143 In comparison to 
microparticles, nanoparticles are hypothesized to better mimic the native bone environment 
and enhance osteogenic differentiation.96 However, drawbacks of nanoparticles include 
reduced scaffold porosity and particle aggregation.143 In interfacial tissue engineering, this 
microscale versus nanoscale debate exists as well. Chung et al.19 directly compared HAp 
microcomposites versus nanocomposites and found that nanocomposites displayed the 
highest strength and stiffness and allowed for more trabecular bone formation at the 
implant-tissue interface. However, Khanarian et al.62 compared HAp microparticle and 
nanoparticle incorporation in agarose gels and found superior mechanical properties and 
matrix production with HAp microparticles relative to HAp nanoparticles. These studies 
suggest the need for further research and characterization of microscale and nanoscale 
interfacial constructs.  
Not all studies that incorporate HAp used synthetic HAp. An newer alternative 
technique to incorporate HAp is by inducing the nucleation and growth of HAp crystals.159 
This approach mimics native HAp deposition by the use of simulated body fluid (SBF), 
which is a solution that contains the approximate concentrations of ions found in vivo. 
Scaffolds can be soaked in this solution and HAp crystals are directly nucleated on the 
surface, where the size of HAp crystals can be regulated by the amount of soak time.123 In 
native bone, HAp is deposited on collagen I fibers, and the size and orientation of the 
deposited HAp crystals are regulated by the collagen fibers.106 Although this nucleation 
technique may be used for bone tissue engineering,158 several interfacial tissue engineering 
studies tried to directly mimic this native mineralization by allowing collagen I nanofibers 
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to soak in SBF.39, 65-69, 77, 130, 131 Tampieri et al.131 developed a tri-layered osteochondral 
scaffold, which consisted of a biomineralized collagen layer to mimic native subchondral 
bone, an intermediate layer composed of collagen and less mineral, and an upper layer 
composed of hyaluronic acid and collagen to mimic the articular cartilage. These constructs 
were implanted subcutaneously in mice for 8 weeks and the layers of the construct were 
found to selectively support osteogenesis or chondrogenesis.131 From the same group, Kon 
et al.67 studied a similar tri-layered scaffold in sheep, except the cartilaginous layer lacked 
hyaluronic acid. Blank scaffolds and scaffolds seeded with autologous chondrocytes were 
implanted in sheep osteochondral defects. The extent of regeneration in the seeded 
constructs was similar to that of the blank scaffolds, suggesting the scaffold induced local 
cellular infiltration in vivo.67 This scaffold has even been further tested in horses and in 
human clinical trials.66, 68, 69 In another study, Liu et al.77 created a continuous gradient of 
HAp on a collagen construct by a controlled diffusion-precipitate method that allowed 
calcium and phosphate solutions to diffuse into the construct via opposing gradients. This 
resulted in a calcium rich and a calcium depleted side, where nano-HAp precipitation was 
the most prominent in the interior of the scaffold.77 
HAp nucleation has additionally been performed on PCL74, 97, 113 and poly(D,L-
lactide) (PDLLA).157, 162 Li et al.74 created a continuously graded HAp scaffold by locally 
varying the immersion time of PCL nanofibers in SBF. The PCL scaffold was placed in a 
tilted position in a glass beaker and a mineral solution was fed into the beaker at a constant 
rate. Thus, because the scaffold region at the bottom of the beaker was exposed to SBF for 
a longer period, there was more HAp deposition at the bottom than in the scaffold region 
 13 
at the top of the beaker. After seeding with mouse preosteoblasts for 3 days in vitro, the 
cell density within the scaffold was found to increase with increasing mineral content along 
the mineral gradient.74 HAp has additionally been nucleated onto scaffoldless 
osteochondral constructs, which were composed of ECM directly secreted by 
mesenchymal stem cells (MSCs).87 HAp was deposited onto the constructs with an 
alternate soaking process with calcium and phosphate solutions. Scaffolds containing HAp 
exhibited accelerated osteoinduction in vivo as compared to scaffolds without HAp.87 
 
β-Tricalcium Phosphate (TCP) Nanoparticles 
In addition to being osteoconductive and biocompatible, β-TCP has received great 
attention from the interfacial and bone tissue engineering communities due to its tunable 
bioresorption rates.100 Erisken et al.34 recently created a functionally graded β-TCP 
scaffold via a hybrid twin-screw extrusion/electrospinning (TSEE) process for 
osteochondral interfaces. This process allowed the time-dependent feeding of β-TCP 
nanoparticles and PCL solution resulting in a continuous gradation of β-TCP in an 
electrospun nanofibrous mesh. The same group further tested the scaffold for its linear 
viscoelastic and compressive properties by testing scaffolds seeded with mouse 
preosteoblasts and unseeded scaffolds.35 They found that the viscoelastic and 
biomechanical properties increased (i.e., became closer to the native osteochondral 
interface) by increasing the culture period. Another group fabricated a multilayer scaffold 
that employed β-TCP, in which the scaffold contained a bone phase, a cartilage phase, and 
a transition phase in between. The bone phase was created by ceramic stereolithography 
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and the cartilage phase, consisting of collagen I, was added to the bone phase by gel casting. 
In addition, the gel casting method was proposed to aid in the reduction of delamination 
between bone and cartilage layers.8 
 
Other Mineral Nanoparticles 
Although the primary mineral components used in tissue engineering are 
hydroxyapatite and β-TCP, other mineral nanomaterial components such as amorphous 
calcium phosphate and β-glycerophosphate (β-GP) have been incorporated into interfacial 
constructs.36, 47, 48, 103 Harley et al.47 developed a layered scaffold with a continuous 
interface via a liquid-phase cosynthesis technique. The bone phase was composed of a 
mineralized type I collagen/chondroitin sulfate and the cartilage phase was composed of 
unmineralized collagen II/chondroitin sulfate. The layers were then allowed to diffuse, 
creating a graded interface.47 Erisken et al.36 used the previously described TSEE process 
to create scaffolds with opposing gradients of insulin and β-GP. The scaffolds were seeded 
with human adipose-derived stromal cells and it was found that the cells differentiated 
selectively towards chondrogenic or osteogenic lineages depending upon the location in 
the scaffold.36 As an alternative electrospinning technique, Ramalingham et al.103 used a 
two-spinnerette approach to create a scaffold of continuously graded amorphous calcium 
phosphate nanoparticles. The spinnerettes were set 2.5 cm apart oriented vertically above 
a spinning mandrel, where each spinnerette was connected to a syringe loaded with either 
PCL or PCL with calcium phosphate nanoparticles. Preosteoblast cells were seeded onto 
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the constructs for 7 days and it was observed that cell adhesion and proliferation increased 
as the calcium phosphate concentration increased along length of scaffold.103 
 Emerging Nanoparticle Materials 
Although most nanoparticle materials used in interfacial tissue engineering are 
mineral-based, it is important to consider the potential benefits of other nanoparticle 
materials as well. Some emerging nanoparticle materials in interfacial tissue engineering 
are magnetic,46, 130 fluorescent,72 or silver.97 Grogan et al.46 fabricated a graded scaffold by 
mixing alginate hydrogels with cells labeled with magnetic iron-oxide nanoparticles and 
exposing the cells to varying external magnetic fields. The resulting scaffold produced a 
scaffold with varying cellular orientations that closely mimicked that of the osteochondral 
interface.46 Lee et al.72 developed another interesting use for fluorescent nanoparticles in 
interfacial tissue engineering. They created an in vivo cell tracking system to monitor the 
migration of mesenchymal stem cells in osteochondral defects.72 Nirmala et al.97 
introduced the use of silver nanoparticles for osteochondral constructs. They incorporated 
hydroxyapatite and silver nanoparticles in PCL electrospun nanofibers and then submerged 
the constructs in SBF to allow for further mineralization. Incorporating the silver 
nanoparticles resulted in superior mechanical properties and apatite deposition.97 
Additionally, silver nanoparticles are known for their antimicrobial properties, providing a 
further advantage of silver nanoparticle incorporation.125 
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Summary of Nanoparticles 
Overall, nanoparticle use in interfacial tissue engineering is primarily focused on 
the incorporation of natural materials like hydroxyapatite and β-TCP. The most common 
methods utilize the nucleation of hydroxyapatite onto collagen scaffolds, which closely 
mimics the natural mineral deposition in vivo. In general, scaffolds incorporating nano-
HAp and other mineral gradients appear to result in superior interface mechanical 
properties as well as enhance the selective cellular response within the constructs. Although 
there is some debate on whether nanoscale or microscale minerals are superior for 
interfacial constructs, nanomaterials certainly show promise for the field. Additionally, 
further developments in the newly emerging nanoparticle materials have the potential to 
advance the interfacial tissue engineering field. These emerging nanomaterials provide new 
methods to produce gradient scaffolds (e.g., using magnetic fields) and fluorescent 
nanoparticles additionally provide a new method to evaluate the constructs in vivo.  
 
NANOFIBERS 
Nanofibers are another promising nanomaterial used in interfacial tissue 
engineering due to their high surface-to-volume ratio and their ability to mimic the fibrous 
organization of the ECM.118 Nanofibers possess unique mechanical properties whereby the 
tensile modulus, shear modulus, and tensile strength have shown the capacity to increase 
as the diameter of the nanofiber decreases.16, 153 These properties are especially useful to 
the bone-tendon/ligament interface, where the native mechanical loading transitions from 
primarily compressive in bone to tensile loading. Three common methods to produce 
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nanofibers are self-assembly, electrospinning, and phase separation. Additionally, the 
materials that constitute these nanofibers in interfacial tissue engineering are primarily 
collagen and synthetic polymers. Thus, the following sections will discuss the collagen and 
synthetic nanofibers for interfacial tissue applications and each section will discuss how 
the materials are incorporated. 
 
Collagen Nanofibers 
As the most common bodily protein, accounting for 30% of all proteins in the body, 
and giving rise to the structural support and tensile strength of the native ECM,61 collagen 
is the most commonly employed nanofibrous material in interfacial tissue engineering. 
Collagen I is the most prevalent type of collagen in bone, while collagen II is more 
prevalent in hyaline cartilage. However, collagen I is primarily the only type of collagen 
currently being incorporated into interfacial constructs. Additionally, all publications 
currently employing collagen I nanofibers into their interfacial constructs use collagen self-
assembly to create the nanofibers.12, 39, 65-69, 130, 131 Cheng et al.12 encapsulated rabbit MSCs 
into collagen microspheres that were fabricated out of self-assembled collagen I 
nanofibers. The encapsulated microspheres were then either chondrogenically or 
osteogenically induced and the microspheres were brought together to form three layers, a 
chondrogenic and osteogenic layer, and an intermediate layer in between containing 
undifferentiated MSCs in collagen microspheres. Compared to biphasic control scaffolds 
that did not contain an intermediate layer, the triphasic scaffolds successfully formed a 
calcified cartilage layer.12 As previously mentioned in the HAp nanoparticle section, the 
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other group incorporating collagen nanofibers via self-assembly developed a tri-layered 
osteochondral scaffold, which consisted of a biomineralized collagen layer to mimic native 
subchondral bone, an intermediate layer composed of collagen and less mineral, and an 
upper layer composed of hyaluronic acid and collagen to mimic the articular cartilage.131 
This group went on to study a similar tri-layered scaffold in sheep, horses, and even in 
human clinical trials.66-69 
Synthetic Nanofibers 
Although natural material incorporation more closely mimics the native ECM of 
tissues, due to the ability to control degradation and tune mechanical properties,139 
synthetic nanofibers have additionally received a lot of attention in interfacial tissue 
engineering. Primarily synthetic nanofibers are made via electrospinning, however one 
interfacial tissue engineering strategy used phase separation to make nanofibers.132 
Through this phase separation technique, Tan et al.132 created nanofibrous scaffolds out of 
poly(l-lactic acid) (PLLA). The PLLA scaffolds supported the differentiation of human 
bone marrow stem cells along osteogenic or chondrogenic lineages when exposed to the 
respective growth signals.132  
As previously described, several studies have incorporated synthetic nanofibers 
with mineral-based nanoparticles, where the fibers were electrospun PCL, PLGA, or 
PDLLA.34-36, 74, 97, 103, 113, 157 Other electrospun interfacial constructs incorporate only the 
synthetic nanofiber itself.78, 126, 151 Xie et al.151 fabricated a unique “aligned-to-random” 
oriented nanofibrous scaffold by specifically designing a collector with varying electric 
fields. These scaffolds were created to mimic the change in collagen fiber orientation in 
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the bone-tendon insertion site. Tendon fibroblasts cultured on these scaffolds were 
observed to be aligned in the aligned fiber portion and were oriented more randomly in the 
random fiber portion. Although collagen II was not observed on any portion of the scaffolds 
after 7 days of culture, collagen I deposition was oriented in the direction of the nanofibers 
in the aligned portion of the scaffold and was randomly distributed in the random 
portion.151 Aside from electrospinning and phase separation, Liu et al.78 fabricated 
nanofibrous hollow microspheres via self-assembled star-shaped PLLA. These 
microspheres were designed to be injectable for cartilage and osteochondral defects, mimic 
the nanoscale topography of native ECM, and they were designed to be highly porous. In 
comparison to solid microspheres composed of the same material, the nanofibrous 
microspheres supported a significantly larger amount of cartilage regeneration in an ectopic 
model.78 
Alternative synthetic materials that have emerged are carbon nanofibers and 
nanorods.108 Rodrigues et al.136 tested both pure polyvinyl alcohol (PVA) hydrogels and 
carbon-reinforced hydrogels in osteochondral defects. The reinforced gels contained either 
carbon nanofibers or carbon nanorods. These carbon nanomaterials are desirable because 
they are light weight and possess high stiffness and axial strength.136 After 12 weeks of 
implantation, the carbon nanofiber-reinforced PVA accumulated the most calcium and 




Summary of Nanofibers 
Although self-assembled collagen fibers are the most commonly employed 
nanofiber for interfacial tissue engineering applications, other promising synthetic 
nanofiber materials are being explored, including carbon nanofibers. The unique 
mechanical properties as well as the ability to mimic the native ECM of interfacial tissues 
make these materials highly desirable for interfacial constructs. Specifically, 
electrospinning has been successfully used to spatially control the alignment of nanofibers, 
which resulted in a gradation in cellular alignment and ECM secretion. Overall, it appears 
nanofibers are used primarily in conjunction with nanoparticles and are used as a tool to 
create gradients in mineral content. Thus, nanofiber use may create gradients in mechanical 
properties and cellular responses that mimic native tissue interfaces. 
 
STRATEGIES INCORPORATING NANOMATERIALS IN HARD-SOFT 
TISSUE INTERFACES 
 
Though it is certainly important to consider types of nanomaterials to be used in 
interfacial tissue engineering, it is essential to consider the overall interfacial strategy used 
that employs these materials. As stated in the introduction, interfacial tissue engineering 
strategies as a whole are primarily stratified in nature. This trend certainly remains evident 
(Tables 2.1 and 2.2) in strategies that employ nanomaterials, where the majority of the 
strategies are stratified (i.e. biphasic or triphasic) or homogeneous (i.e. nanocomposite). 
The stratified approaches more closely mimic the native tissue components and/or 
structure, however, they may risk delamination between phases. The use of homogeneous 
constructs reduces the risk of delamination,47, 152 although homogeneous approaches lack 
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to regenerate the structural/functional anisotropy that exists in tissue interfaces. 
Consequently, continuous interfaces have received recent attention in the literature as they 
provide a more seamless transition between tissues.27 Continuous interfaces that employ 
nanomaterials are certainly a minority (Tables 2.1 and 2.2) as compared to the stratified 
and homogeneous approaches, although continuous approaches are more common in bone-
tendon/ligament interfaces. Interestingly, the main continuous approaches involve 
electrospinning techniques. However, Detamore and Berkland et al.28-30, 91, 122 have created 
continuous interfaces by loading a mold with opposing gradients of osteogenic and 
chondrogenic microspheres. Additionally, strategies that incorporate a continuous or 
stratified design primarily create a gradient of ceramic components. However, other 
gradient approaches exist, including gradients in fiber151 and cellular46 alignment. 
 
CONCLUSION AND FUTURE DIRECTIONS 
As the field of interfacial tissue engineering progresses, the underlying goal 
remains, which is to regenerate a structural and functional interface that transitions between 
two dissimilar tissues. This chapter has provided an overview of the structural and 
functional characteristics of the most widely explored tissue interfaces, specifically the 
osteochondral and bone-tendon/ligament interfaces. However, tissue engineering studies 
of other tissue interfaces (e.g., muscle-tendon interface) are beginning to emerge as well.71 
Highlighted in this chapter is the burgeoning integration of nanomaterial use in 
interfacial tissue engineering strategies. The nanomaterials currently being used in 
interfacial applications are nanoparticles and nanofibers. Interestingly, the most common 
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nanomaterials used in interfacial strategies are mineral-based nanoparticles and collagen 
nanofibers, which are components found in the native interfaces. This use of raw materials 
further emphasizes the potential of using raw materials in tissue engineering strategies.26 
However, nanomaterial use in general provides many benefits to interfacial strategies, 
including superior mechanical properties of the interface, and providing a more biomimetic 
environment.  
In addition to the type of nanomaterial employed, the overall strategy to regenerate 
the interface is crucial as well. As previously mentioned, interfacial strategies that employ 
nanomaterials are primarily stratified or homogeneous, although continuous gradient 
approaches are gaining attention in the field. Furthermore, it is important to note that 
although these strategies are defined as osteochondral or bone-tendon/ligament strategies, 
approaches from either interface can be tailored for the design of a desired interface. 
Because interface structure and function are both crucial entities for successful 
regeneration of interfaces, future successful interfacial designs will likely incorporate a 
strategy that mimics the gradient of natural interface as well as incorporate the nanoscale 
components of the interface. Thus, continuous gradients that incorporate gradients of 







CHAPTER 3: ENABLING SURGICAL PLACEMENT OF HYDROGELS 
THROUGH ACHIEVING PASTE-LIKE RHEOLOGICAL BEHAVIOR IN 




 Hydrogels are a promising class of materials for tissue regeneration, but they lack 
the ability to be molded into a defect site by a surgeon because hydrogel precursors are 
liquid solutions that are prone to leaking during placement. Therefore, although the main 
focus of hydrogel technology and developments are on hydrogels in their crosslinked form, 
our primary focus is on improving the fluid behavior of hydrogel precursor solutions. In 
this work, we introduce a method to achieve paste-like hydrogel precursor solutions by 
combining hyaluronic acid nanoparticles with traditional crosslinked hyaluronic acid 
hydrogels. Prior to crosslinking, the samples underwent rheological testing to assess yield 
stress and recovery using linear hyaluronic acid as a control. The experimental groups 
containing nanoparticles were the only solutions that exhibited a yield stress, 
demonstrating that the nanoparticulate rather than the linear form of hyaluronic acid was 
necessary to achieve paste-like behavior. Furthermore, the gels were photocrosslinked and 
further characterized as solids, where it was demonstrated that the inclusion of 
nanoparticles did not adversely affect the compressive modulus and that encapsulated bone 
marrow-derived mesenchymal stem cells remained viable. Overall, this nanoparticle-based 
approach provides a platform hydrogel system that exhibits a yield stress prior to 
                                               
†Published as Beck E.C., Lohman B.L., Tabakh D.B., Kieweg S.L., Gehrke S.H., Berkland C.J., and 
Detamore M.S., Enabling Surgical Placement of Hydrogels Through Achieving Paste-Like Rheological 
Behavior in Hydrogel Precursor Solutions, Annals of Biomedical Engineering, 1-8, 2015 (PMC4540702). 
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crosslinking, and can then be crosslinked into a hydrogel that is capable of encapsulating 
cells that remain viable. This behavior may hold significant impact for hydrogel 
applications where a paste-like behavior is desired in the hydrogel precursor solution. 
 
INTRODUCTION 
Hydrogels are a promising class of tissue regenerative materials because of their 
high water content, 3D structure, tunable mechanical properties, and their ability to be 
delivered in a minimally invasive manner.9, 23, 33 However, hydrogels lack the ability to be 
molded into a defect site by a surgeon because hydrogel precursors are liquid solutions that 
are prone to leaking after placement,110, 135 which confounds their ability to be used by 
surgeons in the clinic. Therefore, although the main focus of hydrogel technology and 
developments are on hydrogels in their crosslinked form, our primary focus is on the fluid 
behavior of hydrogel precursor solutions (i.e., the fluid behavior of the hydrogel prior to 
crosslinking). As an alternative to traditional hydrogels, colloidal gels are mechanically 
dynamic paste-like materials that can be easily molded into place and will ‘set’ after 
placement.147 Colloidal gels attain their cohesiveness through disruptable particle 
interactions and our research group has shown that these gels can successfully fill tissue 
defects, deliver bioactive signals, and promote new tissue formation in non-load bearing 
cranial defect applications.25, 144-146 Our recent work has shown that colloidal gels with 
shear-thinning rheological behavior can be made out of solutions of hyaluronic acid (HA) 
nanoparticles.37 These HA-based colloidal gels have the ability to fully recover after 
compression to high strains and after physically destroying and reassembling the gel, which 
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may be attractive for applications such as for cartilage regeneration.37 However, 
preliminary work demonstrated that these colloidal gels do not retain their integrity over 
time in culture. Therefore, we have created a platform system that combines the HA 
colloidal gels systems with traditional crosslinked HA hydrogels to form a hydrogel 
suitable for load-bearing applications that is paste-like prior to crosslinking for effective 
delivery in situ. Although other systems, including dermal fillers, employ HA particles 
with traditional crosslinked HA hydrogels,51-55, 111, 134 or use alternate means to induce a set 
strength in injectable materials,32, 81 our HA nanoparticles (HAnp) are fabricated with a 
specific molecular weight (MW) designed to achieve paste-like rheological behavior and a 
yield stress and they have never before been encapsulated within crosslinked HA 
hydrogels.37 This yield stress is especially desirable to enable a surgeon to mold the 
material into the defect site without the concern that the material will flow or leak from the 
defect, which is the main concern for traditional hydrogel precursor solutions. The HAnp 
will additionally allow the surgeon to mold the hydrogel precursor solution to obtain 
appropriate contouring of the defect site, which in some cases may not be possible with 
traditional hydrogel precursor solutions. Therefore, combining these HAnp with traditional 
crosslinked HA hydrogels may allow the material to be implanted in situ with appropriate 
placement and contouring, and the precursor solution can then be crosslinked to form a 
more rigid structure. Thus, the primary objective of this work was to characterize the 
rheological behavior of HAnp-incorporated hydrogel precursor solutions. An additional 
objective was to ensure that HAnp did not negatively influence the mechanics or 
cytocompatibility of the hydrogel after crosslinking.  
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MATERIALS AND METHODS 
Materials  
Unless otherwise stated, all materials were purchased from Sigma-Aldrich (St. 
Louis, MO). EDC (1-Ethyl-3-[3-dimethylaminopropyl]carbodiimide hydrochloride) was 
purchased from Thermo Scientific (Rockford, IL). HA (16 kDa and 1 MDa) was purchased 
from Lifecore Biomedical (Chaska, MN). All cell culture materials were purchased from 
Invitrogen (Grand Island, NY). 
 
Synthesis and Characterization of Methacrylated HA (MeHA) and HAnp 
MeHA was prepared by reacting HA (MW 1 MDa) with 20-fold molar excess 
glycidyl methacrylate (e.g., 20 mol glycidyl methacrylate per 1 mol HA monomer) in the 
presence of 20-fold molar excess triethylamine and tetrabutyl ammonium bromide for 12 
days stirring in a 50:50 water:acetone solution at 200 rpm. MeHA was then dialyzed against 
deionized (DI) water for 2 days and was then frozen and lyophilized. The degree of 
methacrylation was analyzed with 1H NMR (Avance AV-III 500, Bruker) by calculating 
the ratio of the relative peak area of methacrylate protons to methyl protons.63 HAnp were 
prepared using carbodiimide crosslinking chemistry using EDC with adipic acid 
dihydrazide (AAD) as the crosslinker.37 Briefly, 300 mg HA (16 kDa) was dissolved in 
120 mL DI water in a 500 mL round flask stirring at 300 rpm. Then, 200 mL acetone was 
added to the flask and stirred for 15 min. AAD (60 mg) was dissolved in 1 mL DI water 
and added to the flask for 10 min. Similarly, 140 mg EDC was dissolved in 1 mL DI water 
and added to the flask for 20 min. Another 200mL acetone was then added to the flask and 
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the reaction was allowed to stir for 3 hours. The solution was then dialyzed against DI 
water for 2 days and the particles were frozen and lyophilized. Repeated batches of HAnp 
were fabricated in this manner and combined for later testing. Particle size was measured 
using a ZetaPALS dynamic light scattering instrument (Brookhaven, USA). Particle 
morphology was examined with Scanning Transmission Electron Microscopy (STEM) 
images using a FEI Technai G2 transmission electron microscope at 200 kV.  
 
Preparation of Colloidal Gels 
Gels were made by mixing varying weight percents of HA (i.e., MeHA and HAnp) 
in 0.01M phosphate buffered saline (PBS) containing 0.05% (w/v) Irgacure (I-2959) 
photoinitiator (e.g., 15% HAnp = 15 mg HAnp in 100 µL PBS). Additionally, linear HA 
(HAlin) at 16 kDa (i.e., the same MW used to make the HAnp) was mixed with MeHA as 
a control to discern whether yield stress differences were due to the HA being in the 
nanoparticulate form or due to the mere addition of extra HA.  
 
Rheological Testing 
Prior to crosslinking the hydrogels, the shear stress of the precursor solutions (n=5) 
were measured over a shear rate sweep of 1-100 s-1 using an AR-2000 rheometer (TA 
Instruments, New Castle, DE) equipped with a 20 mm diameter plate at 37 °C at a gap of 
500 µm. Preliminary work suggested that a 15% HAnp solution was sufficient to obtain a 
yield stress, and 4% MeHA was chosen because it was at the reconstitution limit of MeHA. 
Formulations tested were 4% MeHA, 15% HAlin, 4% MeHA + 15% HAlin, 30% HAlin, 
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4% MeHA + 30% HAlin, 15% HAnp, 4% MeHA + 15% HAnp, 30% HAnp, and 4% 
MeHA + 30% HAnp. The yield stresses of solutions were calculated using a three 
parameter fitting technique in MATLAB (MathWorks, Natick, MA) to fit the data to the 
Herschel-Bulkley equation (Equation 3.1), where  is the shear stress, is the yield stress, 
 is the consistency index,  is the shear rate, and n is the flow behavior index. 
 
n (Equation 3.1) 
Oscillatory tests were performed first by doing a stress sweep at 1 Hz to determine 
the linear viscoelastic region of the solutions. Solutions (n=5) were then exposed to three 
phases of oscillatory shearing at 1 Hz: 5 minutes at a constant shear stress of 10 Pa (i.e., 
within the linear viscoelastic region of the pseudoplastic solutions), a disruption phase 
lasting 30 seconds at a constant shear stress of 1000 Pa (i.e., sheared above the yield stress), 
and another 5 minutes at a constant shear stress of 10 Pa.  
 
Characterization of Crosslinked Hydrogels 
Gel solutions of experimental groups containing 4% MeHA were placed in a 2 mm 
thick mold between glass slides and exposed to 312 nm UV light at 3.0 mW/cm2 
(Spectrolinker XL-100; Spectronics Corp.) for 15 min on each side. Gels were cut using a 
3 mm biopsy punch. To calculate the swelling degree, gels were swollen in PBS for 24 
hours and then weighed and lyophilized (n=6). The dry weight was recorded after 
lyophilization and the swelling ratio (Q) was calculated as the ratio of total wet mass to dry 
mass. To obtain the compressive modulus, gels were swollen in PBS for 24 hours or two 
weeks (n=6) and were compressed using a RSA-III dynamic mechanical analyzer (TA 
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Instruments) at a rate of 0.005 mm/s until mechanical failure and the elastic modulus was 
calculated as the slope under the linear portion of the stress-strain curve. 
 
Cell Viability 
Rat Bone Marrow-Derived Mesenchymal Stem Cells (rBMSCs) were harvested 
from the femurs of male Sprague-Dawley rats (200-250g) following an approved 
University of Kansas IACUC protocol. The rBMSCs were cultured in monolayer until 
passage 4 for cell seeding. Media consisted of low glucose Dulbecco’s Modified Eagle’s 
Medium, 10% Qualified Fetal Bovine Serum, 1% Antibiotic-Antimycotic and was replaced 
every other day throughout culture. For encapsulation, cells were suspended in the 
photoinitiator solution at a cell density of 10 million cells mL-1 and then mixed with either 
4% MeHA or 4% MeHA + 15% HAnp. Hydrogels were then fabricated using the same 
previously described technique to make acellular gels. After 4 weeks of culture, the gels 
were stained with live/dead reagent (2 mM calcein AM, 4 mM ethidium homo-dimer-1; 
Molecular Probes), incubated for 20 min, and then analyzed using fluorescence microscopy 
on a Zeiss Axio Observer A1 (Carl Zeiss, Oberkochen, Germany). 
 
Statistics 
SPSS statistical software was used to compare experimental groups using a single-
factor ANOVA followed by a Tukey’s post hoc test, where p ≤ 0.05 was considered 
significant. In addition, SPSS was used to construct standard box plots to eliminate outliers 
for compression testing. After outlier removal, n=5-6 samples for statistical analysis.  
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RESULTS 
Macroscopic Observation of Hydrogel Formulations 
When HAnp (average diameter = 246 nm) were mixed with MeHA (degree of 
methacrylation = 21%), non-Newtonian paste-like behavior with shape-retention were 
observed (Figure 3.1A-C). In contrast, solutions composed of pure MeHA or MeHA 
solutions containing HAlin did not exhibit this behavior, and instead exhibited Newtonian 
or zero yield stress pseudoplastic behavior. STEM images of HAnp confirmed the 
formation of nanoparticles (Figure 3.1D). 
 
Yield Stress Evaluation of Hydrogel Formulations Prior to Crosslinking 
The experimental groups containing HAnp were the only solutions that exhibited a 
yield stress (Figure 3.2A-C). Although the yield stress of the 15% HAnp gels was 177 ± 
31 Pa (average ± standard deviation), this yield stress was not found to be significantly 
different from the linear HA groups. However, solutions that contained unreacted HAlin 
polymer instead of HAnp did not exhibit a yield stress even though they were fit to 
Equation 3.1. The combination of 4% MeHA with 15% HAnp produced a synergistic 
effect, increasing the yield stress of the HAnp by a factor of 3.4 with the addition of the 
MeHA (p < 0.001). 
 
Rheological Recovery of Hydrogel Formulations Prior to Crosslinking 
The storage modulus of solutions lacking HAnp was negligible (i.e., all storage 
moduli were less than 20 Pa), but the storage modulus increased with increasing HAnp 
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concentration (Figure 3.2D). Specifically, compared to the storage modulus of 4% MeHA, 
the storage moduli of 4% MeHA increased 380- and 770- fold with the addition of either 
15% HAnp or 30% HAnp, respectively (p<0.001). Recovery was assessed by the restoring 
of the original storage modulus after the disruption phase. All samples containing HAnp 
recovered their original storage moduli within 5 min of disruption.  
 
Mechanical Analysis of Gels After Crosslinking 
After characterizing the rheological behavior of the gels prior to crosslinking in 
their precursor solution form, the gels were crosslinked with ultraviolet (UV) light and 
further characterized as solids. Preliminary tests revealed that crosslinked MeHA was 
necessary to obtain gels with stable integrity over time in a 37oC saline environment, 
therefore only gels containing MeHA were characterized after crosslinking. It should first 
be noted that gels containing 4% MeHA and either 15% HAlin or 30% HAlin were tested 
to compare with the associated HAnp gels, however, the mixtures containing 30% HAlin 
remained as solutions after crosslinking, rendering it impossible to cut gels for further 
testing, so the 30% HAlin mixtures were therefore discarded from further analysis. 
Although the addition of HAnp concentration resulted in at least a 5-fold increase in the 
compressive modulus compared to 4% MeHA gels, the increase was not significant. 
However, the addition of HAnp did significantly decrease the swelling degree after one 
day of swelling from 57 for 4% MeHA gels to 25 and 19 with the addition of 15% HAnp 
and 30% HAnp, respectively (p<0.001) (Figure 3.3A-B). After 14 days of swelling, the 
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compressive moduli of the MeHA + HAnp gels decreased to a range where they were not 
significantly different from that of 4% MeHA gels after one day of swelling. 
 
Cell Viability of Cells Encapsulated within Crosslinked Gel Networks 
Due to autofluorescence of the HAnp gels, live/dead quantification could not be 
performed. However, after 4 weeks, rBMSCs encapsulated in the MeHA and HAnp 
networks were viable as indicated by green fluorescence and minimal cell death (i.e., red 
fluorescence) was observed (Figure 3.3C-D).  
 
DISCUSSION  
In this work, we have introduced a method to overcome one of the major drawbacks 
of using hydrogels in the clinic (i.e., leaking from the defect site) by modifying traditional 
crosslinked hydrogels with the inclusion of HAnp. The combination of MeHA mixed with 
HAnp resulted in a hydrogel that exhibited ‘paste-like’ rheological behavior in its precursor 
solution. Although the underlying mechanism for the resulting paste-like behavior 
associated with the inclusion of HAnp is currently unknown, it has been hypothesized to 
be a result of dangling HA chains on the surface of the HAnp.38 These dangling chains are 
hypothesized to cause physical entanglements between individual HAnp and 
entanglements between HAnp and MeHA. The goal of this current experimental work was 
to first characterize the rheological effect of adding our unique HAnp to MeHA and 
therefore, further research is necessary to understand the mechanism for the induced paste-
like behavior of incorporating HAnp into hydrogel precursor solutions. 
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This desired paste-like behavior is attributed to the yield stress. The yield stress 
denotes the threshold where the solution transitions between an elastic solid and a 
pseudoplastic liquid, and it is desirable because it will prevent the hydrogel from flowing 
away from the site of interest. In a surgical context, this translates to allowing appropriate 
shaping and contouring to the defect site of interest. Yield stresses of up to 62 Pa have been 
previously reported for HA-based solutions,101 but this yield stress may not be sufficient 
for topical application. In the current study, we demonstrated the ability to obtain solutions 
with yield stresses over 700 Pa. For context, the yield stresses for common paste-like 
materials, such as toothpaste, are approximately 200 Pa. Because the only solutions 
exhibiting a yield stress were solutions that incorporated HAnp, the yield stress was 
attributed to the HA being in the nanoparticulate form, as the addition of HA that was the 
same MW but was linear instead of in nanoparticle form was insufficient for achieving a 
yield stress. Furthermore, the combination of 4% MeHA with 15% HAnp produced a 
synergistic effect upon the yield stress. It should be noted that the 4% MeHA with 15% 
HAnp solution is a 19% overall concentration compared to the 15% HAnp solution, but 
this small increase in concentration is not assumed to account for the 3.4-fold increase in 
yield stress when 4% MeHA and 15% HAnp were combined. Additionally, preliminary 
work using a lower MW MeHA (16 kDa) did not result in this synergistic effect seen with 
the 1 MDa MeHA,4 suggesting the synergistic effect is MW dependent. Results suggest a 
desirable yield stress can be obtained for various applications by modulating the 
concentration of HAnp and the concentration and MW of MeHA, and future work will 
focus on creating a model to predict the yield stress based on these components. 
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In addition to exhibiting a yield stress, it is desirable for injectable materials to be 
able to recover rapidly after shearing.93 All samples containing HAnp recovered their 
original storage moduli within 5 min of disruption. Additionally, in contrast to the yield 
stress, which was dependent upon the presence of MeHA and concentration of HAnp, the 
storage modulus was dependent only on the concentration of HAnp, regardless of the 
presence of MeHA. Overall, because HAnp gels exhibit a yield stress and recover rapidly, 
including HAnp in a gel network may allow for precise molding without the risk of material 
leaking from an implantation site (Figure 3.4), making these gels suitable for a variety of 
topical and minimally invasive applications. 
After appropriate shaping and contouring of these hydrogel pastes, it is important 
for the pastes to set up to form a rigid hydrogel network, thus emphasizing the importance 
of incorporating MeHA in the gel precursor solutions. Although the HAnp-incorporated 
solutions exhibited the desirable yield stress and recovery after shearing, HAnp networks 
alone disintegrated rapidly in solution without the addition of MeHA. Therefore, we further 
characterized our MeHA-containing experimental groups as solids after photocrosslinking. 
The standard deviations of the compressive moduli for gels containing 15% HAlin were 
much larger than that of the other gels, including gels containing 15% or higher HAnp, 
which suggests that the mechanical properties of MeHA gels are better controlled with HA 
when it is in the nanoparticle form rather than in the linear form. Although the incorporation 
of HAnp did not have a significant effect on the compressive modulus after 1 day of 
swelling, after 14 days of swelling, the compressive moduli of the HAnp gels decreased to 
a range where they were not significant from that of 4% MeHA gels after one day of 
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swelling. This decrease in the mean values of moduli for the HAnp groups may alert us to 
the possibility that the HAnp network may be short-lived, although it should be noted that 
the 4% MeHA gels were disintegrated at two weeks, while the presence of HAnp kept the 
gels intact. In these particular gels, the HAnp are only physically entrapped in the system, 
so it is possible that chemically crosslinking the HAnp into the system may preserve and 
increase the mechanical properties if desirable. Furthermore, although the HAnp network 
may be short lived, the entire purpose of adding these HAnp into traditional hydrogel 
precursor solutions is to allow for the precursor solution to achieve paste-like rheological 
behavior, which is only necessary up until the point of crosslinking the solution. After 
crosslinking, the paste-like rheology is irrelevant to the network, given that we have shown 
we do not significantly alter the mechanical properties of the HAnp-incorporated hydrogels 
in their final crosslinked form.     
Finally, rBMSCs encapsulated in these HAnp networks were viable at 4 weeks, 
which suggests that minimal cytotoxicity is feasible for HAnp-incorporated networks. 
Furthermore, the 4% MeHA gels with cells remained integrated at 4 weeks, suggesting that 
the inclusion of cells may be beneficial to the network given the disintegration of acellular 
4% MeHA gels within 2 weeks, although it is unknown at this time whether cells were 
maintaining this network through attachments to the material or through ECM secretion. 
Although it does appear that there was some cell death in the HAnp networks, due to 
autofluorescence, the extent of cellular death could not be quantified. However, the goal of 
cell encapsulation for this study was to show that cells could remain viable in these 
networks, and future work will in addition consider biochemical content and gene 
 36 
expression of encapsulated cells to further characterize cellular viability and performance. 
Additionally, because it is likely that these materials will be crosslinked in situ, future in 
vivo work with these materials will evaluate the toxicity of UV light to surrounding tissues. 
However, UV photocrosslinking has already been successfully performed in situ without 
toxicity concerns associated with UV light.95      
 
CONCLUSION 
Overall, the present work provides a platform hydrogel system that exhibits a yield 
stress prior to crosslinking, can recover its network rapidly, and can then be crosslinked 
into a more rigid hydrogel that is capable of encapsulating cells that remain viable. This 
behavior holds significant impact for any application of a hydrogel where a paste-like 
behavior is desired for its precursor solution, including but not limited to healthcare 
applications. As an example, for applications that cannot tolerate a liquid draining away 
from an irregularly shaped defect, or spilling from any kind of container at an angle to the 
direction of gravity, a Herschel-Bulkley or ‘paste-like’ rheology enables placement of the 
material prior to crosslinking. The yield stress in this platform system can be tailored by 
modulating the HAnp and MeHA MW and concentration. Furthermore, the MW of MeHA 
can be adjusted to result in crosslinked hydrogels of desirable mechanical properties, or 
alternately the HAnp can be crosslinked into the system. Additionally, the current study 
employed this system comprised of HA, however this platform hydrogel technology may 
perhaps be fabricated from other various polymers or biopolymers to suit a variety of 
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CHAPTER 4: CHONDROINDUCTION FROM NATURALLY-DERIVED 
CARTILAGE MATRIX: A COMPARISON BETWEEN DEVITALIZED AND 
DECELLULARIZED CARTILAGE ENCAPSULATED IN HYDROGEL PASTES‡ 
 
ABSTRACT 
Hydrogel precursors are liquid solutions that are prone to leaking after surgical 
placement. This problem was overcome by incorporating either decellularized cartilage 
(DCC) or devitalized cartilage (DVC) microparticles into traditional photocrosslinkable 
hydrogel precursors in an effort to achieve a paste-like hydrogel precursor. DCC and DVC 
were selected specifically for their potential to induce chondrogenesis of stem cells, given 
that materials that are chondroinductive on their own without growth factors are a 
revolutionary goal in orthopedic medicine. We hypothesized that DVC, lacking the 
additional chemical processing steps in DCC to remove cell content, would lead to a more 
chondroinductive hydrogel with rat bone marrow-derived mesenchymal stem cells. 
Hydrogels composed of methacrylated hyaluronic acid and either DCC or DVC 
microparticles were tested with and without exposure to transforming growth factor (TGF)-
β3 over a 6 week culture period, where swelling, mechanical analysis, and gene expression 
were observed. For collagen II, Sox-9, and aggrecan expression, MeHA precursors 
containing DVC consistently outperformed the DCC-containing groups, even when the 
DCC groups were exposed to TGF-β3. DVC consistently outperformed all TGF-β3-exposed 
                                               
‡To be submitted as Beck E.C., Barragan M., Libeer T.B., Kieweg S.L., Converse, G.L., Hopkins, R.A., 
Berkland C.J., and Detamore M.S., Chondroinduction from Naturally-Derived Cartilage Matrix: A 
Comparison Between Devitalized and Decellularized Cartilage Encapsulated in Hydrogel Pastes, 
Biomaterials, 2015. 
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groups in aggrecan and collagen II gene expression as well. Additionally, when the same 
concentrations of MeHA with DCC or DVC microparticles were evaluated for yield stress, 
the yield stress with the DVC microparticles was 2.7 times greater. Furthermore, the only 
MeHA-containing group that exhibited shape retention was the group containing DVC 
microparticles. DVC appeared to be superior to DCC in both chondroinductivity and 
rheological performance of hydrogel precursors, and therefore DVC microparticles may 
hold translational potential for cartilage regeneration. 
 
INTRODUCTION 
Traditional hydrogels are a promising class of regenerative materials for cartilage 
regeneration, but they lack the ability to be molded into a defect site by a surgeon because 
hydrogel precursors are liquid solutions that are prone to leaking after placement.110, 135 To 
overcome this drawback, we recently introduced a method to achieve paste-like hydrogel 
precursor solutions by combining hyaluronic acid nanoparticles with traditional 
crosslinked hyaluronic acid hydrogels, where the paste-like behavior was induced by the 
presence of the hyaluronic acid nanoparticles.5 These hyaluronic acid formulations were 
then crosslinked to form a rigid traditional hydrogel structure. In an effort to introduce 
bioactivity to the material, in the current study we substituted the hyaluronic acid 
nanoparticles for particles made from naturally derived cartilage extracellular matrix 
(ECM). 
 ECM-based materials are attractive for regenerative medicine because of their 
ability to potentially aid in stem cell recruitment, infiltration, and differentiation without 
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supplementing with additional biological factors.6, 10, 104 These ECM materials can be 
obtained from cell-derived matrices secreted during in vitro culture or from native tissue,6, 
11, 13, 22, 116, 156 and they have either been decellularized to remove cellular components and 
nucleic acids or they have been devitalized to kill but not necessarily remove cells within 
the matrix.129 We and other groups have already established that cartilage matrix has 
chondroinductive potential,11, 15, 41, 73, 115, 128 and we recently were the first to compare the 
chondroinductive potential of devitalized cartilage (DVC) with decellularized cartilage 
(DCC) in pellet culture,128 where we observed that rat bone marrow stem cells (rBMSCs) 
exposed to DCC outperformed those cells exposed to DVC or TGF-β3 in 
chondroinductivity.128 However, gene expression was only observed over a period of 7 
days and was only monitored for cells in pellet culture and not within a 3D scaffold.  
 Although it is widely emphasized that for ECM-based tissues in general, improper 
decellularization can result in detrimental inflammatory responses and hinder tissue 
regeneration,59 cartilage matrix is uniquely immunoprivileged in part because cartilage 
matrix is so dense that it protects chondrocytes from T and natural killer cells that are 
released in graft rejection.105 Regarding immune response of allogeneic cartilage matrix, 
the success of Zimmer’s DeNovo® product supports the potential for DVC, as DeNovo® 
relies on juvenile human cartilage donation with living chondrocytes. Therefore, for some 
cartilage tissue applications, this success with a technology that includes cells brings up 
the question of whether or not decellularization is even necessary. Although the goal of 
decellularization is to remove all of the cells without destroying the structure and 
composition of the ECM, all decellularization processes inevitably cause some disruption 
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to the matrix architecture, orientation, and surface landscape,60 which may ultimately limit 
or hinder the chondroinductive potential of the matrix, especially if the decellularization 
removes or alters the bioactive molecules that are responsible inducing chondrogenesis.  
 Therefore, because the long-term chondroinductive potential of DCC and DVC has 
yet to be explored, the objective of this current work was to compare the chondroinductivity 
of DVC versus DCC in MeHA hydrogel pastes for 6 weeks in vitro. Additionally, another 
objective was to observe how DVC and DCC affected the rheology of the hydrogel 
precursors. We hypothesized that a paste-like material composed of DVC would induce 
superior chondrogenesis compared to DCC and compared to hydrogels exposed to TGF-β3 
or the combination of DCC and TGF-β3 over the 6 week period. 
 
MATERIALS AND METHODS 
Synthesis and Characterization of Methacrylated Hyaluronic Acid (MeHA) 
MeHA was prepared by reacting hyaluronic acid (MW 1 MDa, Lifecore 
Biomedical, Chaska, MN) with 20 fold molar excess glycidyl methacrylate (Sigma-
Aldrich, St. Louis, MO) in the presence of triethylamine and tetrabutyl ammonium bromide 
(Sigma-Aldrich) in a 50:50 water:acetone mixture stirring at 200 rpm for 12 days. MeHA 
was then dialyzed against deionized (DI) water for two days and then frozen at -80 °C and 
lyophilized. The degree of methacrylation was determined using 1H NMR (Avance AV-III 




Tissue Retrieval, Devitalization, and Decellularization  
 Ten porcine knees obtained from Berkshire hogs (castrated males that were 
approximately 7-8 months old and 120 kg) were purchased from a local abattoir 
(Bichelmeyer Meats, Kansas City, KS). Articular cartilage from both the knee and hip 
joints was carefully removed and collected with a scalpel. The cartilage was rinsed twice 
in DI water and stored at -20 ºC. After freezing overnight, the cartilage was thawed and 
then coarsely cryoground with dry ice pellets using a cryogenic tissue grinder (BioSpec 
Products, Bartlesville, OK). The dry ice was allowed to sublime overnight in the freezer 
and at this point all of the cartilage was devitalized due to undergoing the freeze/thaw 
processes. Some of the DVC was saved for the study and the rest was processed to make 
DCC. To decellularize the cartilage, the coarse ground cartilage was packed into dialysis 
tubing (3500 MWCO) and decellularized using an adapted version of our previously 
established method using osmotic shock, detergent, and enzymatic washes.20 The packets 
were placed in a hypertonic salt solution (HSS) overnight at room temperature under gentle 
agitation (70 rpm). The packets were then subjected to 220 rpm agitation with two 
reciprocating washes, encompassing triton X-100 (0.01% v/v) followed with HSS, to 
permeabilize intact cellular membranes. The tissue was then treated overnight with 
benzonase (0.0625 KU ml-1) at 37 ºC and then the tissue was treated with sodium-
lauroylsarcosine (NLS, 1% v/v) overnight to further lyse cells and denature cellular 
proteins. After NLS exposure, the tissue was washed with ethanol (40% v/v) at 50 rpm and 
then was subjected to organic exchange resins to extract the organic solvents at 65 rpm. 
The tissue was then washed in saline-mannitol solution at 50 rpm followed by two hours 
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of rinsing with DI water at 220 rpm. The tissue was then removed from the packets and 
was then frozen and lyophilized. Both the DVC and DCC were then further cryoground 
into a fine powder with a freezer-mill (SPEX SamplePrep, Metuchen, NJ) and then 
lyophilized. The DCC and DVC powders were filtered using a 45 µm mesh (ThermoFisher 
Scientific, Waltham, MA) to remove large particles and then frozen until use.  
 
Scanning Electron Microscopy 
 DCC and DVC microparticles were sputter coated with gold and imaged with a 
Versa 3D Dual Beam (FEI, Hillsboro, OR) to observe their surface morphology and size. 
 
Rat Bone Marrow Stem Cell Harvest and Culture 
Rat bone marrow stem cells (rBMSCs) were harvested from the femurs of three 
male Sprague-Dawley rats (200-250 g) following an approved IACUC protocol at the 
University of Kansas. The rBMSCs were first harvested in minimum essential medium-α 
(MEM-α, ThermoFisher) with 10% fetal bovine serum (FBS, MSC qualified, 
ThermoFisher) and 1% antibiotic-antimycotic (ThermoFisher) and then cultured in this 
medium for 1 week to ensure no mycotic contamination from harvesting. The rBMSCs 
were then cultured in MEM-α supplemented with 10% FBS and 1% 
penicillin/streptomycin (ThermoFisher) until the cells reached passage 4 for cell 
encapsulation into the hydrogels. 
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Description of Experimental Groups 
 The four formulations tested for the cell-based analyses using crosslinked 
hydrogels were 3% (by weight) MeHA, 3% MeHA + 5% DCC, 3% MeHA + 10% DCC, 
and 3% MeHA + 10% DVC. Because native extracellular matrix is incorporated into the 
pastes, acellular formulations of the same four groups were prepared and analyzed with the 
cellular groups to quantify the acellular biochemical content and to analyze the effect of 
cells encapsulated in the networks. The 10% concentration was chosen for DCC and DVC 
because it was the percentage that yielded a moderate yield stress (e.g., 100 Pa) without 
affecting the ability to crosslink the paste when exposed to UV light. Both the MeHA and 
MeHA + 10% DCC groups were tested with and without exposure to 10 ng/mL human 
transforming growth factor-β3 (TGF-β3, PeproTech Inc., Rocky Hill, NJ). For the 
rheological testing prior to crosslinking, additional groups of 2.5% DCC, 5% DCC, and 
10% DCC, all of which did not contain MeHA, were tested. DCC and DVC alone cannot 
be crosslinked into a hydrogel network, which is why these three DCC groups were only 
tested rheologically. 
 
Preparation of Hydrogel Pastes, Cell Encapsulation, and Hydrogel Culture 
Conditions 
 Hydrogel pastes were made first by measuring out the desired weight percents of 
MeHA, DVC, or DCC into a mini-centrifuge tube. All materials for cellular analyses were 
then sterilized with ethylene oxide prior to use and were handled under sterile conditions 
thereafter. All gels were mixed in two stages (e.g., in photoinitiator solution overnight and 
then more photoinitiator or cell suspension the day of testing) because some of the samples 
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required mixing with cells and the time it took for MeHA to dissolve to ensure mixture 
homogeneity (i.e., overnight) was deemed too long for adequate cell survival. Therefore, 
cell mixtures were added the next day after the MeHA was given a chance to dissolve in 
half of the final solution. For acellular rheological testing, sterile 0.01M PBS containing 
0.05% (w/v) Irgacure (I-2959) photoinitiator was added until the concentration of MeHA 
and DCC was twice the desired concentration. The samples were mixed, centrifuged, and 
placed in 4 ºC overnight to allow time for the MeHA to dissolve. Prior to testing, more 
photoinitiator solution was added until the desired concentration was reached and the 
samples were again mixed and centrifuged to remove air bubbles. For example, to make a 
3% MeHA solution, 12 mg MeHA and 200 µL photoinitiator solution were mixed and 
allowed to dissolve overnight and then another 200 µL photoinitiator solution was added 
to make the final concentration at 3% MeHA. For cellular testing, the samples were mixed 
with 0.1% (w/v) Irgacure photoinitiator in PBS until the concentration of MeHA and DCC 
was twice the desired final concentration, and then the solutions were centrifuged and 
stored at 4 ºC overnight. Passage 4 rBMSCs were then suspended at 20 million cells/mL 
in incomplete chondrogenic medium consisting of high glucose DMEM (ThermoFisher) 
with 4.5 g/L D-glucose supplemented with 10% FBS, 1% non-essential amino acids, 1% 
sodium pyruvate, 50 μg/mL ascorbic acid, and 0.25 mg/mL penicillin/streptomycin. This 
cell solution was then added to the hydrogel paste solutions until the desired concentration 
of MeHA and DCC or DVC was reached and the final cell concentration and photoinitiator 
concentrations were 10 million cells/mL and 0.05%, respectively. The solutions were then 
either tested rheologically or crosslinked with UV light and further characterized as solids. 
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For gels undergoing crosslinking, hydrogel precursor pastes were loaded into 2 mm thick 
molds between glass slides and exposed to 312 nm UV light at 3.0 mW/cm2 in a UV 
crosslinker (Spectrolinker XL-100, Spectronics Corporation, Westbury, NY) for 2.5 min 
on each side. Each gel was then cut using a 4 mm biopsy punch and placed in one well of 
a 24 well, non-tissue culture-treated plate (Corning Incorporated, Corning, NY). Each gel 
was exposed to 1 mL of incomplete chondrogenic medium or 1 mL of complete 
chondrogenic medium, which consisted of incomplete chondrogenic medium plus 0.1 
mg/mL dexamethasone and 10 ng/mL TGF-β3. The medium was replaced every other day 
throughout the 6 weeks of culture. 
 
Rheological Testing of Hydrogel Precursors 
 Prior to crosslinking the hydrogels, the precursor solutions were loaded into a 3 mL 
syringe and extruded onto a glass slide to macroscopically observe shape retention. The 
gels were extruded in a wavy line appearance to observe whether the formulations 
maintained their shape after crosslinking. 
Using an AR-2000 rheometer (TA instruments, New Castle, DE), the oscillatory 
shear stress of the precursor solutions (n=5) was measured over an oscillatory shear stress 
sweep of 1-600 Pa at 37 ºC, where the rheometer was equipped with a 20 mm diameter 
roughened plate and a roughened Peltier plate cover using a gap of 500 µm. Frozen 
rBMSCs that were thawed and cultured to passage 4 were used to make cellular samples 
for rheological testing. The pastes were then created as previously mentioned for in vitro 
culture. The yield stress was interpolated from the oscillatory stress at which the storage 
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(G’) and loss (G’’) modulus crossed.142 An oscillatory shear stress sweep of 0.1-10 Pa was 
performed to assess the linear viscoelastic region of the solutions to determine the value of 
the storage modulus of each solution. 
  
Mechanical Testing of Crosslinked Hydrogels  
 The gels were allowed to swell to equilibrium for 1 day in either complete or 
incomplete chondrogenic medium and mechanical testing was performed at 1 day and 6 
weeks. The geometric mean diameter of the gels were first determined using forceps and a 
stereomicroscope (20x magnification) and the height of each gel was measured directly 
with a RSA-III dynamic mechanical analyzer (DMA, TA instruments, New Castle, DE). 
The gels (n=5) were compressed on the DMA at a rate of 0.01 mm/s until mechanical 
failure and the modulus was calculated as the slope under the linear portion of the stress-
strain curve (i.e., 0-10% strain).  
 
Swelling Degree and Volume 
 To calculate the swelling degree, the swollen gels (swollen to equilibrium) were 
weighed after 1 day of swelling and then frozen and lyophilized. The dry weight was 
recorded after lyophilization and the swelling degree was calculated as the ratio of total 
wet mass to dry mass. The volume of the gels was recorded at 1 day and after 6 weeks of 
culture and was calculated from the diameter and height of the gels recorded during 
mechanical testing.  
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Biochemical Content Analysis 
 The biochemical content of the MeHA, DVC, and DCC and the biochemical 
content of the gels at 1 day, 3 weeks, and 6 weeks were quantified (n=5). The gels were 
digested overnight in a 1.5 mL papain mixture consisting of 125 mg/mL papain from 
papaya latex), 5 mM N-acetyl cysteine, 5 mM EDTA, and 100 mM potassium phosphate 
buffered saline at 65 ºC. Because some gels remained undigested, the remaining undigested 
gels were removed from the digestion medium and redigested overnight at 37 ºC in 0.5 mL 
hyaluronidase (Sigma-Aldrich, at a concentration of 500 U/mL) in 0.1M PBS. Then 1 mL 
of fresh papain mixture was added to the hyaluronidase solution and allowed to digest 
overnight at 65 ºC. Both the first and second digestion solutions were stored at -20 ºC. Prior 
to biochemical analysis, all digestion solutions were allowed to thaw to room temperature 
and then vortexed and centrifuged at 10,000 rpm for 10 min to pellet fragments of 
polymers. The supernatant was then used to quantify biochemical contents. According to 
manufacturer instructions and using a Cytation 5 Cell-Imaging Multi-Mode reader (Bio-
Tek, Winooski, VT), DNA content was quantified with the PicoGreen assay (Molecular 
Probes, Eugene, OR), glycosaminoglycan (GAG) content was determined with the 
dimethylmethylene (DMMB) assay (Biocolor, Newtownabby, Northern Ireland) using a 
chondroitin sulfate standard, and hydroxyproline content was quantified with a 
hydroxyproline detection kit (Sigma-Aldrich). To obtain the total biochemical content for 
each gel, each of the two digestions for each gel was quantified and later added together. 
GAG and hydroxyproline contents were not normalized to DNA and are rather shown in 
total because of the gels’ inherent initial DNA contents.  
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Gene Expression Analysis 
 RNA was isolated and purified using Qiagen QIAshredders and an RNeasy Kit 
(Valencia, CA) according to the manufacturer’s guidelines (n=6). A high capacity cDNA 
reverse transcription kit (Applied Biosystems, Foster City, CA) was used to convert 
isolated RNA into cDNA. Real-time quantitative polymerase chain reaction (qPCR) was 
performed using a RealPlex MasterCycler (Eppendorf, Hauppauge, NY) and using 
TaqMan gene expression assays from Applied Biosystems for Sox-9 (Rn01751070_m1), 
aggrecan (Rn00573424_m1), collagens type I (Rn01463848_m1) and II 
(Rn01637087_m1), and GAPDH (Rn01775763_g1). The 2-ΔΔCt method was used to 
quantify relative expression levels for each gene where the MeHA gels at day 1 were 
designated as the calibrator group and GAPDH expression was used as the endogenous 
control.80 Last, RNA from DVC and DCC (i.e., no rBMSCs) was isolated, converted to 
DNA, and then PCR was performed with the same previously mentioned TaqMan assays, 
where it was confirmed that all gene expression observed in the study was due to rBMSCs. 
 
Histological Analysis 
 Gels at 1 day and cellular gels at 6 weeks were fixed in 10% formalin for 15 min 
and then embedded in Optimal Temperature Cutting (OCT) medium (TissueTek, Torrance, 
CA) overnight at 37 °C, frozen at -20 °C, and were sectioned at a thickness of 10 µm using 
a cryostat (Microm HM-550 OMP, Vista, CA). The sections were stained with the standard 
Hematoxylin and Eosin (H&E) stain, which stains the nuclei purple and the cytoplasm, 
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connective tissues, and other extracellular substances red or pink. The sections were stained 
with the standard Safranin-O/Fast Green stain, which stains negatively charged GAGs 
orange. The sections were stained immunohistochemically using primary antibodies that 
target both rat and porcine tissues for collagen I (ThermoFisher, NB600408, 1:200 
dilution), collagen II (Abcam, ab34712, 1:200 dilution), and aggrecan (ThermoFisher, 
MA3-16888, 1:100 dilution). Prior to primary antibody incubation, the slides were fixed in 
chilled acetone (-20 °C), treated with proteinase K (Abcam), and exposed to 0.3% 
hydrogen peroxide (Abcam) to suppress endogenous peroxidase activity. Sections were 
blocked with serum according to the Vectastain ABC kit (Vector Laboratories, 
Burlingame, CA) following the manufacturer’s instructions and then incubated with 
primary antibody. Following incubation with the primary antibodies, the sections were 
exposed to biotinylated secondary antibodies (horse anti-rabbit or mouse) and ABC reagent 
according to the manufacturer's protocol. The antibodies were visualized using the 
ImmPact DAB peroxidase substrate (Vector), rinsed in DI water, counter stained with 
VECTOR hematoxylin QS stain, and then dehydrated and mounted. Negative controls 
consisted of substituting primary antibody exposure with exposure to a rabbit IgG isotype 
control (for collagen I and II, Abcam, ab27478) at an antibody concentration calculated to 
be the same used for the corresponding antibodies and omitting the primary antibody for 




GraphPad Prism 6 statistical software (GraphPad Software, Inc., La Jolla, CA) was 
used to compare experimental groups using a one-factor ANOVA (for analyses with one 
time point) or a two-factor ANOVA (for analyses with two or more time points) followed 
by a Sidak’s post hoc test (for two-way ANOVAs with two time points only) or a Tukey’s 
post hoc test (for all other ANOVAs), where p ≤ 0.05 was considered significant. In 
addition, standard box plots were constructed to eliminate outliers. All quantitative results 
are reported as mean ± standard deviation within text or as mean + standard deviation 
within figures.  
 
RESULTS 
Characterization of MeHA, DVC, and DCC Microparticles 
 Analyzing the ratio of the relative peak area of methacrylate protons to methyl 
protons of MeHA revealed the MeHA had a 1.2% degree of methacrylation and the DNA 
and hydroxyproline contents were determined to be 9.2 ± 3.7 ng DNA/mg MeHA and 0.74 
± 0.14 µg hydroxyproline/mg MeHA, respectively (Figure 4.1A-C). Because the GAG 
assay only detects sulfated GAGs, and hyaluronic acid is a non-sulfated GAG, the GAG 
content of MeHA was not detected. The DNA, GAG, and hydroxyproline contents of DVC 
were determined to be 1151 ± 51 ng DNA/mg dry DVC, 252 ± 16 µg GAG/mg dry DVC, 
and 56.1 ± 3.9 µg hydroxyproline/mg dry DVC, respectively (Figure 4.1A-C). Following 
decellularization and cryogrinding to create DCC powder, there was a 44% reduction in 
DNA, a 23% reduction in GAG, and a 23% reduction in hydroxyproline (p<0.05) (Figure 
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4.1A-C). In prior work it was established that no significant reduction in biochemical 
content were observed between native cartilage and cartilage that was cryoground,128 so 
the prior mentioned reductions are in reference to DVC powder.  
 SEM imaging revealed that DVC and DCC microparticles were approximately 45 
µm in diameter or smaller and were noted to be heterogeneous in size and morphology 
(Figure 4.1D). The DCC microparticles were observed to have smoother surfaces overall 
in comparison to the DVC microparticles (Figure 4.1D). Under higher magnification, 
observing the surface morphology revealed a grain-like appearance to the surface of the 
DCC microparticles that was not observed on the DVC microparticles (Figure 4.1D).  
 
Macroscopic Observation and Rheological Testing of Hydrogel Precursor Pastes 
 Macroscopic observation of hydrogel precursor formulations revealed non-
Newtonian and paste-like behavior in precursors containing at least 5% DCC (Figure 4.2). 
Shape retention after extrusion through a 3 mL syringe, which was indicated by the fluid 
retaining the diameter of the syringe orifice after extrusion and after crosslinking, was 
noted in the 10% DCC and MeHA + DVC acellular groups (Figure 4.2). The remaining 
solutions spread out to 2-3 times the diameter of the syringe orifice. All formulations 
containing MeHA were able to be crosslinked to maintain extrusion shape.  
 Solutions exhibiting a measurable yield stress were the 10% DCC, MeHA + 10% 
DCC, and MeHA + DVC formulations (Figure 4.3A). The 10% DCC had a yield stress of 
143 ± 33 Pa, while adding MeHA to 10% DCC reduced the yield stress to 92 ± 88 Pa, 
although the reduction was not significant. The yield stress of the MeHA + DVC group 
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was 2.7 and 1.7 times greater than that of the MeHA + 10% DCC and 10% DCC groups, 
respectively (p<0.05) (Figure 4.3A). 
 All of the groups exhibited viscoelastic behavior, as indicated by a measurable 
storage modulus. However, the storage modulus of the MeHA + DVC group was 
significantly higher than all of the other groups at 1240 ± 520 Pa, which was 58, 2.4, 2.6, 
and 8.8 times higher than the MeHA + 5% DCC, 10% DCC, MeHA + 10% DCC, and the 
cellular MeHA + 10% DCC cellular groups, respectively, which were the groups that had 
a storage modulus greater than 20 Pa (p<0.05) (Figure 4.3B). 
  
Mechanical Testing of Crosslinked Hydrogels 
 One day after crosslinking, all of the groups except for the acellular MeHA group 
had a compressive modulus significantly higher than that of the MeHA group (p<0.05), 
which had a compressive modulus of 1.94 ± 0.13 kPa (Figure 4.4). The compressive 
modulus of the MeHA + DVC group was 6.82 ± 0.79 kPa (Figure 4.4), which was 3.5, 2.2, 
and 1.8 times larger than the MeHA, MeHA + 5% DCC, and MeHA + 10% DCC groups, 
respectively (p<0.05). Furthermore, the modulus of the MeHA + DVC group was 2.3 and 
1.7 times larger than that of the MeHA + TGF-β3 and MeHA + 10% DCC + TGF-β3 groups, 
respectively. Finally, the moduli of the MeHA + DVC and MeHA + TGF-β3 groups were 
1.7 and 1.6 times respectively larger than their acellular controls (p<0.05).  
 At 6 weeks, the MeHA + 5% DCC acellular group, both cellular groups composed 
of MeHA + 10% DCC, and the DVC groups had at least 4 times larger compressive moduli 
than that of the MeHA group, which had a compressive modulus of 0.31 ± 0.13 kPa 
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(p<0.05). The MeHA + DVC group had a compressive modulus of 2.964 ± 0.056 kPa, 
which was 9.1 times larger than that of the MeHA group (p<0.05), but was not significantly 
different from the MeHA + 10% DCC + TGF-β3 group. The modulus of the MeHA + 10% 
DCC + TGF-β3 group was 2.55 ± 0.39 kPa, which was 2 times larger than its acellular 
control (p<0.05). The MeHA + DVC acellular group had a compressive modulus of 2.40 
± 0.44 kPa, which was 1.9 times larger than that of the MeHA + 10% DCC group (p<0.05) 
(Figure 4.4).  
 Over the 6 week culture period, all of the groups had a significant reduction in their 
compressive moduli (p<0.05). However, while the acellular MeHA, MeHA, and MeHA + 
TGF-β3 groups experienced 90%, 83%, and 73% respective reductions in their compressive 
moduli over the culture period (p<0.05), all of the other groups experienced less than 65% 
reductions in their respective compressive moduli (p<0.05). At 6 weeks, the compressive 
modulus of the MeHA + 10% DCC + TGF-β3 was 37% less than its original value at 1 day 
(p<0.05), while the modulus of its respective acellular group was 64% less than its original 
value (p<0.05) (Figure 4.4). 
 
Swelling and Volume Analysis of Crosslinked Hydrogel Pastes 
After swelling to equilibrium for 24 hours, the swelling degree of the MeHA group 
was 34 ± 13 (Figure 5A). The only groups that had significantly smaller swelling degrees 
were the MeHA + 10% DCC acellular group and the MeHA + DVC acellular and cellular 
groups, which had swelling degrees of 17.9 ± 3.1, 15.6 ± 1.3, and 13.27 ± 0.88, respectively 
(p<0.05) (Figure 4.5A). 
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At 1 day after crosslinking, none of the gel volumes deviated significantly from the 
MeHA group, which had a volume of 40.5 ± 2.7 µL (p<0.05) (Figure 4.5B). However, at 
6 weeks after crosslinking, the MeHA group had a volume of 82.7 ± 11.6 µL. The volumes 
of the MeHA + 5% DCC, MeHA + 10% DCC, and MeHA + DVC were 26%, 31.5%, and 
43% lower than that of the MeHA group, respectively (p<0.05) (Figure 5B). In addition, 
the volume of the MeHA + TGF-β3 group was 20.5% and 21.2% lower than that of the 
MeHA acellular and cellular groups, respectively (p<0.05). The DVC group was not 
significantly different from the MeHA + 10% DCC + TGF-β3 group, but the volume of the 
MeHA + 10% DCC + TGF-β3 group was 31% less and 20% less than the MeHA + TGF-
β3 and the MeHA + 10% DCC groups, respectively.   
Over the 6 week culture period, the volumes of all gels, with the exception of the 
MeHA + 10% DCC + TGF-β3 and the acellular MeHA + DVC groups, increased 
significantly (p<0.05). The volume of the MeHA group increased by 2.1 times compared 
to its original volume, while the volumes of the MeHA + TGF-β3, the MeHA + 5% DCC, 
and the MeHA + 10% DCC groups only increased by 49%, 47%, and 45%, respectively 
(p<0.05) (Figure 4.5B).  
 
Biochemical Content of Crosslinked Hydrogels 
All of the cellular groups had significantly higher DNA contents than their 
respective acellular groups at all time points (p<0.05). At one day after crosslinking, the 
MeHA + 10% DCC group had 570 ± 130 ng DNA per gel, and the only gels with a 
significantly different DNA content from this group were the MeHA + 10% DCC + TGF-
 56 
β3 and MeHA + DVC groups, which had DNA contents 45% and 82% higher per gel, 
respectively (p<0.05) (Figure 4.6A). There was no significant difference between the 
MeHA + 10% DCC + TGF-β3 and MeHA + DVC groups, however. At 3 weeks after 
crosslinking, the MeHA + DVC group had a DNA content of 386 ± 73 ng DNA per gel, 
which was 36%, 49%, and 35% less than the MeHA + TGF-β3, MeHA + 5% DCC, and 
MeHA + 10% DCC + TGF-β3 groups, respectively (p<0.05) (Figure 4.6A). There was no 
significant difference between the MeHA + DVC group and the MeHA + 10% DCC group, 
however. After 6 weeks of culture, the MeHA + 5% DCC group contained 1.8 times more 
DNA than the MeHA + 10% DCC group (p<0.05) (Figure 4.6A). However, no other 
cellular groups were significantly different from the MeHA + 10% DCC group. Over the 
course of the 6 week culture period, all of the cellular groups had a significant reduction in 
DNA content (p<0.05), where the DNA content in the MeHA, MeHA + TGF-β3, MeHA + 
5% DCC, MeHA + 10% DCC, MeHA + 10% DCC + TGF-β3, and MeHA + DVC groups 
reduced by 45%, 31%, 16%, 43%, 38%, and 55% compared to their original DNA contents, 
respectively (p<0.05). The acellular groups did not have any significant reduction in DNA 
content over the culture period (Figure 4.6A).  
All of the groups with DCC and DVC had significantly higher initial GAG contents 
at day 1 than that of the MeHA group (p<0.05), which had a GAG content of 15.5 ± 4.6 µg 
GAG per gel. Compared to the MeHA group, the GAG contents of the MeHA + 5% DCC, 
MeHA + 10% DCC, and MeHA + DVC groups were 4.9, 6.3, 6.7, and 12.9 times larger, 
respectively (Figure 4.6B). At day 1, the GAG content of the MeHA + DVC group was 
16.6% higher than its respective acellular group (p<0.05). Furthermore, the GAG content 
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of the MeHA + DVC group was 15, 2.1, and 1.9 times larger than the MeHA + TGF-β3, 
MeHA + 10% DCC, and the MeHA + 10% DCC + TGF-β3 groups, respectively. At 3 
weeks, all of the groups with DCC and DVC contained significantly larger GAG contents 
than the MeHA group (p<0.05), which had a GAG content of 12.5 ± 4.6 µg GAG per gel. 
The GAG contents of the MeHA + 5% DCC, MeHA + 10% DCC, and MeHA + DVC 
groups were 3.2, 4, 3.6, and 4.1 times larger than that of MeHA, respectively (Figure 4.6B). 
In addition, the GAG content of the MeHA + DVC group was 52% less than its respective 
acellular control (p<0.05). Furthermore, there were no significant differences among the 
MeHA + DVC, the MeHA + 10% DCC + TGF-β3, and the MeHA + 10% DCC groups. At 
6 weeks, again all of the groups with DCC and DVC contained significantly larger GAG 
contents than the MeHA group (p<0.05), which had a GAG content of 1.7 ± 1.2 µg GAG 
per gel. Compared to the MeHA group, the GAG content of the MeHA + 5% DCC, MeHA 
+ 10% DCC, and MeHA + DVC groups were 17, 24, 20, and 29 times larger, respectively 
(Figure 4.6B). The GAG content of the MeHA + DVC group was 48% less than its 
respective acellular control (p<0.05), but there were no significant differences among the 
MeHA + DVC, the MeHA + 10% DCC + TGF-β3, and the MeHA + 10% DCC groups. 
Over the 6 week culture period, all of the groups with DCC and DVC had significant 
reductions in GAG content, where the GAG contents of the MeHA + 5% DCC acellular 
and cellular groups, the MeHA + 10% DCC acellular, cellular, and TGF-β3-exposed 
groups, and the acellular and cellular MeHA + DVC groups, reduced by 54%, 62%, 69%, 
58%, 66%, 44%, and 75%, respectively.  
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Furthermore, all of the groups with DCC and DVC had significantly higher initial 
hydroxyproline contents at day 1 than that of the MeHA group (p<0.05), which had a 
hydroxyproline content of 2.57 ± 0.23 µg hydroxyproline per gel. Compared to the MeHA 
group, the hydroxyproline contents of the MeHA + 5% DCC, MeHA + 10% DCC, and 
MeHA + DVC groups were 15, 32, 34, and 43 times larger, respectively (Figure 4.6C). At 
day 1, the hydroxyproline content of the MeHA + DVC group was 1.3 times higher than 
that of the MeHA + 10% DCC group (p<0.05). Additionally, the MeHA + 10% DCC group 
contained 2.1 times the amount of hydroxyproline of the MeHA + 5% DCC group (p<0.05). 
At 3 weeks, all of the DCC and DVC groups contained significantly larger hydroxyproline 
contents than the MeHA group (p<0.05), which contained 1.90 ± 0.40 µg hydroxyproline 
per gel. Compared to the MeHA group, the hydroxyproline contents of the MeHA + 5% 
DCC, MeHA + 10% DCC, and MeHA + DVC groups were 16, 36, 33, and 29 times larger, 
respectively (Figure 4.6C). In addition, the hydroxyproline content of the MeHA + DVC 
group was 27.4% less than its respective acellular control (p<0.05) and the MeHA + 10% 
DCC group contained 2.2 times the amount of hydroxyproline found in the MeHA + 5% 
DCC group (p<0.05). However, there were no significant differences among the MeHA + 
DVC, the MeHA + 10% DCC, and the MeHA + 10% DCC + TGF-β3 groups. At 6 weeks, 
again all of the groups with DCC and DVC contained significantly larger hydroxyproline 
contents than that of the MeHA group (p<0.05), which contained 1.64 ± 0.24 µg 
hydroxyproline per gel. Compared to the MeHA group, the hydroxyproline contents of the 
MeHA + 5% DCC, MeHA + 10% DCC, and MeHA + DVC groups were 21, 49, 34, and 
38 times larger, respectively (Figure 4.6C). The hydroxyproline content of the MeHA + 
 59 
10% DCC group was 2.4 and 1.5 times larger than the MeHA + 5% DCC and MeHA + 
10% DCC + TGF-β3 groups, respectively (p<0.05). However, there was no significant 
difference between the MeHA + DVC and the MeHA + 10% DCC + TGF-β3 groups. Over 
the 6 week culture period, the groups that did not have a significant reduction in 
hydroxyproline content were all three MeHA groups, both MeHA + 5% DCC groups, and 
the MeHA + 10% DCC group. The hydroxyproline content of the MeHA + DVC group 
reduced to 56% of its original content over the 6 weeks (p<0.05).  
 
Gene Expression 
Throughout the entire culture period, the MeHA + 5% DCC and MeHA + 10% 
DCC groups never expressed collagen II. At 1 day, the rest of the groups did not have any 
significant differences. At 1 week, the MeHA + TGF-β3 group did not express collagen II, 
and there were no significant differences in expression between the remaining groups. At 
2 weeks, the only groups expressing collagen II were the MeHA + 10% DCC + TGF-β3 
and the MeHA + DVC groups, although the difference between them was not significant. 
At 3 weeks and 6 weeks, the only group expressing collagen II was the MeHA + DVC 
group, which had a relative collagen II expression that was 180 and 320 times larger than 
the calibrator group (i.e., MeHA group at day 1), respectively (p<0.05) (Figure 4.7A).  
At 1 day, the DCC containing groups had at least 98% less collagen I expression 
than the MeHA group (p<0.05) (Figure 4.7B). By 2 weeks, the relative collagen I 
expression of MeHA + DVC increased to 304 times the MeHA group value. However, that 
expression significantly decreased by 86% at 3 weeks, but was still 99 times larger than 
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the relative expression of the MeHA group. Although the collagen I expression reduced 
significantly from 1 day to 1 week for both the cellular and acellular MeHA groups 
(p<0.05), the collagen I expression for these and all groups but the MeHA + DVC groups 
remained steady the rest of the 6 weeks.  
The MeHA + TGF-β3 and MeHA + DVC groups had significantly higher Sox-9 
expression than the groups containing DCC from 1 day to 3 weeks, where the relative 
expression was 2 and 1.3 times the MeHA group, respectively at day 1, and was 3.7 and 3 
times larger than the MeHA group at 3 weeks (p<0.05) (Figure 4.7C). At 6 weeks, the DVC 
group had significantly higher Sox-9 expression than all other groups, where its expression 
was 4.4 and 109 times higher than the MeHA + TGF-β3 and the MeHA + 10% DCC + 
TGF-β3 groups, respectively (p<0.05). 
At day 1, the relative aggrecan expression of the DCC containing groups was 
significantly lower than the MeHA group, whereas the relative expression of MeHA + 
DVC group was 2 times higher than the MeHA group (p<0.05) (Figure 4.7D). Over the 
culture period, both the cellular and acellular MeHA groups significantly reduced their 
aggrecan expression, however the MeHA + DVC group remained significantly higher than 
MeHA and all DCC groups over the 6 weeks (p<0.05). Additionally, the MeHA + DVC 
group’s relative aggrecan expression was 2, 17, 22, 34, and 410 times higher than that of 
MeHA at 1 day, 1 week, 2 weeks, 3 weeks, and 6 weeks, respectively (p<0.05). Lastly, the 
relative aggrecan expression of the MeHA + DVC group at 6 weeks was 80 and 585 times 
higher than that of the MeHA + TGF-β3 and the MeHA + 10% DCC + TGF-β3 groups, 




 Saf-O staining did not reveal an increase in Saf-O staining intensity over the culture 
period. However, at 6 weeks, some nodular Saf-O staining was noted in the MeHA + TGF-
β3 group (Figure 4.8). All DCC and DVC containing groups stained for collagen II; 
however, no changes were noted in the location and intensity of collagen II staining over 
the culture period (Figure 4.8). Collagen I staining was noted again in all of the DCC and 
DVC containing groups. However, the intensity of collagen I staining decreased over the 
culture period for the MeHA + 5% DCC and MeHA + 10% DCC groups (Figure 4.8). The 
intensity of the collagen I staining appeared to increase slightly for the MeHA + DVC 
group. This slight increase in intensity was noted near and within the DVC microparticles. 
Aggrecan staining was noted in all DCC and DVC containing groups, where notably the 
aggrecan staining became more intense near the DCC and DVC microparticles in the 




 We have introduced not only a method to overcome the drawbacks of implanting 
hydrogels in situ (i.e., leaking from the defect site), but in addition, we have introduced a 
method to induce chondrogenesis of cells encapsulated within the networks. Previous 
studies have explored the chondrogenic potential of DCC and DVC.13, 14, 92, 109, 155, 161 Cheng 
et al.14 reported using a porous cartilage matrix composed of homogenized and then 
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lyophilized DVC matrix, of which chondrogenesis was observed even without growth 
factor supplementation. However, these matrices succumbed to cell-mediated contraction, 
but when the matrices were further crosslinked with genipin, they found the materials did 
not exhibit contraction and were chondroinductive.13 The same group infiltrated cartilage 
matrix with woven poly(ε-caprolactone) and observed cartilaginous matrix production.92 
Zheng et al.161 reported using DCC to create nanofibrous ECM scaffolds that induced MSC 
chondrogenesis. Our group was the first to explore the short-term chondrogenic potential 
of DCC versus DVC.128 However, for the first time in this current study, not only were 
DVC and DCC compared for their long-term chondrogenic potential, they were evaluated 
for their ability to exhibit a yield stress in hydrogel precursor solutions. In this current 
study, chondrogenesis was induced through incorporating native cartilage ECM into the 
MeHA/cartilage matrix gel networks, which furthermore resulted in the paste-like behavior 
and yield stress that was observed prior to crosslinking. The yield stress denotes the 
threshold where a solution transitions between an elastic solid and a pseudoplastic liquid, 
and exhibiting a yield stress is crucial because it will prevent the hydrogel precursor from 
flowing away, keeping the material at the site of interest until crosslinking. In a surgical 
context, a material that exhibits a yield stress would allow a surgeon to appropriately shape 
and contour the material to the defect site before crosslinking it in place. The paste-like 
precursor solutions were able to obtain yield stresses of over 200 Pa with MeHA mixed 
with DVC microparticles. For context, the yield stress for a common paste-like material 
such as toothpaste is approximately 200 Pa. However, we did not achieve toothpaste 
consistency with the incorporation of DCC microparticles although we still did note that 
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these materials did have a yield stress. Although at this point without further testing, it is 
uncertain why the DCC microparticles did not impart as high of a yield stress on the pastes 
as the DVC microparticles, the SEM images revealed subtle differences between the DCC 
and DVC, which may provide clues to understanding the observed rheological differences. 
A grain-like appearance was noted only on the DCC and that the DCC microparticles had 
in general, smoother surfaces than the DVC microparticles. Because it is known that 
decellularization can result in changes in matrix architecture and surface ligand 
landscape,60 it is possible that these entities were altered in the decellularization process, 
and thus the decellularization process may have played a role in the reduction of yield stress 
that we observed. It was noted that the yield stress of DCC microparticles alone was higher 
than the yield stress of MeHA combined with the DCC, and this reduction in yield stress 
when MeHA and particles were combined differs from what was noted in previous work, 
where a 3.4-fold increase was observed in the yield stress of hyaluronic acid nanoparticles 
combined with MeHA in comparison to the nanoparticles alone, where the MeHA alone 
had no measurable yield stress.5 That work suggested that the hyaluronic acid nanoparticles 
had some physical or chemical interactions with the MeHA in addition to the interactions 
with the other nanoparticles, whereas in the current study, the interactions between 
particles and MeHA were likely negligible. Of concern is that when rBMSCs were mixed 
in with the DCC group, the precursor had no measurable yield stress, although it still 
exhibited some viscoelastic behavior, evident by its measurable storage modulus and 
macroscopically observed non-Newtonian behavior. Last, although it was not performed 
in the current study, future quantification of syringeability would be of value.   
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 In addition to DVC having superior rheological properties, the DVC invoked 
superior chondroinductivity in comparison to DCC microparticles. For collagen II, Sox-9, 
and aggrecan expression, the MeHA + DVC group repeatedly outperformed the DCC 
containing groups, even when the DCC groups were exposed to TGF-β3. Interestingly, we 
only performed a mild decellularization by removing only 44% of the initial DNA, 23% of 
the initial GAG, and 23% of the initial hydroxyproline and even though the initial 
biochemical contents were not drastically altered, the cellular response to these materials 
was severely affected. The current finding of DVC outperforming DCC in 
chondroinduction is in contradiction to our previously reported increase in 
chondroinductivity of DCC over DVC,128 but we hypothesize the differences between the 
previous and current study is that currently, rBMSCs were encapsulated within a 3D 
scaffold rather than studied in pellet culture, and the long term gene expression over a 6 
week period rather than only 1 week as in the prior study was observed. Moreover, under 
biochemical and histological analysis, other than a slight increase in aggrecan staining near 
the cartilage microparticles over the 6 week culture period, significant tissue synthesis 
overall was not observed, which suggests that although the cells may have been 
chondroinduced, they were not actively secreting large amounts of cartilage matrix. 
However, it is possible that some of the matrix was being remodeled, so a net increase in 
the amount of staining could not be observed even though matrix secretion might have 
been present. Ultimately, without further testing, it still remains unclear as to whether 
decellularization is necessary for cartilage tissue engineering.  
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 The question of whether or not decellularization is needed is complex and will 
depend upon each application of cartilage ECM. It has been established that cells exposed 
to a target ECM will more easily differentiate toward the target tissue,44, 121 where one of 
the reasons for this ECM specific differentiation may be because native ECM may have 
the potential to retain the growth factors that will steer the differentiation toward the 
specific target tissue.6 Decellularizing cartilage ECM may not only alter the matrix 
architecture, but it may furthermore remove some of these important growth factors, 
affecting the bioactivity of the cartilage ECM. Furthermore, altering the architecture may 
hinder growth factor retention. For example, proteoglycans, specifically aggrecan in 
cartilage matrix, are well known for how they affect the mechanical properties of tissues 
and found extensively in native cartilage matrix, are thought to be a reservoir of several 
growth factors,17, 57 and thus, the preservation of these proteoglycans may be crucial to 
successful tissue regeneration. Therefore, although we are still at the beginning stages of 
determining the appropriate ECM processing protocol for cartilage tissue, it may prove to 
be ideal to use unaltered, non-decellularized cartilage tissue for certain applications. 
Applications such as cell-derived matrix, where cartilage ECM can be grown from a 
patient’s own cells,129 would not need to be decellularized since the tissue source would be 
autogenous. Additionally, through the successful use of allograft cartilage as evidenced by 
the success of current allograft products like Zimmer’s DeNovo®, if the cartilage tissue 
would be used for articular cartilage applications, it may not need to be decellularized.  
However, on the opposing side of whether or not to decellularize cartilage tissue 
are cases where cartilage is being used for bone regeneration via endochondral ossification. 
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In these applications where the cartilage will be more exposed to host immunogenic cells,42 
decellularization may be necessary. Additionally, decellularization may be necessary for 
cartilage derived from xenogeneic sources. In the current study, we used porcine cartilage 
as proof of concept for comparing DCC to DVC. However, ultimately it may or may not 
be desired to use xenograft sources for future work. Using xenografts comes with its own 
challenges, such as the need to remove the alpha-Gal epitope, a carbohydrate found within 
xenograft ECM that is known to cause graft failure if not successfully removed.129   
 Although graft failure can be caused through biochemical entities, it is possible for 
graft failure to occur biomechanically. For this reason, we tested the mechanical and 
swelling properties of DCC and DVC-incorporated hydrogel networks after crosslinking. 
Native cartilage is approximately 80% water, which equates to a swelling degree of 
approximately 5, and has an elastic compressive modulus ranging from 240-1000 kPa.2, 76, 
85 However, it must be noted that the biomechanical properties can vary depending on 
parameters such as the method of testing, the strain rate of testing, and cartilage zone 
depth.49 In this work, the swelling degree was significantly lowered from over 30 to 
between 10 and 20 by incorporating 10% DCC or DVC. For tissue engineering, it is neither 
desired for scaffold constructs to swell from the defect site, nor is it desirable for the 
constructs to shrink within the defect site, because in both instances it can cause 
disintegration of the scaffold with host tissue, and thus may hinder cartilage regeneration.13 
In the current study, it was noted that the inclusion of DVC resulted in the gels retaining 
their original volumes throughout culture. However, it was noted that the elastic 
compressive moduli obtained in the current study (ranging from approximately 2 to 8 kPa 
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at day 1) were nowhere near that of native cartilage. Including DCC and DVC with MeHA 
significantly increased the compressive modulus and encapsulation of DVC and cells 
together significantly increased the compressive modulus. Therefore, in the current study, 
although incorporating DVC and DCC may prove to be beneficial for tissue engineering, 
to ultimately obtain mechanical properties to that of native cartilage ECM, it may be 
necessary to increase the degree of methacrylation or to change the photocrosslinkable 
polymer to a polymer that has an inherently higher compressive modulus.114  
   
 
CONCLUSION 
 ECM-based materials are gaining widespread attention in the regenerative 
medicine field and they continue to show great promise toward cartilage regeneration 
applications. In the current study, cartilage matrix microparticles not only induced cells to 
differentiate toward a chondrogenic lineage, but they concurrently provided the hydrogel 
precursor solutions with a yield stress (i.e., paste-like consistency), which translates to a 
tremendous advantage for material placement in clinical applications. Additionally, 
although significant emphasis has been placed on the necessity to decellularize ECM 
components that are used in regenerative medicine products, we challenged that paradigm 
by providing the first direct comparison of the long-term bioactivity of DCC and DVC and 
thereby demonstrating that DVC may be superior in promoting chondrogenesis over DCC. 
Moreover, DVC consistently outperformed all TGF-β3-exposed groups in aggrecan and 
collagen II gene expression, which may present significant advantages in cost and 
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regulatory approval of chondroinductive strategies for cartilage regeneration.127 Certainly 
future work will need to address improving the mechanical properties and overall matrix 
production, where in vivo studies will be paramount, because immunogenicity as well as 
how biomechanical stimulation of DCC and DVC may affect chondroinductivity and 
therefore, hyaline-like cartilage regeneration can be tested. Furthermore, the 
reproducibility and shelf life of these materials must be tested since the heterogeneity of 
cartilage matrix and differences in the quality of cartilage ECM from one hog to another 
may vary and may affect the ability to reproduce similar particles every time. Overall, the 
results of this study suggest that devitalized cartilage may be a promising chondroinductive 




CHAPTER 5: APPROACHING THE COMPRESSIVE MODULUS OF 




ECM-based materials are appealing for tissue engineering strategies because they 
may promote stem cell recruitment, cell infiltration, and cell differentiation without the 
need to supplement with additional biological factors. Cartilage ECM has recently shown 
potential to be chondroinductive, particularly in a hydrogel-based system, which may be 
revolutionary in orthopedic medicine. However, hydrogels composed of natural materials 
are often mechanically inferior to synthetic materials, which is a major limitation for load-
bearing tissue applications. The objective was therefore to create an unprecedented 
hydrogel composed entirely of native cartilage ECM that was both mechanically more 
similar to native cartilage tissue and capable of inducing chondrogenesis. Porcine cartilage 
was decellularized, solubilized, and then methacrylated and UV photocrosslinked to create 
methacrylated solubilized decellularized cartilage (MeSDCC) gels. Methacrylated gelatin 
(GelMA) was employed as a control for both biomechanics and bioactivity. Rat bone 
marrow-derived mesenchymal stem cells were encapsulated in these networks, which were 
cultured in vitro for 6 weeks, where chondrogenic gene expression, the compressive 
modulus, swelling, and histology were analyzed. One day after crosslinking, the elastic 
compressive modulus of the 20% MeSDCC gels was 1070 ± 150 kPa. Most notably, the 
                                               
§To be submitted as Beck E.C., Barragan M., Tadros M.H., Gehrke S.H., and Detamore M.S., Approaching 
the Compressive Modulus of Articular Cartilage With a Decellularized Cartilage-Based Hydrogel, 
Biomaterials, 2015. 
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stress strain profile of the 20% MeSDCC gels fell within the 95% confidence interval range 
of native porcine cartilage. Additionally, MeSDCC gels significantly upregulated 
chondrogenic genes compared to GelMA as early as day 1 and supported extensive matrix 
synthesis as observed histologically. Given that these gels approached the mechanics of 
native cartilage tissue, supported matrix synthesis, and induced chondrogenic gene 
expression, MeSDCC hydrogels may be promising materials for cartilage tissue 
engineering applications. Future efforts will focus on improving fracture mechanics as well 
to benefit overall biomechanical performance. 
 
INTRODUCTION 
 Arthritis is one of the leading causes of disability among US adults.94 Some of the 
current clinical treatments include autologous chondrocyte implantation, mosiacplasty, and 
microfracture.3, 50 However, not only do these treatments involve high risk of donor site 
morbidity and/or the need for multiple surgeries, these treatments still lack the ability to 
regenerate fully functional cartilage tissue.13, 64, 127 Tissue engineering approaches are 
therefore striving to fully regenerate cartilage tissue by utilizing a bioactive and 
bioresorbable construct that provides the necessary cues to facilitate cell growth, 
differentiation, and tissue integration, while providing the mechanical integrity and support 
to allow the tissue to sustain its load bearing function.50 
 Hydrogels have several advantages in cartilage tissue engineering, which include 
ease of formation, the ability to fine tune mechanical properties, the ability to encapsulate 
cells, and vast array of conjugation options for degradability, bioactivity, etc.9, 23, 33 
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Hydrogels can be made from both synthetic (e.g., polyethylene glycol) and natural 
materials (e.g., collagen, gelatin), where both have their own inherent advantages and 
disadvantages. Synthetic materials have the advantage of the ability to more readily control 
the composition and mechanical properties of the hydrogel compared to hydrogels 
composed of natural materials, but natural materials have the additional advantage of 
providing biochemical cues and signals to facilitate cell attachment, growth, and 
differentiation.148  
 One such natural material that is gaining attention in tissue engineering approaches 
is naturally derived extracellular matrix.129 ECM materials can either be obtained from cell-
derived matrices that are secreted during in vitro culture or they can be derived directly 
from native tissue,6, 11, 13, 22, 116, 156 and often they have been decellularized to remove 
cellular components and nucleic acids that may have the potential to cause an adverse 
immunological response.129 We and other groups have already established that 
decellularized cartilage has chondroinductive potential,11, 15, 41, 73, 115, 128 and we recently 
reported the chondroinductive potential of decellularized cartilage (DCC) in pellet 
culture,128 where we observed increased chondroinductivity of rat bone marrow stem cells 
(rBMSCs) exposed to DCC as compared to those cells only exposed to TGF-β3.
128  
 Therefore, in this study we endeavored to create a material that was entirely 
composed of DCC to potentially make the material inherently chondroinductive, and we 
furthermore endeavored to design a material would have the mechanical properties 
necessary to be load-bearing. Several studies have made gels entirely out of ECM by first 
solubilizing the ECM, where the solubilized matrix would form a gel at body 
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temperature.40, 41, 43, 120 One group even utilized solubilized cartilage matrix gels for drug 
delivery, where they noted that the gel maintained enough structural integrity under 
physiological conditions to be a stable drug depot.70 We tried using solubilized cartilage 
hydrogels, but the gels that formed were too compliant and left opportunity for 
improvement for load-bearing applications. Methods of crosslinking unsolubilized 
cartilage have been reported, including crosslinking cartilage ECM with genipin, 
dehydrothermal treatment, ultraviolet irradiation, and carbodiimide chemistry.13, 109 Using 
these methods, cartilage scaffolds were able to be crosslinked and maintained some 
mechanical integrity throughout culture where cell mediated contraction was able to be 
controlled depending on the method of crosslinking. However, the authors of these 
previous studies noted that the constructs would require additional reinforcements to attain 
functional biomechanical properties and additionally, a sole ECM content of 10% was used 
to make the gels. In the current study, we sought to overcome this limitation through 
solubilizing and further crosslinking cartilage tissue. The rationale for solubilizing the 
cartilage tissue was to provide more control over mechanical properties through the ability 
to more finely tune the solid content of the hydrogel. Furthermore, solubilizing the cartilage 
may free up more reactive sites for crosslinking on the cartilage ECM, which may help 
reinforce the biomechanical properties of the solubilized cartilage once it is crosslinked. 
Therefore, based on our experience of functionalizing GAGs such as hyaluronic acid and 
chondroitin sulfate with glycidyl methacrylate,5, 63 which allows the hydrogel to be formed 
through photocrosslinking, we decided to methacrylate solubilized, decellularized cartilage 
ECM. Earlier in 2015, one pioneering study reported methacrylating solubilized cartilage 
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matrix to make photocrosslinkable hydrogels, demonstrating for the first time that native 
tissues can be crosslinked to form hydrogels.141 However, in that study, the solubilized 
cartilage matrix was mixed with methacrylated gelatin (GelMA) and the biomechanics of 
the hydrogels, evaluated via the compressive modulus, still fell short of native cartilage 
tissue. Garrigues et al.41 cleverly reinforced solubilized cartilage ECM through combining 
it with poly(ε-caprolactone) and then electrospinning it into a scaffold. However, the 
Young’s moduli of the cartilage-containing electrospun scaffolds were approximately 10 
kPa, which again fall short of the biomechanics of native cartilage tissue. In this current 
study, the goal was to create the first hydrogel entirely composed of solubilized cartilage 
ECM without additional reinforcements. We hypothesized that this MeSDCC hydrogel 
would have a compressive modulus comparable to native cartilage and would be 
chondroinductive. Therefore, solubilized cartilage hydrogels were photocrosslinked and 
their mechanics as well as chondroinductive potential were analyzed.     
 
METHODS AND MATERIALS 
Tissue Retrieval, Devitalization, and Decellularization  
 Ten porcine knees obtained from Berkshire hogs (castrated males that were 
approximately 7-8 months old and 120 kg) were purchased from a local abattoir 
(Bichelmeyer Meats, Kansas City, KS). Articular cartilage from the knee and hip joints 
was carefully removed and collected using scalpels. The cartilage was then rinsed twice in 
DI water and stored at -20 ºC. After freezing overnight, the cartilage was thawed and then 
coarsely ground with dry ice using a cryogenic tissue grinder (BioSpec Products, 
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Bartlesville, OK). Coarse grinding was performed to reduce diffusion distances during the 
decellularization process. The dry ice was then allowed to evaporate overnight in the 
freezer, at which point the cartilage was referred to as devitalized cartilage (DVC),129 and 
then the DVC was packed into dialysis tubing (3500 MWCO) and decellularized using an 
adapted version of our previously established method using osmotic shock, detergent, and 
enzymatic washes.20 The packets were placed under gentle agitation (70 rpm) in a 
hypertonic salt solution (HSS) overnight at room temperature. The packets were then 
subjected to 220 rpm agitation with two reciprocating washes of triton X-100 (0.01% v/v) 
followed with HSS to permeabilize intact cellular membranes. The tissue was then treated 
overnight with benzonase (0.0625 KU ml-1) at 37 ºC and then with sodium-lauroylsarcosine 
(NLS, 1% v/v) overnight to further lyse cells and denature cellular proteins. After NLS 
exposure, the tissue was washed with ethanol (40% v/v) at 50 rpm and then was subjected 
to organic exchange resins at 65 rpm to extract the organic solvents. The tissue was then 
washed in saline-mannitol solution at 50 rpm followed by two hours of rinsing with DI 
water at 220 rpm. The tissue was then removed from the packets and was then frozen and 
lyophilized. The cartilage was then cryoground into a fine powder with a freezer-mill 
(SPEX SamplePrep, Metuchen, NJ) and was lyophilized overnight. The decellularized 
cartilage powder was then filtered using a 45 µm mesh (ThermoFisher Scientific, Waltham, 
MA) to remove large particles and then frozen until use. 
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Synthesis and Characterization of MeSDCC and GelMA 
DCC powder was first solubilized using an adapted protocol from a previously 
reported method.119 DCC powder was first mixed in 0.1M HCl at a concentration of 10mg 
DCC per 1 mL HCl. Pepsin was then added at a concentration of 1mg/mL and the solution 
was stirred at 200 rpm for 2 days at room temperature. The solution was then brought back 
to physiological pH, verified with litmus paper, by adding 1M NaOH. The solubilized DCC 
powder (SDCC) was then centrifuged at 10,000 x g for 3 min and the supernatant was 
frozen and lyophilized and used to make methacrylated SDCC (MeSDCC).  
MeSDCC was prepared by reacting SDCC with 20 fold molar excess glycidyl 
methacrylate (Sigma-Aldrich, St. Louis, MO) in the presence of trimethylamine and 
tetrabutyl ammonium bromide (Sigma-Aldrich). The reaction solution was a 1:3 
acetone:water mixture, which was stirred at 200 rpm at a concentration of 1 g SDCC for 
every 150 mL solution. The molar excess was approximated based on reacting one glycidyl 
methacrylate group to every monomer present in the solution and with the assumption that 
all monomers were hyaluronic acid. The reaction continued stirring for 6 days, the 
MeSDCC was then precipitated in excess acetone, dialyzed for 2 days in DI water, and 
then lyophilized. Methacrylated gelatin (GelMA) was made with the same protocol used 
to make MeSDCC, except Type A gelatin from porcine skin (Sigma-Aldrich) was used in 
the reaction instead of SDCC. Methacrylation was confirmed using 1H NMR (Avance AV-
III 500, Bruker). 
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Rat Bone Marrow Stem Cell Harvest and Culture 
Rat bone marrow stems cells (rBMSCs) were harvested from both femurs of five 
male Sprague-Dawley rats (200-250 g) following an approved University of Kansas 
IACUC protocol (AUS #175-08). The rBMSCs were first harvested in minimum essential 
medium-α (MEM-α, ThermoFisher) supplemented with 10% fetal bovine serum (FBS, 
MSC qualified, ThermoFisher) and 1% antibiotic-antimycotic (anti-anti, ThermoFisher) 
and were then cultured in this medium for one week to ensure no mycotic contamination 
from harvesting. After 1 week of culture, the anti-anti was substituted for 1% 
penicillin/streptomycin (ThermoFisher) and the cells were cultured in this medium until 
they reached passage 4 for cell encapsulation into the hydrogels. 
 
Description of Experimental Groups 
 Formulations tested in the 6 week culture were both cellular and acellular 
formulations of 10% GelMA, 10% MeSDCC, and 20% MeSDCC (w/v). In addition, 
acellular GelMA was tested at a concentration of 20% under mechanical compression and 
swelling at day 1. Acellular formulations were prepared and analyzed with the cellular 
groups to quantify the acellular biochemical content and to analyze the effect of cells 
encapsulated in the networks. A concentration of 10% for GelMA and MeSDCC was 
chosen as it was a concentration previously reported in literature, and it was verified in our 
preliminary studies by evaluation of a wide range of concentrations.141 A concentration of 




Preparation of Hydrogels, Cell Encapsulation, and Hydrogel Culture Conditions 
 Hydrogels were made by first measuring out the desired weight percents of either 
GelMA or MeSDCC into a 50 mL centrifuge tube. The tubes with the weighed materials 
were then sterilized with ethylene oxide prior to use and from then on were handled under 
sterile conditions. All gels were mixed in two stages (e.g., in photoinitiator solution 
overnight and then more photoinitiator or cell suspension the day of testing). This two-
stage mixing process was used because some of the samples required mixing with cells and 
the time it took for MeSDCC to dissolve to ensure mixture homogeneity (i.e., overnight) 
was deemed too long for adequate cell survival. Therefore, cell suspensions were added 
the next day after the MeSDCC was given a chance to dissolve in half of the final solution. 
For acellular testing, the first stage of mixing involved adding sterile 0.01 M PBS 
containing 0.05% (w/v) Irgacure (I-2959) photoinitiator until the concentration of 
MeSDCC or GelMA was twice the desired concentration. The acellular samples were then 
mixed, centrifuged at 3000 rpm, and stored at 4 ºC overnight to allow time for the MeSDCC 
to dissolve. Prior to testing, more photoinitiator solution was added to the acellular samples 
until the desired concentration was reached. The samples were then mixed again and 
centrifuged to remove air bubbles. For example, to make a 10% MeSDCC solution, 40 mg 
MeSDCC and 200 µL photoinitiator solution were mixed and allowed to dissolve 
overnight, and then another 200 µL photoinitiator solution was added to make the final 
concentration at 10% MeSDCC. For cellular testing, the first stage of mixing involved 
adding 0.1% (w/v) Irgacure photoinitiator in PBS until the concentration of MeSDCC or 
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GelMA was twice the desired final concentration, and then the solutions were centrifuged 
and stored at 4 ºC overnight. Passage 4 rBMSCs were then suspended at 10 million 
cells/mL in incomplete chondrogenic medium consisting of high glucose DMEM 
(ThermoFisher) with 4.5 g/L D-glucose supplemented with 10% FBS, 1% non-essential 
amino acids, 1% sodium pyruvate, 50 μg/mL ascorbic acid, and 0.25 mg/mL 
penicillin/streptomycin. We refer to incomplete chondrogenic medium as medium that did 
not contain growth factors. The cell suspension in incomplete chondrogenic medium was 
then added to the cellular samples until the desired concentration of MeSDCC or GelMA 
was reached and the final cell concentration and photoinitiator concentration was 5 million 
cells/mL and 0.05%, respectively. Both cellular and acellular solutions were then loaded 
into 2 mm thick molds between glass slides and exposed to 312 nm UV light at 3.0 mW/cm2 
in a UV crosslinker (Spectrolinker XL-100, Spectronics Corporation, Westbury, NY) for 
2.5 min on each side. Each gel was then cut using a 4mm biopsy punch and placed in one 
well of a 24 well, non-tissue culture-treated plate (Corning Incorporated, Corning, NY). 
Each gel was exposed to 1 mL of incomplete chondrogenic medium, which was replaced 
every other day throughout the 6 weeks of culture. 
 
Mechanical Testing of Crosslinked Hydrogels and Native Cartilage 
 The gels were allowed to swell to equilibrium for 24 hours in incomplete 
chondrogenic medium and mechanical testing was performed at 1 day and 6 weeks. The 
geometric mean diameter of the gels was first determined using forceps and a 
stereomicroscope (20x magnification) and the height of each gel was measured directly 
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with a RSA-III dynamic mechanical analyzer (DMA, TA instruments, New Castle, DE). 
The gels (n=5) were compressed until mechanical failure at a rate of 0.01 mm/s (i.e., 0.6% 
strain/s) until and the compressive modulus was calculated as the slope of the linear portion 
of the stress-strain curve (i.e., 4-10% strain).  
To compare the compressive modulus to that of native porcine cartilage, cylindrical 
samples of native articular cartilage obtained from the load-bearing region of the femoral 
head of the same porcine tissue harvested to make MeSDCC, were cut to the same height 
as the gel samples using scalpels and were then cut to the appropriate diameter using a 4 
mm biopsy punch. Methacrylated hyaluronic acid (MeHA) gels were tested on the DMA 
as a control. MeHA was prepared by reacting hyaluronic acid (MW 1 MDa, Lifecore 
Biomedical, Chaska, MN) with 20 fold molar excess glycidyl methacrylate (Sigma-
Aldrich) in the presence of triethylamine and tetrabutyl ammonium bromide (Sigma-
Aldrich) in a 50:50 water:acetone mixture stirring at 200rpm for 12 days. MeHA was then 
dialyzed against deionized (DI) water for two days and was frozen and lyophilized. The 
degree of methacrylation was determined to be 1.2% using 1H NMR (Avance AV-III 500, 
Bruker) by calculating the ratio of the relative peak area of methacrylate protons to methyl 
protons.63 MeHA was mixed to a 3% concentration using the same two step procedure as 
described prior and samples were cut using a 4 mm biopsy punch and were allowed to 
swell to equilibrium for 24 hours before testing on the DMA.  
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Swelling Degree and Volume 
 Gels were swollen to equilibrium for 24 hours and the swollen weight was recorded. 
The gels were then frozen and lyophilized. The dry weight was then recorded and the 
swelling degree was calculated as the ratio of total wet mass to dry mass. Gel volume was 
calculated at 1 day and 6 weeks from the diameter and height of the gels that were recorded 
during mechanical testing. 
 
Biochemical Content Analysis 
 The biochemical content of the initial DVC, DCC, SDCC, MeSDCC, and GelMA 
materials as well as the biochemical content of the gels at 1 day, 3 weeks, and 6 weeks of 
culture were quantified (n=5). The materials and gels were digested in a 1.5 mL papain 
mixture consisting of 125 mg/mL papain from papaya latex), 5 mM N-acetyl cysteine, 5 
mM EDTA, and 100 mM potassium phosphate buffered saline at 65 ºC overnight. The 
digestion solutions were stored at -20 ºC until further testing. Prior to biochemical analysis, 
all digestion solutions were allowed to thaw to room temperature and then vortexed and 
centrifuged at 10,000 rpm for 10 min to pellet polymer fragments and the supernatant was 
then used to quantify biochemical contents. Using a Cytation 5 Cell-Imaging Multi-Mode 
reader (Bio-Tek, Winooski, VT), the DNA content was quantified with the PicoGreen 
assay (Molecular Probes, Eugene, OR), the glycosaminoglycan (GAG) content was 
analyzed with the dimethylmethylene (DMMB) assay (Biocolor, Newtownabby, Northern 
Ireland), and hydroxyproline content was determined with a hydroxyproline detection kit 
(Sigma-Aldrich), all according to the manufacturer’s instructions. GAG and 
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hydroxyproline contents were not normalized to DNA and are rather shown in total because 
of the gels’ inherent initial GAG and hydroxyproline contents. 
 
Gene Expression Analysis 
 Using Qiagen QIAshredders and an RNeasy Kit (Valencia, CA) according to the 
manufacturer’s guidelines, RNA was isolated and purified (n=6). The isolated RNA was 
converted into cDNA using a high capacity cDNA reverse transcription kit (Applied 
Biosystems, Foster City, CA). Real-time quantitative polymerase chain reaction (qPCR) 
was performed using a RealPlex MasterCycler (Eppendorf, Hauppauge, NY) and TaqMan 
gene expression assays from Applied Biosystems, which included Sox-9 
(Rn01751070_m1), aggrecan (Rn00573424_m1), collagens type I (Rn01463848_m1) and 
II (Rn01637087_m1), and GAPDH (Rn01775763_g1). The 2-ΔΔCt method was used to 
quantify relative expression levels for each gene where the 10% GelMA gels at day 1 were 
designated as the calibrator group and GAPDH expression was used as the endogenous 
control.80 Finally, RNA from DVC and DCC only (i.e., no rBMSCs) was isolated, 
converted to DNA, and then PCR was performed with the same previously mentioned 
TaqMan assays, where it was confirmed that all gene expression observed in the study was 
that of the rBMSCs. 
 
Histological Analysis 
 Both cellular and acellular gels at day 1 and cellular gels from 6 weeks were 
analyzed histologically. These gels were first fixed in 10% formalin for 15 min, were 
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embedded in Optimal Temperature Cutting (OCT) medium (TissueTek, Torrance, CA) 
overnight at 37 °C, and were then frozen at -20 °C. Sections were cut at a thickness of 10 
µm using a cryostat (Micron HM-550 OMP, Vista, CA). The sections were then stained 
with the standard Hematoxylin and Eosin (H&E) stain, which stains the cytoplasm, 
connective tissues, and other extracellular substances red or pink and stains the nuclei 
purple. The sections were stained for GAGs with the standard Safranin-O/Fast Green (Saf-
O) stain, where the GAGs stain orange in color. Lastly, the sections were stained 
immunohistochemically using primary antibodies that target both rat and porcine tissues 
for collagen I (ThermoFisher, NB600408, 1:200 dilution), collagen II (Abcam, ab34712, 
1:200 dilution), and aggrecan (ThermoFisher, MA3-16888, 1:100 dilution). Prior to 
primary antibody incubation, the slides were first fixed in chilled acetone (-20 °C) and then 
treated with proteinase K (Abcam). The slides were then exposed to 0.3% hydrogen 
peroxide (Abcam) to suppress endogenous peroxidase activity. The sections were then 
blocked with serum according to the manufacturer’s instructions in the Vectastain ABC kit 
(Vector Laboratories, Burlingame, CA) and were then incubated with primary antibody. 
Then the sections were exposed to biotinylated secondary antibodies (horse anti-rabbit and 
mouse) and ABC reagent according to manufacturer protocol. The antibodies were 
visualized using the ImmPact DAB peroxidase substrate (Vector), and then the sections 
were rinsed in DI water, counter stained with VECTOR hematoxylin QS stain, and then 
dehydrated and mounted. Exposure to a rabbit IgG isotype control (for collagen I and II, 
Abcam, ab27478) at an antibody concentration calculated to be the same used for the 
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Statistics were performed on GraphPad Prism 6 statistical software (GraphPad 
Software, Inc., La Jolla, CA). A one-factor ANOVA was used for analyses with one time 
point and a two-factor ANOVA was used for analyses with two or more time points. Both 
ANOVAs were followed by either a Sidak’s post hoc test (for two-way ANOVAs with two 
time points only) or a Tukey’s post hoc test (for all other ANOVAs), where p ≤ 0.05 was 
considered significant. In addition, outliers were eliminated by constructing standard box 
plots. All quantitative results are reported as mean ± standard deviation within the text or 
as mean + standard deviation within the figures. Select significant differences between 
groups are highlighted in the Results section, with complete statistically significant 
differences reported in the figures.  
 
RESULTS 
Characterization of Initial DVC, DCC, MeSDCC, and GelMA DNA and Matrix 
Content 
 
Success of the methacrylation procedure for both MeSDCC and GelMA was 
confirmed via 1H NMR by the emergence of methacrylate peaks between 5 and 6.5 ppm 
(Figure 5.1A-B). The success of the methacrylation procedure was further confirmed with 
the formation of crosslinked GelMA and MeSDCC gels (Figure 5.1C). The DNA, GAG, 
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and hydroxyproline contents of DVC were determined to be 1151 ± 51 ng DNA/mg dry 
DVC, 252 ± 17 µg GAG/mg dry DVC, and 56.1 ± 3.9 µg hydroxyproline/mg dry DVC, 
respectively (Figure 5.2). Following decellularization and cryogrinding, there was a 44% 
reduction in DNA, a 23% reduction in GAG, and a 23% reduction in hydroxyproline 
(p<0.05) (Figure 5.2). After solubilizing and after methacrylating, the DNA content further 
reduced to 4% and 1.7% of that of the original DVC DNA content, respectively (p<0.05), 
although there were no significant reductions in GAG content through the solubilization 
and methacrylation procedure. Following solubilization, the hydroxyproline content was 
reduced by 25% compared to DCC, and then increased by 59% after the methacrylation 
procedure compared to SDCC (p<0.05). The DNA, GAG, and hydroxyproline contents of 
GelMA were 10.10 ± 0.81 ng DNA/mg dry GelMA, 8 ± 15 µg GAG/mg dry GelMA, and 
71.9 ± 1.0 µg hydroxyproline/mg dry GelMA, respectively (Figure 5.2).  
 
Mechanical Testing of Crosslinked Hydrogels 
One day after crosslinking, the compressive modulus of the 10% GelMA was 55 ± 
10 kPa, whereas that of the 10% MeSDCC and 20% MeSDCC groups were 5.3 and 20 
times larger, respectively (p<0.05) (Figure 5.3A). Furthermore, the compressive modulus 
of the 20% MeSDCC group was 3.7 times larger than that of the 10% MeSDCC group 
(p<0.05). In addition, the modulus of the 20% MeSDCC acellular group was 2.3 and 3.4 
times larger than that of the 10% MeSDCC and 20% GelMA acellular groups, respectively 
(p<0.05).  
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 Six weeks after crosslinking, the compressive modulus of the 20% MeSDCC group 
was 560 ± 310 kPa, which was 7.4 and 3.0 times larger than that of the 10% GelMA and 
10% MeSDCC groups, respectively (p<0.05) (Figure 5.3A).  
Over the 6 weeks of culture, the only groups that significantly deviated from their 
original compressive modulus were the 20% MeSDCC groups, where the modulus of the 
20% MeSDCC acellular and cellular groups reduced by 30% and 48%, respectively 
(p<0.05) (Figure 5.3A). Additionally, the modulus of the 10% GelMA group increased by 
37% over the 6 week culture period, although the increase was not significant.  
The stress-strain profiles of native porcine cartilage samples were compared with 
that of the 20% MeSDCC, 20% GelMA acellular, and 3% MeHA groups, where the 95% 
confidence intervals were compared at each level of strain tested. The only stress-strain 
profile that fell within the 95% confidence interval of the native porcine cartilage was that 
of the 20% MeSDCC group until it began to fracture at 7.5% strain (Figure 5.3B).  
 
Swelling and Volume Analysis  
 The only group that had a significantly different swelling degree than 10% GelMA, 
which had a swelling degree of 8.6 ± 1.2 after swelling to equilibrium, was the 10% 
MeSDCC acellular group, which had a swelling degree 56% higher than that of 10% 
GelMA (p<0.05) (Figure 5.4A). In addition, all 20% GelMA and MeSDCC groups had 
between 15% and 38% lower swelling degrees than that of the 10% MeSDCC cellular and 
acellular groups, where the swelling degrees of 20% GelMA, 20% MeSDCC acellular and 
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20% MeSDCC groups were 34%, 19%, and 15% lower than 10% MeSDCC (p<0.05) 
(Figure 5.4A).  
 At one day after crosslinking and swelling to equilibrium, the gel volumes of the 
20% GelMA and all MeSDCC gels were significantly higher than that of 10% GelMA 
(p<0.05) (Figure 5.4B). The 10% MeSDCC group had a volume of 20.24 ± 0.47 µL, while 
the 20% MeSDCC group had a volume 9.6% greater. These 10% and 20% MeSDCC 
groups in turn had volumes that were 17% and 29% higher than that of 10% GelMA, 
respectively (p<0.05).  
 At 6 weeks after crosslinking, the volume of the 20% MeSDCC group was 21.8 ± 
1.2 µL, which was 14% and 9.3% higher than that of 10% MeSDCC and 10% GelMA, 
respectively (p<0.05) (Figure 5.4B). In addition, the volume of the 20% MeSDCC group 
was 92% of its acellular control (p<0.05).  
 Over the course of the 6 weeks, the only group that had a significant change in 
volume was the 10% MeSDCC acellular group, which experienced an 11% reduction in 
volume (p<0.05).  
  
Biochemical Content Analysis 
As expected, all cellular groups had significantly higher DNA contents than their 
respective acellular groups at all time points (p<0.05) (Figure 5.6A). At 1 day after 
hydrogel formation, the 10% GelMA group contained 650 ± 160 ng DNA per gel, and the 
only gel with a significantly different DNA content was the 20% MeSDCC group, which 
had 21% more DNA per gel (p<0.05) (Figure 5.5A). At 3 weeks after crosslinking, the 
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20% MeSDCC group had a DNA content of 833 ± 88 ng DNA per gel, which was 3.2 and 
1.7 times higher than that of the 10% GelMA and 10% MeSDCC groups, respectively 
(p<0.05) (Figure 5.5A). After 6 weeks of culture, the 20% MeSDCC group contained 660 
± 80 ng DNA per gel, which was 2.1 and 1.3 times higher than that of the 10% GelMA and 
10% MeSDCC groups, respectively (p<0.05) (Figure 5.5A). Over the course of the 6 week 
culture period, all cellular groups had a significant reduction in DNA content (p<0.05), 
where the DNA content in the 10% GelMA, 10% MeSDCC, and 20% MeSDCC groups 
reduced by 51%, 30%, and 16%, respectively (p<0.05). The acellular groups did not have 
any significant reduction in DNA content over the culture period (Figure 5.5A).  
Throughout the culture period, there was no detectable level of GAG in the 10% 
GelMA group (Figure 5.5B). At 1 day after crosslinking, the GAG content of the 10% 
MeSDCC group was 74 ± 23 µg GAG per gel, and the GAG content of the 20% MeSDCC 
group was 92% higher (p<0.05) (Figure 5.5B). At 3 weeks, the GAG content of the 10% 
MeSDCC group was 22.3 ± 7.6 µg GAG per gel, which was not significantly different 
from the 20% MeSDCC group (Figure 5.5B). In addition, the GAG content of the 20% 
MeSDCC group was 55% less than its respective acellular control (p<0.05). At 6 weeks, 
the GAG content of the 10% MeSDCC group was 23.7 ± 9.2 µg GAG per gel, and the 
GAG content of the 20% MeSDCC group was 4.1 times larger (p<0.05). In addition, the 
GAG content of the 10% MeSDCC group was 68% less than that of its respective acellular 
control (p<0.05). Over the 6 week culture period, both the 10% MeSDCC group and the 
20% MeSDCC groups experienced 68% and 32% reductions in GAG content, respectively 
(p<0.05) (Figure 5.5B).  
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Finally, at 1 day, the initial hydroxyproline content of 10% GelMA was 108 ± 11 
µg hydroxyproline per gel, where that of the 20% MeSDCC group was 66% higher 
(p<0.05) (Figure 5.5C). At 3 weeks, the 10% GelMA group contained 111 ± 19 µg 
hydroxyproline per gel, which was 53% higher than that of the 10% MeSDCC group and 
22% lower than that of the 20% MeSDCC group (p<0.05). Furthermore, the 20% MeSDCC 
group contained 95% more hydroxyproline than that of the 10% MeSDCC group (p<0.05). 
At 6 weeks, the hydroxyproline content of the 10% GelMA group was 118 ± 17 µg per gel, 
which was 44% higher than that of the 10% MeSDCC group (p<0.05). Furthermore, the 
hydroxyproline content of the 20% MeSDCC group was 80% higher than that of the 10% 
MeSDCC group (p<0.05). Over the 6 week culture period, the only group that experienced 
a significant loss in hydroxyproline was the 20% MeSDCC group, where the 
hydroxyproline loss was 18% (p<0.05) (Figure 5.5C). 
 
Gene Expression Analysis  
 At 1 day after crosslinking, the relative Sox-9 expression of 10% MeSDCC and 
20% MeSDCC were 8.5 and 3.4 times larger than that of 10% GelMA (p<0.05) (Figure 
5.6A). The relative Sox-9 expression of the 10% MeSDCC group was 2.5 times larger than 
that of the 20% MeSDCC group (p<0.05). At 1 week, the relative Sox-9 expression of the 
10% GelMA group was 2.6 times larger than that of the 20% MeSDCC group (p<0.05). 
For the rest of the study, there were no significant differences in Sox-9 expression among 
groups within each time point. From 1 day to 1 week, the relative Sox-9 expression of the 
10% GelMA group increased by a factor of 2.5 (p<0.05), but then decreased by 54% from 
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1 week to 2 weeks (p<0.05), and did not change significantly thereafter. From 1 day to 1 
week, the relative Sox-9 expression of the 10% MeSDCC group decreased by 69% 
(p<0.05), and then further decreased by 80% from 1 week to 2 weeks (p<0.05). The relative 
Sox-9 expression of the 10% MeSDCC group did not change significantly after 2 weeks. 
Last, the relative Sox-9 expression of the 20% MeSDCC group decreased by 72% from 1 
day to 1 week (p<0.05) and did not change significantly thereafter (Figure 5.6A). 
 The relative aggrecan expression of 10% MeSDCC and 20% MeSDCC were 6.5 
and 2.8 times higher than that of 10% GelMA, respectively at 1 day (p<0.05) (Figure 5.6B). 
There were no significant differences among groups at each time point thereafter. By 1 
week, the relative aggrecan expressions of 10% GelMA, 10% MeSDCC, and 20% 
MeSDCC were reduced by 85%, 96%, and 89%, respectively, compared to their expression 
levels at 1 day (p<0.05), and there were no significantly different changes in expression 
thereafter.  
 The 10% MeSDCC and 20% MeSDCC groups had 8.1 and 2.9 fold higher relative 
collagen II expressions at 1 day (p<0.05), and by 1 week, the relative aggrecan expression 
of the 10% MeSDCC group was 2.7 times higher than that of 10% GelMA (p<0.05). 
Furthermore, at one week, the relative collagen II expression of the 10% MeSDCC group 
was 2.7 times higher than that of the 20% MeSDCC group. There were no significant 
differences among groups at each time point thereafter and collagen II expression was not 
detected at all at 6 weeks (Figure 5.6C). Over the culture period, there were no significant 
changes in collagen II expression for the 10% GelMA group, but the relative collagen II 
expression of the 10% MeSDCC group decreased by 73% from 1 day to 1 week (p<0.05), 
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and then it did not change significantly thereafter. The relative collagen II expression of 
the 20% MeSDCC group decreased by 81% from 1 day to 1 week (p<0.05), was not 
detectable at 2 weeks, but was detectable at 3 weeks, although the expression level at 3 
weeks was not significantly different from the expression level detected at 1 week (Figure 
5.6C). 
 The relative collagen I expressions of the 10% MeSDCC and 20% MeSDCC groups 
were 23% and 67% lower than that of the 10% GelMA group at day 1, respectively 
(p<0.05) (Figure 5.6D). There were no significant differences among groups observed 
thereafter within each time point in the culture period. From 1 day to 1 week, the relative 
collagen expression levels of the 10% GelMA, 10% MeSDCC, and 20% MeSDCC groups 
decreased by 94%, 93%, and 72%, respectively (p<0.05), and did not change significantly 
thereafter (Figure 5.6D). 
 
Histological Analysis 
H&E staining revealed regions of tissue growth within the 10% MeSDCC and 20% 
MeSDCC groups at 6 weeks. Saf-O did not stain for GAGs in any of the 10% GelMA 
stains; however, an increase in Saf-O staining intensity was notably observed over the 6 
week culture period in the 10% and 20% MeSDCC groups, particularly in the regions 
surrounding rBMSCs (Figure 5.7). All MeSDCC groups stained for collagen II, although 
no increase in collagen II staining intensity was observed for those groups. However, the 
10% GelMA group had an increase in collagen II staining intensity over the culture period 
(Figure 5.7). Collagen I staining was noted in the 10% GelMA group, although there were 
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no significant changes in staining over the culture period and minimal collagen I staining 
was observed in the other groups (Figure 5.7). Finally, the 10% GelMA and the 20% 
MeSDCC groups had a slight increase in aggrecan staining over the culture period (Figure 
5.7).   
 
DISCUSSION 
 In the current study, we were the first to create hydrogels derived entirely from 
solubilized cartilage ECM and test their chondroinductivity. ECM-based materials are 
attractive for tissue engineering strategies because they can potentially aid in stem cell 
recruitment, cell infiltration, and cell differentiation without supplementing with additional 
biological factors.6, 10, 104 However, one of the major limitations of using natural polymers 
in hydrogels is their reduced mechanical integrity.133 While native human articular 
cartilage has an elastic compressive modulus ranging from 240-1000 kPa,2, 76, 85 the 
compressive modulus of hydrogels composed of natural materials are typically an order of 
magnitude less than native cartilage tissue.133 However, it must be noted that 
biomechanical properties of cartilage can vary depending on parameters such as the method 
of testing, the strain rate of testing, and cartilage zone depth.49 Although certainly other 
mechanical properties have been explored and analyzed in cartilage tissue engineering, 
including the aggregate modulus, hydraulic permeability, and fracture stress,133, 150 in the 
current study the compressive modulus and the overall stress-strain profile of the gel 
constructs were the primary emphases. Gels composed entirely of crosslinked solubilized 
cartilage matrix were created that had a compressive modulus in the same range of values 
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reported for native cartilage. The 20% MeSDCC gels had a compressive modulus of 1070 
± 150 kPa after one day of culture, which was more than 3 fold higher than that of the 20% 
GelMA acellular group. Furthermore, when the 95% confidence intervals of the stress 
strain profiles of the 20% MeSDCC gels were compared to native porcine cartilage, it was 
found that the stress strain profile of the 20% MeSDCC gels actually fell within the 
confidence interval of native cartilage, and they were the only gels to do so. Although the 
20% gels fractured early at 7.5% strain, the fact that they fell within the stress strain profile 
of native cartilage tissue was promising. Clinically, these results could potentially translate 
to a surgeon being able to inject the paste into a cartilage defect and then crosslink the paste 
into a gel, allowing the patient to walk after the procedure. Certainly the early fracture 
stress needs to be addressed, however.150 Modifications to the hydrogel may be made such 
as increasing the solid content or methacrylation efficiency, to improve the fracture stress. 
At this stage, due to not knowing the exact biochemical content of MeSDCC, the degree 
of methacrylation could not be calculated through the NMR spectra, so this is one limitation 
of using MeSDCC as a hydrogel material. However, the ability to modulate the mechanical 
properties through the solid content is a tremendous advantage compared to crosslinking 
cartilage particles, where the solid content would be confined due to particles only 
crosslinking in the vicinity of other particles.  
 The mechanical properties of MeSDCC hydrogels may be able to be improved 
through mechanical stimuli in vivo, as mechanical stimulation alone is known to induce 
chondrogenesis.140 Therefore, once the material is implanted in vivo, there could be less of 
a decrease in the compressive modulus long-term like what was observed after 6 weeks of 
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in vitro culture in the current study. However, superior matrix synthesis was observed in 
the MeSDCC gels over the GelMA gels even in vitro via hematoxylin and eosin staining 
and Saf-O staining, even though the biochemical content analysis did not show an increase 
in the amount of matrix produced. This could be due to the cells assisting in the 
biodegradation and remodeling of the ECM, whereby even though some matrix is being 
lost, new matrix is simultaneously being formed. Low overall matrix production is 
consistent with findings from Visser et al.;141 however, they observed an increase in 
collagen I expression when exposed to MeSDCC as opposed to the current study, where a 
decrease in collagen I expression was noted while exposed to MeSDCC in reference to 
GelMA gels.  
Compared to GelMA gels, a significant increase in collagen II, Sox-9, and aggrecan 
expression was observed in the MeSDCC gels. Although a significant reduction in all 
chondrogenic gene expression was noted after 1 day, this reduction does not necessarily 
mean aggrecan and collagen II synthesis stopped. GelMA is widely used in the field of 
tissue engineering for its low cost, its abundant cell adhesion sites, and for its ability to 
support chondrocyte differentiation.114, 141 Therefore, it is possible that all gels had 
sufficient cartilage ECM production and the low chondrogenic gene expression levels were 
low only in reference to GelMA at day 1, the calibrator group. Through collagen II IHC 
analysis for example, the GelMA gels were noted to have an increase in collagen II staining 
at 6 weeks compared to day 1, even though the collagen II expression after 1 day was 
significantly reduced. Because the MeSDCC gels contained so much collagen II initially, 
it was difficult to discern any new collagen II production, but at least the relative level of 
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collagen II staining remained the same throughout culture. It must be noted that an increase 
in matrix synthesis and an increase in chondrogenic gene expression at day 1 was observed 
without any growth factor supplementation. ECM-based materials, like these MeSDCC 
hydrogels, are attractive for regenerative medicine because of their ability to potentially 
aid in stem cell recruitment, infiltration, and differentiation without supplementing with 
additional biological factors.6, 10, 104, 129 The ability to cause some differentiation shows 
great promise in using these materials for cartilage tissue engineering and may even make 
these gels more economical than using other natural materials such as hyaluronic acid or 
gelatin.127  
Of note was the limited removal of DNA in a mild decellularization process, which 
may need to be addressed in future work if it is deemed that a higher degree of 
decellularization is required for successful cartilage regeneration in vivo. However, non-
decellularized products, such as Zimmer’s DeNovo® product, rely on the 
immunoprivileged environment and so far there have been no reports to the best of our 
knowledge of allograft rejection or disease transmission even though the product is 
composed of living allogeneic cells. Additionally, although the DeNovo® product is 
composed of human juvenile cartilage, it has been observed to create hyaline-like cartilage 
in goats, where no T-cell-mediated response was noted.1 Furthermore, even though the 
decellularization process in the current study only removed 44% of the DNA, the DNA 
content of the SDCC and MeSDCC was reduced to 4% and 1.7% of that of the original 
DVC DNA content, respectively (p<0.05). At this stage, it is unknown whether the 
solubilization and methacrylation process were removing DNA, or if the DNA was 
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modified to a degree where the PicoGreen assay could no longer detect the DNA. Due to 
the low pH and pepsin exposure during the solubilization process, the DNA would likely 
be denatured to a single-stranded state and would in addition, be hydrolyzed and further 
degraded.88 Furthermore, the dialysis step after methacrylation would likely remove these 
degraded DNA segments and low molecular weight nucleotides and amino acids, leaving 
behind higher molecular weight methacrylated GAGs and collagen. Future work will 
certainly need to address how solubilization and methacrylation affect cartilage DNA and 
other biochemical contents and how they affect the retained growth factors. However, 
depending on the application of MeSDCC gels, decellularization may not even be 
necessary.  
In addition to mechanics and gene expression, the swelling and volume of the 
materials were analyzed throughout culture. One major concern of using hydrogels for 
tissue engineering is cell-mediated contraction of the gel construct throughout culture.13, 
141 Contraction of gels can cause disintegration with host tissue, which could potentially 
hinder successful cartilage regeneration and may even dislodge the hydrogel from the 
defect site. In the current study, however, the only gels that had a significant reduction in 
volume were the 20% MeSDCC gels, where the gels only reduced in volume by 2%, which 
is unlikely a concern for cartilage tissue engineering applications. In addition to volume, 
the swelling of the materials is important as well due to a drastic increase in swelling after 
surgical placement is undesirable. The swelling degree was significantly lowered by 
increasing the amount of material in the hydrogels from 10% to 20%, which is to be 




 We created crosslinkable hydrogels composed entirely of native cartilage ECM. 
The cartilage was first solubilized and then methacrylated to create photocrosslinkable 
gels. Compared to the traditional GelMA hydrogels, these MeSDCC gels supported 
rBMSC growth, ECM production, caused significant upregulation of chondrogenic genes 
at 1 day after crosslinking, and remarkably, the mechanics of the MeSDCC gels were 
characteristically similar to that of native porcine cartilage until their failure. The 
concentration of MeSDCC was found to affect chondroinduction and mechanical 
properties, where the 20% MeSDCC gels were superior in mechanical performance and 
promoting ECM synthesis, while the 10% MeSDCC gels were superior in 
chondroinduction. Future work will address improving the fracture mechanics, and 
chondrogenesis and immune compatibility in vivo. In the current study, we have shown 








CHAPTER 6: CHONDROINDUCTIVE HYDROGEL PASTES COMPOSED OF 
NATURALLY DERIVED DEVITALIZED CARTILAGE** 
 
ABSTRACT 
Hydrogels have several advantages for cartilage tissue engineering, but hydrogel 
precursors are liquid solutions that are prone to leaking from the defect site once implanted 
in vivo. In prior work, we addressed this drawback by adding hyaluronic acid nanoparticles 
to traditional photocrosslinkable polymers to induce paste-like behavior in hydrogel 
precursors, and the hydrogel precursors could then be crosslinked to form rigid hydrogel 
networks. In the current study, the objective was not only to create a hydrogel precursor 
that exhibited a yield stress, but to additionally create a chondroinductive biomaterial for 
cartilage tissue engineering applications. Given that cartilage extracellular matrix (ECM) 
has recently become known for its chondroinductive potential, devitalized cartilage ECM 
(DVC) were mixed with DVC that had been solubilized and methacrylated (MeSDVC) as 
a new two-component hydrogel precursor solution. Precursors composed of 10% 
MeSDVC and 10% MeSDVC with 10% DVC were evaluated rheologically and then 
photocrosslinked and further characterized as solids. The crosslinked gels contained 
encapsulated rat bone marrow stem cells (rBMSCs) and were cultured in vitro for 6 weeks 
in incomplete chondrogenic medium (i.e., no growth factors), where the MeSDVC + DVC 
gels were exposed to both incomplete and complete (i.e., addition of TGF-β3) chondrogenic 
                                               
**To be submitted as Beck E.C., Barragan M., Tadros M.H., Kieweg, S.L., and Detamore M.S., 
Chondroinductive Hydrogel Pastes Composed of Naturally Derived Devitalized Cartilage, Annals of 
Biomedical Engineering, 2015. 
 98 
media. The compressive modulus, gene expression, biochemical content, swelling, and 
histology of the gels were analyzed. Prior to crosslinking, non-Newtonian behavior was 
observed in all hydrogel precursors and a yield stress of over 1800 Pa was observed when 
MeSDVC and DVC particles were combined. The DVC-containing gels repeatedly 
outperformed the MeSDVC-only group in chondrogenic gene expression, especially at 6 
weeks, where the relative collagen II expression of the DVC-containing groups with and 
without TGF-β3 exposure was 40 and 78 fold higher, respectively, than that of MeSDVC 
alone. Of translational relevance, DVC-containing groups did not have any significant cell-
mediated contraction, while the MeSDVC gels contracted 18% over the culture period. 
Future work will address the combinations of DVC and MeSDVC that yield mechanics 
closer to that of native cartilage tissue and will test for chondrogenesis in vivo. Overall, 
these two cartilage-derived components are promising materials for cartilage tissue 
engineering applications.    
 
INTRODUCTION 
Hydrogels have several advantages for cartilage tissue engineering, including the 
ease of formation, the ability to encapsulate cells, and the ability to fine tune mechanical 
properties.9, 23, 33 Although hydrogels are promising materials for cartilage regeneration, 
they cannot be molded into a defect site by a surgeon because hydrogel precursors are 
liquid solutions that are prone to leaking after placement.110, 135 To address this drawback, 
we recently published a method to achieve paste-like hydrogel precursor solutions by 
combining hyaluronic acid nanoparticles with traditional crosslinked hyaluronic acid 
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hydrogels, known as methacrylated hyaluronic acid (MeHA).5 This paste-like behavior was 
induced by incorporating hyaluronic acid nanoparticles,5 where the MeHA mixed with 
hyaluronic acid nanoparticles were together referred to as hydrogel pastes prior to 
crosslinking. The hydrogel pastes were then crosslinked to form a rigid traditional hydrogel 
structure. In this current study, in an effort to introduce bioactivity to the hydrogel itself, 
the two components of the hydrogel paste, both the MeHA and nanoparticles were 
substituted with components made from naturally derived cartilage extracellular matrix 
(ECM). 
Materials derived from ECM are attractive for regenerative medicine because they 
may promote stem cell recruitment, infiltration, and differentiation without the need to 
supplement with additional biological factors.6, 10, 104 We and other groups have recently 
established that cartilage ECM has chondroinductive potential,11, 15, 41, 73, 115, 128 where we 
observed that rat bone marrow stem cells (rBMSCs) exposed to cartilage ECM 
outperformed those cells exposed to TGF-β3 in chondroinductivity.
128 ECM materials in 
general can be obtained from cell-derived matrices, which are ECM materials secreted 
during in vitro culture, or they can be obtained from native tissue.6, 11, 13, 22, 116, 156 
Additionally, ECM materials are generally either decellularized to remove cellular 
components and nucleic acids or they are devitalized to kill but not necessarily remove 
cells within the matrix.129  
Decellularization processes are known to inevitably cause some disruption to the 
matrix architecture, orientation, and surface landscape.60 Therefore, in this current work, 
only unaltered DVC was studied. The objective was to create a hydrogel paste that was 
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entirely derived from DVC that was capable of inducing chondrogenesis. Prior studies have 
made traditional hydrogels entirely out of ECM by first solubilizing the ECM, and the 
solubilized matrix could then form a gel at body temperature.40, 41, 43, 120 One group even 
used solubilized cartilage matrix as a depot for delivering drugs, where the gel maintained 
enough structural integrity under physiological conditions to sufficiently deliver bioactive 
molecules.70 When we tried using this thermoresponsive method to create solubilized 
cartilage hydrogels, the gels that formed were too compliant and left opportunity for 
improvement for load-bearing applications, so methods to further crosslink the cartilage 
were desired. The crosslinking of unsolubilized cartilage has been reported, including 
crosslinking cartilage ECM with genipin, dehydrothermal treatment, ultraviolet irradiation, 
or carbodiimide chemistry.13, 109 Using these methods, cartilage scaffolds were crosslinked 
and maintained some mechanical integrity throughout culture. Furthermore, cell mediated 
contraction was able to be controlled depending on the method of crosslinking. However, 
the authors noted that the constructs would need added reinforcements to achieve 
functional biomechanical properties. In the current study, these added reinforcements were 
attained by first solubilizing and then further crosslinking the cartilage tissue. Solubilizing 
the cartilage tissue allows for more fine-tuning of mechanical properties through allowing 
the control of the solid content of the hydrogel. Furthermore, solubilizing cartilage can 
remove particles that may cause premature gel fracture and it may open up more reactive 
sites on the cartilage ECM for crosslinking, which may help reinforce the ECM-based gels 
once they are crosslinked.  
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Therefore, with prior experience with functionalizing GAGs, such as hyaluronic 
acid and chondroitin sulfate with glycidyl methacrylate,5, 63 which allows 
photocrosslinking of the hydrogel material, in the current study, the solubilized cartilage 
ECM was methacrylated. One pioneering study recently reported methacrylating 
solubilized cartilage matrix to make photocrosslinkable hydrogels, and they demonstrated 
for the first time that native tissues can be crosslinked forming hydrogels.141 However, in 
that study, the solubilized cartilage matrix was reinforced with methacrylated gelatin 
(GelMA). In another study, solubilized cartilage ECM was cleverly reinforced by 
combining it with poly(ε-caprolactone) and then electrospinning it into a scaffold,41 
although the biomechanics of the scaffolds in that study still fell short of that of native 
cartilage tissue. The purpose of the current study was to create, for the first time, a hydrogel 
entirely composed of cartilage ECM without the use of GelMA and to additionally mix the 
methacrylated cartilage ECM with particles to give the hydrogel precursor a yield stress 
before crosslinking. We hypothesized that the hydrogel precursors containing DVC 
particles would exhibit a yield stress, and would be more chondroinductive than that of the 
methacrylated cartilage alone.  
 
METHODS AND MATERIALS 
Tissue Retrieval, Devitalization, and Cryogrinding  
 Twenty porcine knees were purchased from a local abattoir (Bichelmeyer Meats, 
Kansas City, KS). The knees came from Berkshire hogs, which were castrated males that 
were approximately 7-8 months old and 120 kg in weight. Articular cartilage from both the 
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knee and hip joints was carefully removed and collected using scalpels and was then rinsed 
twice in deionized (DI) water and stored at -20 ºC. After freezing overnight, the cartilage 
was thawed, mixed with dry ice and coarsely ground using a cryogenic tissue grinder 
(BioSpec Products, Bartlesville, OK). The dry ice was allowed to evaporate overnight in 
the freezer, where the cartilage was then referred to as devitalized cartilage (DVC), and 
then the DVC was lyophilized. The DVC was then cryoground into a fine powder using a 
freezer-mill (SPEX SamplePrep, Metuchen, NJ) and was lyophilized again overnight. The 
DVC powder was then filtered using a 106 µm mesh (ThermoFisher Scientific, Waltham, 
MA) to remove large particles and then frozen until use. 
 
Synthesis and Characterization of MeSDVC 
DVC powder was first solubilized using an adapted protocol from our previously 
reported method.119 First, DVC powder was mixed in 0.1M HCl at a concentration of 10 
mg DVC per 1 mL HCl. Pepsin was then added to the solution at a concentration of 1 
mg/mL. The mixture was then stirred at 200 rpm at room temperature. After 2 days of 
stirring, the solution was then brought back to physiological pH by adding 1M NaOH. This 
solubilized DVC powder (SDVC) was then centrifuged at 10,000 x g for 3 min to pellet 
any unsolubilized particulates and the supernatant was frozen and lyophilized and later 
used to make methacrylated SDVC (MeSDVC).  
MeSDVC was created by reacting SDVC with 20 fold molar excess glycidyl 
methacrylate (Sigma-Aldrich, St. Louis, MO) in the presence of trimethylamine and 
tetrabutyl ammonium bromide (Sigma-Aldrich) in a 1:3 acetone:water mixture at a 
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concentration of 1 g SDVC for every 150 mL solution. This solution was then stirred at 
200 rpm for 6 days. The molar excess was approximated based on reacting one glycidyl 
methacrylate group to every monomer present in the solution and with the assumption that 
all monomers were hyaluronic acid. After 6 days, the MeSDVC was then precipitated in 
excess acetone, was dialyzed for 2 days in DI water, and then was lyophilized. Successful 
methacrylation was confirmed using 1H NMR (Avance AV-III 500, Bruker). 
 
Rat Bone Marrow Stem Cell Harvest and Culture 
Following an approved IACUC protocol at the University of Kansas (AUS #175-
08), rat bone marrow stems cells (rBMSCs) were harvested from the femurs of two male 
Sprague-Dawley rats (200-250 g). The rBMSCs were first cultured for one week in 
minimum essential medium-α (MEM-α, ThermoFisher) supplemented with 10% fetal 
bovine serum (FBS, MSC qualified, ThermoFisher) and 1% antibiotic-antimycotic (anti-
anti, ThermoFisher) to ensure no mycotic contamination from harvesting. After 1 week of 
culture, the anti-anti was substituted for 1% penicillin/streptomycin (ThermoFisher), in 
which the cells were then cultured until they reached passage 4 for cell encapsulation into 
the hydrogels. 
 
Description of Experimental Groups 
 Both acellular and cellular crosslinked formulations of 10% MeSDVC and 10% 
MeSDVC 10% DVC (w/v) were tested for 6 weeks in vitro along with one cellular group 
composed of 10% MeSDVC 10% DVC that was exposed to 10 ng/mL human transforming 
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growth factor-β3 (TGF-β3, PeproTech Inc., Rocky Hill, NJ). In addition, one acellular 
group composed of 20% MeSDVC was tested at day 1 after crosslinking. The acellular 
formulations were analyzed along with the cellular groups to quantify the acellular 
biochemical content and to analyze the effect of cells encapsulated in the networks. Ten 
percent MeSDVC was chosen as it was a concentration previously reported in literature for 
methacrylated gelatin (GelMA) gels.141 A concentration of 20% MeSDVC was chosen as 
that is the approximate concentration of dry mass in native cartilage matrix.85 Prior to 
crosslinking, the aforementioned cellular and acellular groups (except the growth factor 
group) and additional groups of 5% DVC and 10% DVC were tested rheologically. 
However, DVC alone cannot be crosslinked into a hydrogel network, which is why these 
two DVC groups were only tested rheologically.  
 
Preparation of Hydrogel Pastes, Cell Encapsulation, and Hydrogel Culture 
Conditions 
 
 Hydrogel pastes were created by first measuring the desired weight percents of 
MeSDVC and DVC in a mini-centrifuge tube. All materials used for future cell 
encapsulation were then sterilized with ethylene oxide prior to use and were handled under 
sterile conditions thereafter. The pastes were mixed in two stages (e.g., in photoinitiator 
solution overnight and then more photoinitiator solution or cell suspension the day of 
testing) due to the longer time it took for MeSDVC to dissolve (i.e., overnight) to ensure 
mixture homogeneity. This length of time was deemed too long for adequate cell survival 
for the groups incorporating cells. Therefore, cell mixtures were added the day after the 
MeSDVC was mixed and given a chance to dissolve in half of the final solution. For 
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rheological testing of acellular groups, two stages of mixing was performed to maintain the 
same mixing process for both cellular and acellular groups. Sterile 0.01M PBS containing 
0.05% (w/v) Irgacure (I-2959) photoinitiator was added to the acellular groups until the 
concentration of MeSDVC and DVC was twice the desired concentration. The samples 
were then mixed, centrifuged at 3000 rpm, and stored at 4 ºC overnight to allow the 
MeSDVC to adequately dissolve. Prior to rheological testing, more photoinitiator solution 
was added until the desired final concentration of materials was reached. The samples were 
then again mixed and centrifuged to remove air bubbles. For example, to make a 10% 
MeSDVC solution, 40 mg MeSDVC and 200 µL photoinitiator solution were mixed and 
allowed to fully dissolve overnight and then another 200 µL photoinitiator solution was 
added to make the final concentration at 10% MeSDVC the following day. For cellular 
testing, the samples were first mixed with 0.1% (w/v) Irgacure photoinitiator in PBS until 
the concentration of MeSDVC and DVC was twice the desired final concentration, and 
then the solutions were centrifuged and stored at 4 °C overnight just like the acellular 
groups. The following day however, passage 4 rBMSCs were then suspended at 20 million 
cells/mL in incomplete chondrogenic medium consisting of high glucose DMEM 
(ThermoFisher) with 4.5 g/L D-glucose supplemented with 10% FBS, 1% non-essential 
amino acids, 1% sodium pyruvate, 50 μg/mL ascorbic acid, and 0.25 mg/mL 
penicillin/streptomycin. This cell suspension was then added to the hydrogel paste 
solutions until the desired concentration of MeSDVC and DVC was reached and the final 
cell concentration and photoinitiator concentration were 10 million cells/mL and 0.05%, 
respectively. These solutions were then either tested rheologically or they were crosslinked 
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with UV light and further characterized as solids. For pastes undergoing crosslinking, the 
paste solutions were loaded into 2 mm thick molds between glass slides and exposed to 
312 nm UV light at 3.0 mW/cm2 in a UV crosslinker (Spectrolinker XL-100, Spectronics 
Corporation, Westbury, NY) for 2.5 min on each side for a total of 5 min. Using a 4 mm 
biopsy punch, each gel was cut and placed in one well of a 24 well, non-tissue culture-
treated plate (Corning Incorporated, Corning, NY). Each gel was then exposed to 1 mL of 
incomplete chondrogenic medium or 1 mL of complete chondrogenic medium, which 
consisted of incomplete chondrogenic medium and 0.1 mg/mL dexamethasone and 10 
ng/mL TGF-β3. The medium was replaced every other day throughout the 6 week study. 
 
Rheological Testing of Hydrogel Precursors 
 Prior to crosslinking the hydrogel precursor pastes, the precursor solutions were 
shaped into spheres to demonstrate their shaping capabilities, and they were then loaded 
into a 3 mL syringe and extruded onto a glass slide to macroscopically observe shape 
retention. The gels were extruded in a wavy line appearance to observe whether the 
formulations could maintain shaping after crosslinking. 
The oscillatory shear stress of the precursor solutions (n=5) was measured over an 
oscillatory shear stress sweep of 1-2500 Pa at 37 °C using an AR-2000 rheometer (TA 
instruments, New Castle, DE) and a gap of 500 µm. The rheometer was equipped with a 
20 mm diameter roughened plate and a roughened Peltier plate cover. Frozen rBMSCs that 
were thawed and cultured to passage 4 were used to make the cellular samples for 
rheological testing. The pastes for rheological testing were created as previously mentioned 
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for the in vitro culture. The yield stress was interpolated from the point at which the storage 
(G’) and loss (G’’) modulus crossed.142 Additionally, an oscillatory shear stress sweep of 
0.1-10 Pa was performed to assess the linear viscoelastic region of the hydrogel precursors 
to determine the storage modulus of each solution. 
 
Mechanical Testing of Crosslinked Hydrogels  
 After swelling to equilibrium for 24 hours in either complete or incomplete 
chondrogenic medium, mechanical testing was performed. In addition, the groups in the 6 
week study were tested at 6 weeks as well. First, the geometric mean diameter of the gels 
was determined using forceps and a stereomicroscope (20x magnification) and then the 
height of each gel was measured directly using a RSA-III dynamic mechanical analyzer 
(DMA, TA instruments, New Castle, DE). The gels (n=5) were then compressed at a rate 
of 0.01 mm/s until mechanical failure. The compressive modulus was calculated as the 
slope of the linear portion of the stress-strain curve (i.e., 5-15% strain). 
 
Swelling Degree and Volume 
 Gels that were swollen to equilibrium were weighed 1 day after crosslinking and 
were then frozen and lyophilized (n=5). The dry weight was then recorded and the swelling 
degree was calculated as the ratio of total wet mass to dry mass. From the diameter and 
height readings recorded during mechanical testing, the volume of each gel (n=5) was 
calculated at 1 day and after 6 weeks of culture. 
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Biochemical Content Analysis 
 The biochemical content of the starting materials, which include MeSDVC, SDVC, 
and DVC, and the biochemical content of the gels at 1 day, 3 weeks, and 6 weeks were 
quantified (n=5). The gels were each digested overnight in a 1.5 mL papain mixture 
consisting of 125 mg/mL papain from papaya latex), 5 mM N-acetyl cysteine, 5 mM 
EDTA, and 100 mM potassium phosphate buffered saline at 65 °C. The digested solutions 
were then frozen and stored at -20 °C. Prior to biochemical analyses, all digested gel 
solutions were thawed to room temperature and then vortexed and centrifuged at 10,000 
rpm for 10 min to pellet fragments of polymers. The supernatant was then used to quantify 
DNA, GAG, and hydroxyproline contents. Using a Cytation 5 Cell-Imaging Multi-Mode 
reader (Bio-Tek, Winooski, VT) and according to manufacturer instructions, the DNA 
content was quantified with the PicoGreen assay (Molecular Probes, Eugene, OR), the 
glycosaminoglycan (GAG) content was determined with the dimethylmethylene blue 
(DMMB) assay (Biocolor, Newtownabby, Northern Ireland), and the hydroxyproline 
content was quantified using a hydroxyproline detection kit (Sigma-Aldrich). Neither the 
GAG or hydroxyproline contents were normalized to DNA and instead are shown in total 
because of the gels’ inherent initial DNA contents (i.e., true normalization to DNA content 
of seeded cells is not possible).  
 
Gene Expression Analysis 
 RNA was isolated and purified using Qiagen QIAshredders followed by an RNeasy 
Kit (Valencia, CA) according to manufacturer guidelines (n=6). Isolated RNA was 
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converted into cDNA using a high capacity cDNA reverse transcription kit (Applied 
Biosystems, Foster City, CA). Real-time quantitative polymerase chain reaction (qPCR) 
was performed using a RealPlex MasterCycler (Eppendorf, Hauppauge, NY) and TaqMan 
gene expression assays from Applied Biosystems for Sox-9 (Rn01751070_m1), aggrecan 
(Rn00573424_m1), collagens type I (Rn01463848_m1) and II (Rn01637087_m1), and 
GAPDH (Rn01775763_g1). Relative gene expression levels for each gene were calculated 
using the 2-ΔΔCt method where the 10% MeSDVC gels at day 1 were designated as the 
calibrator group and GAPDH expression was used as the endogenous control.80 Last, RNA 
from DVC only (i.e., no rBMSCs) was isolated, converted to DNA, and then PCR was 
performed with the same previously mentioned TaqMan assays, where it was confirmed 
that all gene expression observed in the study was that of the rBMSCs. 
 
Histological Analysis 
 Cellular gels from day 1 and 6 weeks were fixed in 10% formalin for 15 min and 
then embedded in Optimal Temperature Cutting (OCT) medium (TissueTek, Torrance, 
CA) overnight at 37 °C. Then the gels were frozen at -20 °C and were sectioned at a 
thickness of 10 µm using a cryostat (Micron HM-550 OMP, Vista, CA). The sections were 
then stained with the standard Hematoxylin and Eosin (H&E) stain, which stains the 
cytoplasm, connective tissues, and other extracellular substances red or pink and the nuclei 
purple. In addition, sections were stained with the standard Safranin-O/Fast Green (Saf-O) 
stain, which stains negatively charged GAGs orange. Last, the sections were stained 
immunologically using primary antibodies that target both rat and porcine tissues for 
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collagen I (ThermoFisher, NB600408, 1:200 dilution), collagen II (Abcam, ab34712, 1:200 
dilution), and aggrecan (ThermoFisher, MA3-16888, 1:100 dilution). The slides were first 
fixed in chilled acetone (-20 °C), treated with proteinase K (Abcam), and exposed to 0.3% 
hydrogen peroxide to suppress endogenous peroxidase activity. Then the sections were 
blocked with serum according to the Vectastain ABC kit (Vector Laboratories, 
Burlingame, CA) following the manufacturer’s instructions and were then incubated with 
primary antibody. Following primary antibody incubation, the sections were exposed to 
biotinylated secondary antibodies (horse anti-rabbit and mouse) and ABC reagent 
according to the manufacturer protocol. Antibodies were visualized using the ImmPact 
DAB peroxidase substrate (Vector). The sections were then rinsed in DI water, counter 
stained with VECTOR hematoxylin QS stain, and then were dehydrated and mounted. 
Negative controls consisted of omitting the primary antibody (for aggrecan) or substituting 
with a rabbit IgG isotype control (for collagen I and II, Abcam, ab27478) at an antibody 
concentration calculated to be the same used for the corresponding antibodies.  
 
Statistical Analysis 
Using GraphPad Prism 6 statistical software (GraphPad Software, Inc., La Jolla, 
CA), experimental groups were compared using a one-factor ANOVA (for analyses with 
one time point) or a two-factor ANOVA (for analyses with two or more time points) 
followed by either a Sidak’s post hoc test (for two-way ANOVAs with two time points 
only) or a Tukey’s post hoc test (for all other ANOVAs), where p ≤ 0.05 was considered 
significant. Standard box plots were constructed to eliminate outliers. All quantitative 
 111 
results are reported as mean ± standard deviation within the text or as mean + standard 
deviation within the figures. Furthermore, unless otherwise stated, all groups discussed in 
the Results section are cell-encapsulated. 
 
RESULTS 
Characterization of MeSDVC, SDVC, and DVC particles 
 Success of the methacrylation procedure MeSDVC was confirmed via 1H NMR by 
the emergence of methacrylate peaks between 5 and 6.5 ppm (Figure 6.1). The DNA 
content of the DVC particles was 1170 ± 68 ng DNA per mg dry DVC, where the SDVC 
and MeSDVC had DNA contents that were 92% and 97% less than DVC, respectively 
(p<0.05) (Figure 6.2A). The GAG content of the DVC particles was 380 ± 57 µg GAG per 
mg dry DVC, and the SDVC and MeSDVC had GAG contents that were 44% and 41% 
less than that of DVC, respectively (p<0.05) (Figure 6.2B). Last, the hydroxyproline 
content of DVC was 48.60 ± 0.58 µg hydroxyproline per mg dry DVC, where the 
hydroxyproline content of SDVC was 26% lower than that of DVC (p<0.05) (Figure 6.2C). 
The hydroxyproline content of MeSDVC was not significantly different from that of DVC, 
but was 41% higher than that of SDVC (p<0.05).   
 
Macroscopic Observation and Rheological Testing of Hydrogel Precursors 
 Macroscopic observation of hydrogel precursors revealed non-Newtonian and 
paste-like behavior in all precursors (Figure 6.3). Furthermore, all solutions except the 5% 
DVC and 10% DVC groups were able to be shaped and molded into a sphere, where it was 
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noted that the pastes incorporating particles were easier to shape and manipulate because 
the solutions containing only MeSDVC were sticky. Shape retention after extrusion 
through a 3 mL syringe was indicated by the fluids that retained the diameter of the syringe 
orifice. All pastes exhibited shape retention except the 5% DVC group, which spread out 
over 2 times the diameter of the syringe orifice. Furthermore, all formulations containing 
MeSDVC were able to be crosslinked to maintain extrusion shape (Figure 6.3).  
 Additionally, all solutions exhibited a yield stress (Figure 6.4A). The yield stress 
of 10% MeSDVC acellular group was 725 ± 55 Pa, where the difference in yield stress 
compared to its respective cellular group was not significant. The 5% DVC and 10% DVC 
groups had yield stresses that were 96% and 92% lower, respectively, than that of 10% 
MeSDVC (p<0.05), while the MeSDVC + DVC acellular group had a yield stress that was 
94% higher than that of 10% MeSDVC (p<0.05) (Figure 6.4A). Furthermore, when cells 
were mixed into the MeSDVC + DVC group, the yield stress was not significantly different 
from the acellular group, but it was 62% higher than that of the 20% MeSDVC acellular 
group (p<0.05). 
 All solutions exhibited viscoelastic behavior, which was indicated by a measurable 
storage modulus, although the storage modulus of the 5% DVC was the lowest at 1.33 ± 
0.80 Pa (Figure 6.4B). The storage modulus of the 10% MeSDVC acellular group was 773 
± 84 Pa. The only groups that were significantly different from the 10% MeSDVC acellular 
group were the acellular and cellular MeSDVC + DVC groups, where their storage moduli 
were 5.7 and 7.2 times higher than that of the 10% MeSDVC acellular group, respectively 
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(p<0.05). Last, the storage modulus of the MeSDVC + DVC cellular group was 2 times 
higher than that of the 20% MeSDVC acellular group (p<0.05).  
 
Mechanical Testing of Crosslinked Hydrogel Pastes 
One day after crosslinking, the compressive modulus of the 10% MeSDVC 
acellular group was 135 ± 37 kPa (Figure 6.5). None of the groups were significantly 
different from the 10% MeSDVC acellular group except the 20% MeSDVC acellular 
group, which had a modulus of 675 ± 130 kPa (p<0.05).  
 Six weeks after crosslinking, the compressive modulus of the 10% MeSDVC 
acellular group was 32 ± 12 kPa, although there were no significant differences compared 
to other groups (Figure 6.5). However, over the 6 weeks of culture, while most of the 
groups did not deviate significantly from their original compressive modulus, the 
compressive modulus of the 10% MeSDVC acellular and cellular groups reduced by 77% 
and 86%, respectively (p<0.05).   
 
Swelling and Volume Analysis of Crosslinked Hydrogel Pastes 
 The only group that had a significantly lower swelling degree than that of the 10% 
MeSDVC group, which had a swelling degree of 10.5 ± 3.5 after swelling to equilibrium, 
was the 20% MeSDVC acellular group, where its swelling degree was 36% lower than that 
of the 10% MeSDVC group (p<0.05) (Figure 6.6A).  
 At one day after crosslinking and swelling to equilibrium, the gel volume of the 
10% MeSDVC group was 19.26 ± 0.54 µL, where the volumes of the MeSDVC + DVC 
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cellular, acellular, and TGF-β3 exposed groups were 17%, 20%, and 17% higher, 
respectively (p<0.05) (Figure 6.6B). Furthermore, the volume of the MeSDVC + DVC 
group was 22.6 ± 1.7 µL and it was not significant from its respective acellular and growth 
factor exposed group.  
 At 6 weeks after crosslinking, again all three of the MeSDVC + DVC groups had 
significantly higher volumes than that of the 10% MeSDVC group (p<0.05) (Figure 6.6B). 
The volume of the 10% MeSDVC group was 15.8 ± 2.1 µL, while the volume of the cellular 
MeSDVC + DVC group was 36% larger (p<0.05).  
 Over the course of 6 weeks, the only groups that had a significant change in volume 
were the 10% MeSDVC acellular and cellular groups, where they each decreased in 
volume by 27% and 18%, respectively (p<0.05) (Figure 6.6B). The volumes of all three 
MeSDVC + DVC groups remained constant throughout the 6 week study.  
 
Biochemical Content of Crosslinked Hydrogel Pastes 
All cellular groups had significantly higher DNA contents than their respective 
acellular groups at all time points (p<0.05) (Figure 6.7A). At 1 day after crosslinking, the 
10% MeSDVC group contained 680 ± 170 ng DNA per gel, and both the MeSDVC + DVC 
cellular and growth factor exposed groups contained 26% and 28% more DNA, 
respectively, (p<0.05). At 3 weeks after crosslinking, the 10% MeSDVC group had a DNA 
content of 386 ± 37 ng DNA per gel, which was not significantly different from any of the 
other cellular groups (Figure 6.7A). After 6 weeks of culture, the 10% MeSDVC group 
contained 241 ± 18 ng DNA per gel, which was 42% lower than the DNA content of the 
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MeSDVC + DVC + TGF-β3 group (p<0.05) (Figure 6.7A). Over the course of the 6 week 
culture period, all cellular groups had a significant reduction in DNA content (p<0.05), 
where after 3 weeks the DNA content in the 10% MeSDVC, MeSDVC + DVC, and the 
MeSDVC + DVC + TGF-β3 groups decreased by 43%, 43%, and 49%, respectively 
(p<0.05). By 6 weeks, the DNA contents of the 10% MeSDVC and MeSDVC + DVC 
groups were significantly lower than their 3 week values, where their total reductions in 
DNA over the entire culture period was 65% and 72%, respectively (p<0.05). There was 
not a significant reduction in DNA content for the growth factor exposed group after 3 
weeks. Finally, the acellular groups did not have any significant reduction in DNA content 
over the culture period (Figure 6.7A).  
At one day after crosslinking, the GAG content of the 10% MeSDVC group was 
86 ± 15 µg GAG per gel, where that of the MeSDVC + DVC group was 3.9 fold higher 
(p<0.05) (Figure 6.7B). Additionally, the MeSDVC + DVC and the TGF-β3 exposed 
groups contained 45% and 27% more GAG than their acellular control (p<0.05). At 3 
weeks, the GAG content of the 10% MeSDVC was 40.7 ± 2.5 µg GAG per gel, whereas 
that of the MeSDVC + DVC group was 4.7 fold higher (p<0.05) (Figure 6.7B). At 6 weeks, 
the GAG content of the 10% MeSDVC group was 25.2 ± 3.0 µg GAG per gel, whereas 
that of the MeSDVC + DVC group was 3.7 fold higher (p<0.05). In addition, the GAG 
content of the MeSDVC + DVC + TGF-β3 group was 75% larger than that of the MeSDVC 
+ DVC group (p<0.05). From day 1 to 3 weeks, the GAG contents of the 10% MeSDVC, 
the MeSDVC + DVC, and the MeSDVC + DVC + TGF-β3 group decreased by 53%, 43%, 
and 26%, respectively (p<0.05). By 6 weeks, the GAG contents of the MeSDVC + DVC 
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and the MeSDVC + DVC + TGF-β3 groups decreased by 72% and 44%, respectively, 
compared to their original GAG contents (p<0.05).   
Finally, at day 1, the initial hydroxyproline content of the 10% MeSDVC group 
was 66.4 ± 2.8 µg hydroxyproline per gel, whereas that of the MeSDVC + DVC group was 
2.7 fold higher (p<0.05) (Figure 6.7C). At 3 weeks, the MeSDVC + DVC group contained 
144 ± 21 µg hydroxyproline per gel, which was 2 times higher than that of the 10% 
MeSDVC group and 22% lower than that of the MeSDVC + DVC + TGF-β3 group 
(p<0.05). At 6 weeks, the hydroxyproline content of the MeSDVC + DVC group was 114 
± 11 µg hydroxyproline per gel, which was 89% higher than that of the 10% MeSDVC 
group and 28% lower than that of the MeSDVC + DVC + TGF-β3 group (p<0.05). The 
only group that experienced a loss in hydroxyproline content from day 1 to 3 weeks was 
the MeSDVC + DVC group, where at 3 weeks the hydroxyproline content was 81% of its 
original content at day 1 (p<0.05). By 6 weeks, all three of the DVC-incorporating groups 
experienced a significant loss in hydroxyproline, where the hydroxyproline contents for 
the MeSDVC + DVC and the MeSDVC + DVC + TGF-β3 groups were 64% and 95% of 
their original contents at day 1 (p<0.05).  
 
Gene Expression Analysis 
At 1 day after crosslinking, the relative Sox-9 expression of 10% MeSDVC was 9.4 
times larger than that of the MeSDVC + DVC group (p<0.05) (Figure 6.8A). Furthermore, 
growth factor exposure had no significant effect on Sox-9 expression compared to the 
MeSDVC + DVC group. At 1 week, the relative Sox-9 expression of the 10% MeSDVC 
 117 
group was 73% larger than that of the TGF-β3 exposed group (p<0.05). At 2 weeks, the 
relative Sox-9 expression of the MeSDVC + DVC group was 89% larger than that of the 
10% MeSDVC group and 37% smaller than that of the TGF-β3 exposed group (p<0.05). 
At 3 weeks, the relative Sox-9 expression of the MeSDVC + DVC group was 5.2 fold 
higher than that of the 10% MeSDVC group (p<0.05). At 6 weeks, the relative Sox-9 
expression of the MeSDVC + DVC group was 15 and 5.6 times larger than that of the 10% 
MeSDVC and the TGF-β3 exposed groups, respectively (p<0.05) (Figure 6.8A). From 1 
day to 3 weeks, the relative Sox-9 expression of the 10% MeSDVC group decreased by 
82% (p<0.05), but did not change significantly thereafter. From 1 day to 1 week, the 
relative Sox-9 expression of the MeSDVC + DVC group increased by a factor of 6.6 
(p<0.05), and did not change significantly thereafter. Finally, the relative Sox-9 expression 
of the MeSDVC + DVC + TGF-β3 group increased by a factor of 6.6 from 1 day to 1 week 
(p<0.05), increased by a factor of 2.9 from 1 week to 2 weeks (p<0.05), decreased by 54% 
from 2 weeks to 3 weeks (p<0.05), and then decreased again by 87% from 3 weeks to 6 
weeks (p<0.05) (Figure 6.8A). 
 The relative aggrecan expression of 10% MeSDVC was 42 times higher than that 
of the MeSDVC + DVC group at day 1 (p<0.05) (Figure 6.8B). There were no significant 
differences among groups at 1 week. At 2 weeks, the relative aggrecan expression of the 
MeSDVC + DVC group was 2.8 times higher than that of 10% MeSDVC and 41% lower 
than that of the TGF-β3 exposed group (p<0.05). At 3 weeks, the relative aggrecan 
expression of the MeSDVC + DVC group was 8.6 times higher than that of the 10% 
MeSDVC group (p<0.05). At 6 weeks, there was no detectable aggrecan expression in the 
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TGF-β3 exposed group. However, the relative aggrecan expression of the MeSDVC + DVC 
group was 53 times higher than that of the 10% MeSDVC group (p<0.05). From day 1 to 
1 week, the relative aggrecan expression of the 10% MeSDVC group decreased by 94% 
(p<0.05), and did not change significantly thereafter. The relative aggrecan expression of 
the MeSDVC + DVC group increased by a factor of 3.3 from 1 day to 1 week (p<0.05), 
and did not change significantly thereafter. Last, from 1 day to 2 weeks, the relative 
aggrecan expression of the MeSDVC + DVC + TGF-β3 group increased by a factor of 5.9 
(p<0.05), and then decreased by 45% from 2 weeks to 3 weeks (p<0.05) (Figure 6.8B).   
 There were no significant differences between groups for collagen II expression 
from day 1 through 6 weeks (Figure 6.8C). Additionally, there was no detectable collagen 
II expression in the DVC-incorporated groups at 2 and 3 weeks, and there was no detectable 
collagen II expression in the 10% MeSDVC group at week 3. However, at 6 weeks, the 
relative collagen II expressions of the MeSDVC + DVC and the TGF-β3 exposed groups 
were 78 and 40 fold higher than that of the 10% MeSDVC group, respectively (p<0.05). 
Due to many groups not having detectable collagen II expression throughout the culture 
period, for observing differences within groups throughout the culture period, only 
differences from day 1 to 6 weeks were reported here. From 1 day to 6 weeks, the relative 
collagen II expression for 10% MeSDVC did not change significantly. However, the 
relative collagen II expression for the MeSDVC + DVC and the MeSDVC + DVC + TGF-
β3 groups increased by a factor of 131.1 and 92.9, respectively (p<0.05) (Figure 6.8C).  
 The relative collagen I expression of the 10% MeSDVC group at 1 day was 17.9 
fold higher than that of the MeSDVC + DVC group (p<0.05) (Figure 6.8D). The relative 
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collagen I expression of the 10% MeSDVC group was 84% and 92% less than that of the 
MeSDVC + DVC group at 1 week and 2 weeks, respectively (p<0.05). At 3 weeks and at 
6 weeks, there were no significant differences among groups. From 1 day to 1 week, the 
relative collagen I expression of the 10% MeSDVC group decreased by 98% (p<0.05) and 
did not change significantly thereafter. Finally, the relative collagen I expression level for 
the DVC-incorporating groups did not change significantly throughout the culture period 
(Figure 6.8D).  
 
Histological and Immunohistochemical Evaluation 
At 6 weeks, there were no discernable changes in any of the constructs other than 
the DVC-containing groups appeared to have a decreased cell density compared to their 
respective cell densities at day 1. However, throughout culture, the cells remained evenly 
distributed. Saf-O stained MeSDVC and DVC particles a dark red/orange color and the 
staining intensity of the DVC particles appeared to fade over the 6 weeks in culture (Figure 
6.9). All groups stained for collagen II, where the collagen II staining for the DVC-
incorporated groups was slightly darker at 6 weeks compared to 1 week (Figure 6.9). The 
10% MeSDVC group had a slight increase in collagen I staining over the culture period, 
whereas the DVC-incorporating groups had a slight decrease in collagen I staining (Figure 
6.9). The MeSDVC + DVC group had the least amount of collagen I staining at 6 weeks. 
Aggrecan staining revealed a slight increase in aggrecan deposition in the 10% MeSDVC 
gels over the 6 week culture period (Figure 6.9). Additionally, the MeSDVC + DVC group 
had an increase in aggrecan staining over the course of the 6 weeks (Figure 6.9). Finally, 
 120 
no discernable changes in aggrecan staining was observed at 6 weeks for the MeSDVC + 
DVC + TGF-β3 group compared to its aggrecan staining at day 1 (Figure 6.9).  
 
DISCUSSION 
To the best of our knowledge, we were the first group to create a covalently 
crosslinked hydrogel composed entirely of cartilage ECM and we are the first to 
additionally add cartilage matrix particles to give the hydrogel precursor a yield stress 
before crosslinking. Although the major focuses of hydrogel technologies are on hydrogels 
in their crosslinked form, our group additionally focuses on the fluid behavior of the 
hydrogel precursor solutions by fabricating colloidal gels instead, which are dynamically 
paste-like materials prior to crosslinking that can be molded into place and will ‘set’ after 
placement.147 Colloidal gels are cohesive through disruptable particle interactions, we have 
previously shown that these gels are capable of successfully filling tissue defects, 
delivering bioactive signals, and promoting new tissue formation in non-load bearing 
cranial defect applications.25, 144-146 Preliminary work demonstrated that these colloidal gels 
did not retain their integrity over time in culture and recently, we published a method to 
combine colloidal gel systems with traditional crosslinked hyaluronic acid hydrogels to 
form a hydrogel suitable for load-bearing applications that exhibits a yield stress prior to 
crosslinking.5 This yield stress, the threshold level where a solution transitions from an 
elastic solid to a pseudoplastic liquid, is crucial as it will enable a surgeon to mold and 
shape the material into the defect site without the concern that the material will flow or 
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leak from the defect, which is a major concern for traditional hydrogel precursor 
solutions.110, 135  
In prior work from our group, only the colloidal solutions employing particulates 
were observed to exhibit a yield stress,5 and therefore in the current study, it was 
hypothesized that particulates would be necessary to achieve a paste-like precursor 
solution. All samples tested in the current study, including the non-particulate samples 
composed of MeSDVC, were noted to have a yield stress. Ten percent MeSDVC alone had 
a yield stress of over 700 Pa, and when it was combined with 10% DVC particles, which 
had a yield stress of only 58 Pa, the combined materials had a yield stress of over 1800 Pa. 
This synergistic effect was similarly noted in prior work,5 which suggests that there may 
be some physical or chemical interactions between DVC and MeSDVC. For context, 
toothpaste, a common paste-like material, has a yield stress of approximately 200 Pa. 
Additionally, when cells were mixed in with the materials, the cells did not significantly 
affect the yield stress value, which is advantageous because these materials can be mixed 
with cells if necessary in a surgical context and would still allow for appropriate shaping 
and contouring. Although the MeSDVC + DVC precursor solutions are easily molded, 
shaped, and extruded through a syringe, there may be applications where the yield stress 
may need to be reduced. In this case, the concentrations of MeSDVC and DVC can be 
altered. Furthermore, future quantification of syringeability would be of value.  
This is not the first time yield stress has been reported in hydrogel precursors for 
tissue engineering purposes. One group used a dual component, “dock-and-lock”, self-
assembling gelation mechanism to create shear-thinning, self-healing, and injectable 
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hydrogels.81 Elder et al.32 reported a method to modify the viscosity of hyaluronic acid 
hydrogel precursors by attaching peptides that self-assemble into β-sheets onto the 
hyaluronic acid. Although methods to induce yield stress in hydrogel precursor solutions 
have been reported, to the best of our knowledge, this current study is the first example of 
inducing yield stress in hydrogel precursors with ECM-based materials. 
ECM-materials were used in the current study to not only impart a yield stress on 
the materials, but to further make the material inherently chondroinductive. A few other 
groups have recently reported the chondroinductivity of cartilage ECM.11, 15, 41, 73, 115, 128 
For example, Cheng et al.14 developed a porous cartilage matrix composed of homogenized 
and then lyophilized cartilage matrix, which induced chondrogenic differentiation even 
without growth factor supplementation. However, these matrices contracted in vitro, so the 
cartilage matrix was then further crosslinked with genipin and found the crosslinking 
degree affected matrix synthesis and cell-mediated contraction. Although at a 0.05% 
genipin concentration, they found that the materials did not exhibit contraction and were 
chondroinductive.13 Rowland et al.109 further studied the crosslinking of these matrices, 
where it was reported that the crosslinking method affected the chondrogenesis and matrix 
synthesis of MSCs. Visser et al.141 solubilized cartilage ECM and functionalized it with 
methacrylate groups, and demonstrated for the first time that hydrogels could be formed 
from ECM materials. However, these materials were not found to significantly affect the 
chondrogenic differentiation of MSCs. In the current study, compared to MeSDVC alone, 
an upregulation of Sox-9 and aggrecan was noted at two weeks when rBMSCs were 
exposed to DVC particles, with or without TGF-β3 supplementation. Furthermore, at 6 
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weeks, the DVC particle groups with and without TGF-β3 had a relative collagen II 
expression that was 40 and 78 fold higher, respectively, than that of MeSDVC alone 
(p<0.05). Additionally, collagen II expression of the DVC particle groups significantly 
increased over the culture period, whereas the relative collagen II expression of the 
MeSDVC group alone did not change. Although a significant increase was not observed in 
matrix production of the cells either histologically or through biochemical analysis, which 
could be a result of simultaneous bioabsorption and remodeling of the ECM, a slight 
increase in collagen II staining was observed in the DVC particle groups, in agreement 
with the gene expression data. A slight increase in aggrecan staining was noted in the 10% 
MeSDVC group, and this group was noted to have a significantly higher aggrecan gene 
expression than the other groups at day 1. Although the TGF-β3 group had no discernable 
changes in aggrecan staining over the 6 weeks, it had the highest aggrecan gene expression 
at 2 weeks. Even though at weeks 1 and 2, the relative collagen I expression in the DVC 
particle groups was higher, at day 1, the relative collagen I expression in the DVC particle 
groups was significantly lower. Furthermore, collagen I staining actually increased slightly 
in the MeSDVC group over the culture period, while it decreased in the DVC particle 
groups. Overall, the gene expression and histological data pointed toward the DVC 
particles as an important component for upregulating chondrogenic genes, even though the 
particles are not necessary for inducing a yield stress in these MeSDVC and DVC systems.  
 Not only are the particles likely necessary for chondrogenesis, but they are 
successful in reducing hydrogel contraction. Hydrogel contraction is a major concern for 
tissue engineering because it can cause disintegration with host tissue, which could 
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potentially hinder successful cartilage regeneration and may even dislodge the hydrogel 
from the defect site.13, 141 In prior work, Guilak and colleagues observed how the 
crosslinking degree and method of crosslinking affected gel contraction.13, 109 However, in 
the current study, we observed that the inclusion of particles affected gel contraction and 
swelling. In the current study, gels composed only of MeSDVC contracted by 18% over 
the culture period, but the gels containing DVC particles did not have a significant change 
in volume.  
 Another important feature for hydrogels in cartilage tissue engineering is their 
ability to withstand mechanical loading and one major disadvantage of using natural 
materials is their decreased mechanical integrity.133 The compressive modulus of hydrogels 
composed of natural materials are typically an order of magnitude less than that of native 
cartilage tissue,133 which has a compressive elastic modulus ranging from 240-1000 kPa.2 
However, the biomechanical properties of cartilage can vary depending on parameters such 
as the method of testing, the cartilage zone depth, and the strain rate of testing.49 In the 
study performed by Visser et al.,141 the solubilized cartilage matrix was reinforced with 
methacrylated gelatin (GelMA); however, the biomechanics of the hydrogels, evaluated 
via the compressive modulus, still fell short of native cartilage tissue. Another group used 
poly(ε-caprolactone) to reinforce solubilized cartilage ECM by combining them and then 
electrospinning them into a scaffold.41 However, the Young’s moduli of these scaffolds 
were only approximately 10 kPa. In the current study, although we only observed 
compressive moduli in the range from 70-170 kPa for all of the 10% MeSDVC and 
MeSDVC + DVC groups, we did observe a compressive modulus of approximately 675 
 125 
kPa in the acellular 20% MeSDVC group, which is on the same order of magnitude as 
native articular cartilage. Because there was such a difference in the modulus from 20% 
MeSDVC to MeSDVC + DVC even though both gels had a solids content of 20%, future 
work will be necessary to determine ratios of DVC particles and MeSDVC that still allow 
for sufficient chondrogenesis and reduced contraction, while maintaining the appropriate 
biomechanics. Furthermore, it is possible that once these materials are implanted in vivo, 
the biomechanical stimulation may help increase matrix synthesis and improve the 
mechanical properties.140   
 Even though DVC particles may hinder the biomechanical performance and are 
not necessarily needed to induce a yield stress if using MeSDVC as a hydrogel material, 
we have still demonstrated that the particles are likely contributing to enhanced 
chondrogenesis and the elimination of hydrogel contraction. Because the DVC particles 
contain mostly unaltered cartilage ECM, other than the DVC particles are cryoground, they 
may retain more of the bioactivity of the cartilage matrix than MeSDVC since MeSDVC 
is altered cartilage ECM, where it contained 97% less DNA and 41% fewer GAGs than 
DVC. Proteoglycans, specifically aggrecan in cartilage matrix, are found extensively in 
native cartilage matrix and are thought to be a reservoir of several growth factors.17, 57 It 
can therefore be hypothesized that some of the growth factors inducing chondrogenesis 
within cartilage ECM may have been altered or removed in the processing of MeSDVC 
are retained in DVC.  
Of interest is that the processing of MeSDVC appears to have removed much of the 
DNA content. It is uncertain at this time whether or not the DNA was altered and unable 
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to be detected via the PicoGreen assay, or if the MeSDVC process actually decellularizes 
the tissue as well and future work will certainly need to address this issue. The low pH 
exposure during the solubilization process would likely denature the DNA to a single-
stranded state, and would in addition hydrolyze and further degrade the DNA.88 
Furthermore, the dialysis step after methacrylation would likely remove these degraded 
DNA segments and low molecular weight nucleotides and amino acids, leaving behind 
higher molecular weight methacrylated GAGs and collagen. Furthermore, a recent study 
found that pepsin, although previously known to only digest protein, is in addition, capable 
of digesting nucleic acids.79 These results are consistent with our findings since there was 
no mass loss during the solubilization/pepsin digestion process. Therefore, future work will 
certainly need to address what immunological effects may occur by digesting tissues in 
pepsin. Currently, it is unknown whether decellularizing of cartilage tissue is necessary or 
to what exact degree cells must be removed to enable the material to be implanted in vivo 
without an adverse immunological response. For example, Zimmer’s DeNovo® product, 
which is composed of living, allogeneic human cells, has no reports of allograft rejection 
or disease transmission and it has been observed to create hyaline-like cartilage in goats, 
where no T-cell-mediated response was noted.1 Therefore, because cartilage tissue may be 
immunoprivileged for osteoarthritis applications, and because decellularization can result 
in changes in matrix architecture and surface ligand landscape,60 decellularization may not 
even be necessary for some cartilage tissue engineering applications.  
In addition, it must be noted that the inclusion of cells may or may not be necessary 
for future clinical application of these materials. It is possible that a cell source could come 
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from the subchondral bone if microfracture is performed prior to implanting the acellular 
pastes. Therefore, future work will also consider the ability of cells to migrate into and 
remodel the pastes to determine whether or not cell encapsulation is necessary.  
 
CONCLUSION 
In this current study, we created a potentially chondroinductive hydrogel that is 
entirely composed of cartilage-derived ECM and we have shown that by mixing in DVC 
particles, we can modulate the yield stress of the hydrogel precursors and prevent 
contraction after crosslinking. Furthermore, these two-component gels induced 
chondrogenic gene expression after 2 weeks compared to MeSDVC gels alone, and they 
had reduced cell-mediated contraction. Future work will address combinations of DVC and 
MeSDVC components that yield mechanics closer to that of native tissue and will further 
address tissue integration and regeneration in vivo. Ultimately, the combination of these 









CHAPTER 7: CONCLUSION 
 Hydrogels are a promising class of tissue regenerative materials for several reasons, 
including their high water content, 3D structure, and tunable mechanical properties.9, 23, 33 
However, hydrogels in their precursor form (i.e., prior to crosslinking) are traditionally 
liquid solutions that lack a yield stress. The crux, therefore, of hydrogel technology for in 
situ implantation, is creating a hydrogel precursor that is capable of remaining within the 
defect site.110, 135 As an alternative to traditional hydrogels, predecessors to this current 
thesis developed a new type of tissue engineering scaffold called a colloidal gel, which is 
a mechanically dynamic paste-like material that can be easily molded into place and will 
‘set’ after placement.147 It was found that these gels, composed of oppositely charged 
PLGA nanoparticles, could successfully fill tissue defects, deliver bioactive signals, and 
promote new tissue formation in non-load bearing cranial defect applications.25, 144-146 A 
more recent predecessor found colloidal gels could be made out of solutions of hyaluronic 
acid (HA) nanoparticles.37 These HA-based colloidal gels exhibited shear-thinning 
rheological behavior and had the ability to fully recover after compression to high strains 
even after physically destroying and reassembling the gel, which made them attractive for 
applications such as for cartilage regeneration.37 Therefore, the work in the current thesis 
started with these HA-based colloidal gels and the primary objective was to develop a 
mechanically dynamic, “paste-like” hydrogel material that could retain its molded or 
extruded shape, would “set” after placement, and could withstand mechanical loading. 
Preliminary work with the HA-based colloidal gels demonstrated that they did not retain 
their integrity over time in culture, and therefore, although they were mechanically 
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dynamic, at their current state, they could be improved for cartilage tissue engineering 
applications.  
 When the HA nanoparticles were mixed with methacrylated hyaluronic acid 
(MeHA), a more traditional photocrosslinkable hydrogel material, the solutions exhibited 
a yield stress prior to crosslinking. Furthermore, it was found that if MeHA and linear HA 
(made with the same MW as the HA nanoparticles) were mixed, the solutions lacked a 
yield stress, which demonstrated that the nanoparticulate form of HA was necessary to 
achieve the paste-like behavior, although at this stage, the underlying mechanism causing 
this paste-like behavior is still unknown. Additionally, unlike the gels consisting of only 
HA nanoparticles that were previously found to disintegrate in vitro, the gels consisting of 
HA nanoparticles and MeHA were able to be photocrosslinked into mechanically stable 
hydrogels that could encapsulate cells that remained viable. However, gels were found to 
be mechanically weak after crosslinking in comparison to native articular cartilage tissue. 
Around the completion of this first study, our research group started working with cartilage 
extracellular matrix (ECM), as it was in the beginning stages of being explored as a 
chondroinductive material.11, 15, 41, 73, 115 Therefore, the new objective of this current thesis 
became to improve the mechanics of the two-component hydrogel system after 
crosslinking so the hydrogels could withstand loads similar to that of native articular 
cartilage. Furthermore, the objective was to make the hydrogel chondroinductive by 
incorporating cartilage ECM, and ensure that the paste-like consistency prior to 
crosslinking was preserved. 
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 The first new edition of the hydrogel two-component system in the current thesis 
replaced the HA nanoparticles with cartilage ECM microparticles. Furthermore, both 
devitalized (DVC) and decellularized (DCC) cartilage microparticles were tested in these 
hydrogel pastes to determine if decellularization affects long-term chondroinductivity. It is 
widely emphasized in the literature that improper decellularization of ECM-based tissues 
can result in detrimental inflammatory responses and ultimately hinder tissue 
regeneration.59 However, cartilage ECM may be uniquely immunoprivileged in part 
because the ECM is so dense that it protects chondrocytes from T and natural killer cells 
that are released in graft rejection.105 Therefore, the goal of this study was to compare the 
chondroinductive potential of DVC and DCC, especially since decellularization processes 
inevitably cause some disruption to the matrix architecture, orientation, and surface 
landscape,60 which may ultimately limit or hinder the chondroinductive potential of the 
matrix. When DCC and DVC particles were mixed with MeHA, chondrogenic gene 
expression analysis found that the MeHA precursors containing DVC consistently 
outperformed the DCC-containing groups, even when compared to the groups exposed to 
TGF-β3. Additionally, MeHA solutions containing DVC exhibited a higher yield stress 
compared to that of MeHA and DCC precursors. Overall, DVC appeared to be superior to 
DCC in both chondroinductivity and rheological performance of hydrogel precursors, 
which is contradictory to a prior study from our group that reported rat bone marrow stem 
cells (rBMSCs) exposed to DCC outperformed those cells exposed to DVC or TGF-β3 in 
chondroinductivity.128 However, it is hypothesized that the differences observed between 
this prior study, Sutherland et al.,128 and the current thesis was a result of the scaffold 
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formulation since the current thesis evaluated rBMSCs encapsulated within a 3D hydrogel 
scaffold, whereas the Sutherland et al.128 study was a pellet culture. Furthermore, 
Sutherland et al.128 only evaluated short term gene expression over 1 week, while the 
current thesis observed the long term gene expression over 6 weeks. The current thesis 
work is the only long-term evaluation of DVC and DCC and although the long-term gene 
expression of cells exposed to DVC emphasizes that DVC may be superior in 
chondroinductivity in vitro, in vivo studies will be crucial to evaluate this concept further. 
In vivo studies will be able to not only compare chondroinductive potential, but will 
additionally be able to compare the immunological responses to these materials. Although 
in vivo studies are indeed suggested to study further the chondroinductive potential of DCC 
and DVC, the current thesis work did evaluate the materials implanted in a human cadaver. 
A hydrogel paste, consisting of MeHA and DCC, was implanted in a defect created in a 
human cadaver elbow joint and then were UV crosslinked in situ. The gels were able to be 
successfully molded into the defect and after crosslinking, the joint was able to be 
articulated without dislodging the gel (Figure 7.1), which suggested that these pastes 
indeed had potential for cartilage tissue engineering applications.  
 Because MeHA mixed with DCC still produced gels that were mechanically weak 
compared to native cartilage, it was then sought out to incorporate a crosslinkable material 
that would more closely match the mechanics of native cartilage tissue and be 
chondroinductive simultaneously. Therefore, the goal was to make a hydrogel out of 
cartilage ECM. Several studies had reported making gels out of ECM by first solubilizing 
the ECM, where the solubilized matrix would form a gel at body temperature.40, 41, 43, 120 
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Therefore, in this current thesis it was hypothesized that an in situ-gelling material may not 
only be chondroinductive, but it would additionally eliminate the need for 
photocrosslinking, a process which can be detrimental to cells and nearby tissues. 
However, preliminary testing in the current thesis determined that the gels that formed were 
compliant without further UV crosslinking, which left opportunity to improve the gels for 
load-bearing applications and it was decided to methacrylate the solubilized cartilage 
ECM, making photocrosslinkable MeSDCC (Methacrylated Solubilized Decellularized 
Cartilage). The elastic compressive modulus of the gels containing 20% MeSDCC were 
1070 ± 150 kPa, which is similar to that reported for native articular cartilage. Furthermore, 
it was found that the stress-strain profiles of the 20% MeSDCC gels fell within the 95% 
confidence interval range for native porcine cartilage tissue. In addition, the MeSDCC gels 
significantly upregulated chondrogenic gene expression compared to a more traditionally 
used material, methacrylated gelatin. Finally, the MeSDCC gels supported extensive 
matrix synthesis. However, although the MeSDCC gels appeared to be more 
chondroinductive than methacrylated gelatin, it was noted that the chondrogenic potential 
could be improved. Specifically, it was noted in the study that there was no detectable 
levels of collagen II gene expression at 6 weeks and that aggrecan expression levels 
decreased over the culture period.     
 Given that in the current thesis it was found that DVC particles may be superior in 
promoting chondrogenesis to DCC particles, and because DVC particles induced 
significant collagen II expression long-term, in the final study of this current thesis, the 
DVC particles were mixed with methacrylated and solubilized DVC (MeSDVC), in an 
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attempt to create a hydrogel paste that could be crosslinked to form a gel that exhibited 
similar biomechanics to native cartilage tissue and could induce chondrogenesis. Prior to 
crosslinking, the MeSDVC and MeSDVC + DVC particle gels were found to exhibit a 
yield stress. However, the gels containing DVC repeatedly outperformed the MeSDVC 
group in chondrogenic gene expression and did not have any cell-mediated contraction, 
which is a phenomenon observed in the MeSDVC gels and is detrimental for hydrogels 
because it can hinder tissue regeneration and integration. Although the compressive moduli 
of the DVC-containing groups were much less than that of native cartilage and the 20% 
MeSDCC gels from work earlier on in this current thesis, overall, this two-component 
system has been shown to be chondroinductive, and mechanically, is a vast improvement 
over the HA-based hydrogels at the beginning of this thesis.  
 Because the compressive modulus of the MeSDVC + DVC gels were found to be 
much lower than that of the 20% MeSDCC and native cartilage, future work should 
definitely consider improving the overall mechanical performance of the MeSDVC + DVC 
gels. Interestingly, the compressive modulus of the 20% MeSDVC gels in aim 3 was found 
to be lower than that of 20% MeSDCC gels from aim 2 and overall the stress strain profiles 
were observed to be significantly different from each other (Figure 7.2). This difference 
could be due to a number of reasons although the exact reason for the difference is unknown 
at this time and would need further work to fully understand the cause. However, the 
difference could be due to one or a combination of the following reasons: (1) MeSDCC 
and MeSDVC were made from materials of the same breed of pig, and have similar 
biochemical contents, but they were made in different batches, so it is possible that there 
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could be some batch-to-batch variation in the methacrylation process, (2) even though we 
tried to control for the same breed of pig, there could be variations within the same breed 
of pigs since the MeSDCC was made from a completely separate batch of pigs than the 
MeSDVC was, and (3), because the decellularization process is known to cause changes in 
ECM, it is possible that something was changed through decellularization that ultimately 
affected the mechanics of the MeSDCC gels. However, the MeSDVC gels did not fracture 
early like the MeSDCC gels (Figure 7.2) and therefore, perhaps they would be more 
beneficial for future work. Because the compressive modulus of the 20% MeSDVC group 
was within the range of reported values for native articular cartilage, future work could 
explore varying the ratios of MeSDVC and DVC to obtain gels that more closely mimic 
native cartilage mechanically, while still being able to take advantage of the 
chondroinductive properties of DVC microparticles. Specifically, since MeSDVC alone 
already has a yield stress, the amount of DVC in the solutions may be able to be reduced 
such that there is still an associated chondrogenic response, but the mechanical properties 
are improved.   
 From the results of the current thesis, DVC is still considered to be necessary in the 
hydrogel pastes due to its superior chondroinductive properties compared to DCC and 
compared to methacrylated cartilage ECM alone. Because all three of my 6 week in vitro 
studies were performed similarly with the same kind of cells, and because each of the gels 
was tested against a GAPDH control, the PCR between studies can be compared and 
evaluated with the 2-ΔΔCt method to approximate differences observed among groups of 
different experiments. Overall, although the 10% MeSDCC gels had significantly higher 
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aggrecan and Sox-9 expression at day 1 compared to the other groups, high levels of 
collagen II gene expression are only observed for the DVC-containing groups (Figure 7.3).  
 Therefore, in terms of deciding whether to use MeSDCC and MeSDVC, the 
mechanics as well as the chondroinductive properties must be considered. MeSDCC had 
more chondroinductive potential early on and did have a compressive modulus similar to 
that of native cartilage, and the DVC-containing gels, although weaker than the MeSDCC, 
were the only groups to induce collagen II expression. Therefore, in considering the next 
steps for the work in this current thesis, testing DVC in comparison to DCC in vivo should 
be held paramount. In vivo studies will help discern whether there is any immunological 
response to DVC and furthermore, they will ultimately be able to discern which of the two 
materials is superior in inducing chondrogenesis. After DVC and DCC are compared, it 
can then be decided how to incorporate either MeSDVC or MeSDCC. If MeSDCC is 
chosen to be pursued, the early fracture stress will need to be addressed and if MeSDVC is 
chosen to be pursued, the biomechanics will need to be improved upon. However, overall, 
the work of this current thesis has shown that a two component system is the most 
successful in creating a hydrogel precursor that is paste-like prior to crosslinking, and after 
crosslinking, can withstand native cartilage tissue loading, retain its original volume 
throughout culture, and is chondroinductive. Specifically, the MeSDVC/MeSDCC 
component has been shown to be initially chondroinductive while enabling the pastes to be 
crosslinked and withstand native cartilage tissue loading, while the DVC particles have 
been shown to be crucial for long-term chondrogenesis and gel volume retention. 
Therefore, the results of this current thesis suggest the combination of MeSDVC/MeSDCC 
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with DVC particles is the most promising for future work. This two-component hydrogel 
paste has been taken from an idea to providing promising results and producing numerous 
new avenues for research to consider for cartilage tissue engineering applications. 
Furthermore, this two-component hydrogel paste could be applied for other tissue 
engineering applications as well that cannot tolerate a liquid draining away from an 
irregularly shaped defect and this application does not necessarily need to apply to 
cartilage. The two components could be made from any tissue of interest, whether its bone, 
cartilage, muscle, skin, etc., and the two-components could be fabricated using similar 
methods as to what is reported in the current thesis. Therefore, this current thesis lays the 
foundation for an endless opportunity of future hydrogel research in the tissue engineering 
field.  
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Figure 1.1: Conversion of Hydrogel Precursors into Hydrogel Precursor Pastes  
 
Hydrogel pastes are created by mixing traditional photocrosslinkable polymers with 
particulates. The photocrosslinkable polymer gives the paste its ‘set’ strength after 
photocrosslinking while the particles impart a yield stress on the paste prior to crosslinking. 
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Figure 1.2: Schematic of the Progression of Thesis Aims 
 
The two-component hydrogel pastes in aim 1 are hyaluronic acid nanoparticles (HAnp) 
and methacrylated hyaluronic acid (MeHA). In Aim 2, DCC and DVC particles replace the 
HAnp. In Aim 3, MeSDCC is evaluated alone as a hydrogel material and then two 




Figure 2.1: Structure and Components of Tissue Interfaces 
 







Figure 3.1: Hyaluronic Acid Nanoparticle (HAnp)-Incorporated Solutions Impart 
Paste-Like Gross Rheological Behavior 
 
(A-C) Images of select experimental groups loaded onto the lower rheometer plate prior to 
rheological testing. (A) 4% Methacrylated hyaluronic acid (MeHA) with 15% HAnp gel 
solution with shape-retention, (B) 4% MeHA with 15% linear HA (HAlin) and (C) 4% 
MeHA formulations yielding low viscosity solutions absent of yield stress. Because there 
were no visible differences between the remaining linear HA groups and Figure 1B, and 
likewise, no visible differences between the remaining HAnp-containing solutions and 
Figure 1A, the photographs of these remaining experimental groups were omitted from this 
figure. (D) Scanning transmission electron microscopy (STEM) observation of HAnp. The 





Figure 3.2: Rheological Behavior of Solutions Prior to Crosslinking 
 
(A-B) Shear rate sweep of formulations without yield stress (A) and formulations with 
yield stress compared to 4% Methacrylated Hyaluronic Acid (MeHA) (B). Data points are 
mean + standard deviation (n=5) and the lines are used to connect the data points to discern 
between samples. For the 30% hyaluronic acid nanoparticle (HAnp) formulation, shear 
banding was observed at low shear rates so those data were excluded. (C) Yield stress 
obtained from fit to Herschel-Bulkley equation. (D) Storage modulus of formulations 
before, after, and during disruption. Data reported as mean + standard deviation (n=5). 






Figure 3.3: Characterization of Gels After Crosslinking  
 
Compressive modulus (A) and swelling degree (B) of crosslinked gels. Data are reported 
as mean + standard deviation (n=6). Formulations with different letters indicate statistically 
significant differences (p<0.05). Live/Dead image analysis of cells encapsulated and 
cultured for 4 weeks within 4% Methacrylated Hyaluronic Acid (MeHA) (C) and 4% 






Figure 3.4: Hyaluronic Acid Nanoparticle (HAnp)-Incorporated Solutions Maintain 
Shaping Before and After Crosslinking 
 
(A) A solution containing 4% MeHA with 15% HAnp can be readily loaded into a 1 mL 
syringe and extruded. (B) After extrusion, the HAnp-incorporated solution maintained 
extruded shaping, which demonstrates that this formulation could be implanted in vivo 
without the risk of leaking from the implantation site. (C) After photocrosslinking the 
HAnp-incorporated solution, the solution was a crosslinked hydrogel network that retained 




Figure 4.1: Biochemical Contents and SEM Images of Hydrogel Paste Components  
 
A) PicoGreen content, B) GAG content, and C) Hydroxyproline content of DVC, DCC, 
and MeHA. Following decellularization, there was a 44% reduction in DNA, a 23% 
reduction in GAG, and a 23% reduction in hydroxyproline content. Data reported as mean 
+ standard deviation (n=5); ^below detectable limit, *significantly different from DVC 
(p<0.05), #significantly different from DCC (p<0.05). D) SEM images of DCC and DVC 
microparticles under 500x and 12,000x magnifications. Under 500x magnification, the 
DCC microparticles were noted to have more smooth surfaces overall in comparison to the 
DVC microparticles and under 12,000x magnification, the surfaces of the DCC 
microparticles were noted to have a grain-like appearance that was non-existent in the DVC 





Figure 4.2: Macroscopic Rheological Evaluation of Hydrogel Precursors Before and 
After Crosslinking  
 
All formulations were acellular unless noted. Non-Newtonian behavior was observed in 
solutions containing at least 5% DCC, whereas shape retention (indicated by the solution 
retaining extrusion orifice diameter) was only noted in 10% DCC and 3% MeHA + 10% 





Figure 4.3: Yield Stress (A) and Storage Modulus (B) of Hydrogel Precursor 
Solutions 
 
Only the 10% DCC, 3% MeHA + 10% DCC, and 3% MeHA + 10% DVC groups exhibited 
a measurable yield stress, while all groups had a measurable storage modulus. Data 
reported as mean + standard deviation (n=5); *significantly different from 3% MeHA 
acellular group (p<0.05), #significantly different from 3% MeHA + 10% DCC acellular 
group (p<0.05), $significantly different from 10% DCC group (p<0.05), &significantly 




Figure 4.4: Compressive Moduli of Crosslinked Hydrogels After 1 Day and 6 Weeks 
of Culture 
 
Gels containing at least 10% DCC or DVC microparticles had significantly larger moduli 
than 3% MeHA gels alone. Data reported as mean + standard deviation (n=5); 
*significantly different from 3% MeHA at same time point (p<0.05), %significantly 
different from acellular group of same formulation at same time point (p<0.05), 
#significantly different from all other groups at same time point (p<0.05), $significantly 
different from 3% MeHA + 10% DCC at same time point (p<0.05), @significantly 
different from 3% MeHA + TGF-β3 and 3% MeHA + 5% DCC at same time point (p<0.05), 





Figure 4.5: Swelling Degree (A) and Volume (B) of Crosslinked Hydrogels  
 
The only gels with significantly smaller swelling degrees than the 3% MeHA gels were the 
3% MeHA + 10% DCC acellular group and the 3% MeHA + 10% DVC acellular and 
cellular groups. At day 1, there were no significant differences between groups. However, 
the inclusion of DCC or DVC or exposure to TGF-β3 significantly reduced the volume at 
6 weeks. Data reported as mean + standard deviation (n=5); *significantly different from 
3%MeHA at same time point (p<0.05), %significantly different from acellular group of 
same formulation at same time point (p<0.05), $significantly different from 3%MeHA + 
10% DCC at same time point (p<0.05), !significantly different from same group at first 




Figure 4.6: Biochemical Content of Gels over the 6 Week Culture Period 
 
A) DNA content, B) GAG content, and C) Hydroxyproline content. All gels contained 
significantly higher DNA contents than their respective acellular groups at all time points 
and all gels containing DCC or DVC had significant reductions in GAG over the 6 week 
culture period. Data reported as mean + standard deviation (n=5); ^below detectable limit, 
*significantly different from 3%MeHA at same time point (p<0.05), %significantly 
different from acellular group of same formulation at same time point (p<0.05), 
#significantly different from all other groups at same time point (p<0.05), $significantly 
different from 3% MeHA + 10% DCC at same time point (p<0.05), !significantly different 
from same group at first time point (p<0.05), +significantly different from same group at 




Figure 4.7: Relative Gene Expression of A) Collagen II, B) Collagen I, C) Sox-9, and 
D) Aggrecan  
 
The DVC group consistently outperformed the other groups in collagen II, Sox-9, and 
aggrecan expression, even when compared to TGF-β3 exposed groups. Data reported as 
mean + standard deviation (n=5); *significantly different from 3%MeHA at same time 
point (p<0.05), #significantly different from 3%MeHA +TGF-β3 at same time point 
(p<0.05), @significantly different from all DCC containing groups at same time point 
(p<0.05), %significantly higher than same group at previous time point (p<0.05), 
$significantly higher than same group at first time point (p<0.05), !significantly lower than 




Figure 4.8: Histological Analysis of Gels  
 
All gels stained red/orange for GAGs, although no increase in the amount of staining was 
noted over the culture period. However, nodular Saf-O staining was noted in the 3% MeHA 
+ TGF-β3 group. All DCC and DVC containing groups stained for Collagen II, however 
no changes were noted in the location and intensity of collagen II staining over the culture 
period. Collagen I staining was noted again in all DCC and DVC containing groups. 
However, the intensity of collagen I staining decreased over the culture period for the 3% 
MeHA + 5% DCC and 3% MeHA + 10% DCC groups and appeared to increase slightly 
for the 3% MeHA + 10% DVC group. Aggrecan staining was noted in all DCC and DVC 
containing groups, where the aggrecan staining became more intense near the DCC and 
DVC microparticles in the 3% MeHA + 10% DCC + TGF-β3 and 3% MeHA + 10% DVC 




Figure 5.1: NMR of GelMA (A) and MeSDCC (B) Before and After Methacrylation 
and (C) Gross Morphology of Crosslinked Hydrogels 
 
Methacrylation was confirmed on both materials by the emergence of methacrylate peaks 
between 5 and 6.5 ppm. The GelMA and MeSDCC were successfully crosslinked into 
hydrogels. The photograph is of the GelMA and MeSDCC gels 6 weeks after crosslinking 
and they are pink from soaking in cell media. The scale bar is 5 mm.
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Figure 5.2: Biochemical Contents of DVC, DCC, SDCC, MeSDCC, and GelMA  
 
A) PicoGreen content, B) GAG content, and C) Hydroxyproline content of each material. 
Decellularization removed 44% of the DNA, 23% of the GAGs, and 23% of the 
hydroxyproline (p<0.05). After solubilizing and after methacrylating, the DNA content 
further reduced to 4% and 1.7% of that of the original DVC DNA content, respectively 
(p<0.05). Data reported as mean + standard deviation (n=5); *significantly different from 
DVC (p<0.05), #significantly different from DCC (p<0.05), @significantly different from 
SDCC (p<0.05), $significantly different from MeSDCC (p<0.05). 
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Figure 5.3: Mechanical Testing of Crosslinked Hydrogels  
 
A) Compressive modulus of gels after 1 day and 6 weeks of culture. At day 1, the 
compressive modulus of the 10% MeSDCC and 20% MeSDCC cellular groups were 5.3 
and 20 times larger than the 10% GelMA gels, respectively. Data reported as mean + 
standard deviation (n=5); * significantly different from 10% GelMA at same time point 
(p<0.05), #significantly different from 10% MeSDCC at same time point (p<0.05), 
&p<0.05 for specified comparison, @significantly different from same group at first time 
point (p<0.05), -not tested. B) Stress-Strain Curves of Native Porcine Cartilage Compared 
to Select Hydrogels. Data are reported as mean ± 95% confidence interval. The stress strain 
profile of native porcine cartilage were compared to that of 20% MeSDCC, 20% GelMA 
acellular, and 3% MeHA gels, where 20% MeSDCC was the only hydrogel that fell within 
the 95% confidence interval of native porcine cartilage until they began to fracture at 7.5% 
strain on average.  
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Figure 5.4: Swelling Degree (A) and Volume (B) of Crosslinked Hydrogels  
 
A) The 10% MeSDCC gel had a significantly higher swelling degree compared to 10% 
GelMA, while the 20% GelMA and 20% MeSDCC groups had significantly lower swelling 
degrees compared to 10% MeSDCC. B) The only group that had a significant change in 
volume was the 10% MeSDCC acellular group, which experienced an 11% volume 
reduction (p<0.05). Data reported as mean + standard deviation (n=5); *significantly 
different from 10% GelMA at same time point (p<0.05), #significantly different from 10% 
MeSDCC at same time point (p<0.05), !significantly different from acellular group at same 
time point (p<0.05), &p<0.05 for specified comparison, @significantly different from 




Figure 5.5: Biochemical Content of Gels over the 6 Week Culture Period  
 
A) DNA content, B) GAG content, and C) Hydroxyproline content. All cellular groups had 
significantly higher DNA contents than their respective acellular groups at all time points 
(p<0.05). Over the course of the 6 week culture period, all cellular groups had a significant 
reduction in DNA content, both the 10% MeSDCC group and the 20% MeSDCC groups 
experienced a significant reduction in GAG content, and the only group that experienced a 
significant loss in hydroxyproline was the 20% MeSDCC group. Data reported as mean + 
standard deviation (n=5); ^below detectable limit, *significantly different from 10% 
GelMA at same time point (p<0.05), #significantly different from 10% MeSDCC at same 
time point (p<0.05), !significantly different from acellular group at same time point 
(p<0.05), &p<0.05 for specified comparison, @significantly different from same group at 






Figure 5.6: Relative Gene Expression of A) Sox-9, B) Aggrecan, C) Collagen II, and 
D) Collagen I 
 
MeSDCC gels significantly upregulated chondrogenic genes compared to GelMA as early 
as day 1. Data reported as mean + standard deviation (n=5); *significantly different from 
10% GelMA at same time point (p<0.05), #significantly different from 10% MeSDCC at 
same time point (p<0.05), @significantly different from same group at first time point 






Figure 5.7: Histological Evaluation of Gels  
 
H&E stained the nuclei dark purple and MeSDCC light purple. GelMA and new tissue 
formation in the 20% MeSDCC group at 6 weeks was stained pink. Regions of new tissue 
formation can be observed within the 20% and 20% MeSDCC groups at 6 weeks. All 
MeSDCC gels stained red/orange for GAGs, while no GAG staining was observed in the 
10% GelMA group. Regions of new tissue formation surrounding rBMSCs were observed 
to stain for GAGs. All MeSDCC groups stained for collagen II, although no increase in 
collagen II staining was observed for those groups throughout culture. However, the 10% 
GelMA group had an increase in collagen II staining at 6 weeks. Minimal collagen I 
staining was observed in the MeSDCC groups. Collagen I staining was noted in the 10% 
GelMA group, although there were no significant changes in staining over the culture 
period. Last, a slight increase in aggrecan staining was observed in the 10% GelMA and 




Figure 6.1: NMR of MeSDVC Before and After Methacrylation 
 
Methacrylation was confirmed by the emergence of methacrylate peaks circled between 5 




Figure 6.2: Biochemical Contents of DVC, SDVC, and MeSDVC  
 
A) PicoGreen content, B) GAG content, and C) Hydroxyproline content of each material. 
The SDVC and MeSDVC had DNA contents that were 92% and 97% less than DVC, 
respectively, and had GAG contents that were 44% and 41% less than that of DVC, 
respectively (p<0.05). The hydroxyproline content of SDVC was 26% lower than that of 
DVC (p<0.05). While the hydroxyproline content of MeSDVC was not significant from 
DVC, it was 41% higher than that of SDVC (p<0.05). Data reported as mean + standard 
deviation (n=5); *statistically significant from DVC (p<0.05), #statistically significant 






Figure 6.3: Macroscopic Rheological Evaluation of Hydrogel Precursors Before and 
After Crosslinking 
 
All formulations were acellular unless noted and cellular formulations were pink in color 
due to presence of cell culture medium. Non-Newtonian behavior was observed in all 
solutions. However, the 5% DVC and 10% DVC formulations were the only solutions that 
could not be molded and shaped into a sphere. Shape retention (indicated by the solution 
retaining extrusion orifice diameter) was noted in all solutions except the 5% DVC 




Figure 6.4: Yield Stress (A) and Storage Modulus (B) of Hydrogel Precursor 
Solutions  
 
All solutions had a measurable yield stress and storage modulus, while the groups 
containing both MeSDVC and DVC had the highest reported values. No significant 
differences were observed with the incorporation of cells. Data reported as mean + standard 
deviation (n=5); *significantly different from 10% MeSDVC acellular, #significantly 




Figure 6.5: Compressive Modulus of Crosslinked Hydrogels After 1 Day and 6 
Weeks of Culture 
 
None of the groups were significantly different from the 10% MeSDVC acellular group 
except the 20% MeSDVC acellular group, which had a modulus of 675 ± 130 kPa (p<0.05). 
Additionally, the only groups that significantly deviated from their original compressive 
modulus over the 6 week period were the 10% MeSDVC acellular and cellular groups. 
Data reported as mean + standard deviation (n=5); *significantly different from all other 
groups at same time point (p<0.05), @significantly different from same group at first time 




Figure 6.6: Swelling Degree (A) and Volume (B) of Crosslinked Hydrogel Pastes 
 
A) The only group that had a significantly lower swelling degree than that of the 10% 
MeSDVC group was the 20% MeSDVC acellular group. B) Over the course of the 6 weeks, 
the only groups that had a significant reduction in volume were the 10% MeSDVC acellular 
and cellular groups. Data reported as mean + standard deviation (n=5); *statistically 
significant from 10% MeSDVC at same time point (p<0.05), !statistically significant from 
acellular group at same time point (p<0.05), &p<0.05 for specified comparison, 





Figure 6.7: Biochemical Content of Gels over the 6 Week Culture Period 
 
A) DNA content, B) GAG content, and C) Hydroxyproline Content. All cellular groups 
had significantly higher DNA contents than their respective acellular groups at all time 
points. Over the course of the 6 week culture period, all groups had significant reductions 
in biochemical content (p<0.05), except for the TGF-β3 exposed group, which did not have 
a significant reduction in hydroxyproline. Data reported as mean + standard deviation 
(n=5); *significantly different from 10% MeSDVC at same time point (p<0.05), 
#significantly different from acellular group at same time point (p<0.05), &p<0.05 for 
specified comparison, @significantly different from same group at first time point 





Figure 6.8: Relative Gene Expression of A) Sox-9, B) Aggrecan, C) Collagen II, and 
D) Collagen I 
 
From 2 weeks onward, the DVC-incorporating groups repeatedly outperformed the 
MeSDVC group in chondrogenic gene expression, especially at 6 weeks with collagen II. 
Data reported as mean + standard deviation (n=5); *statistically significant from 10% 
MeSDVC at same time point (p<0.05), #statistically significant from 10% MeSDVC 10% 
DVC at same time point (p<0.05), @statistically significant from same group at first time 
point (p<0.05), $statistically significant from same group at previous time point (p<0.05), 






Figure 6.9: Histological Evaluation of Gels 
 
H&E staining revealed the cells remained evenly distributed throughout culture. MeSDVC 
and DVC particles were stained a dark red/orange color with Saf-O staining and the color 
of the DVC particles appeared to fade over the 6 weeks. A slight increase in collagen II 
staining was noted in the DVC-incorporating groups at 6 weeks. A slight increase in 
collagen I staining was observed for the 10% MeSDVC group at 6 weeks, whereas the 
DVC-incorporated groups had a slight decrease in staining at 6 weeks. A slight increase in 
aggrecan staining at 6 weeks was observed next to the cells of the 10% MeSDVC group. 
Additionally, the 10% MeSDVC 10% DVC group had a slight increase in aggrecan 
staining near the location of the rBMSCs at 6 weeks. Last, the 10% MeSDVC + 10% DVC 
+ TGF-β3 group had no discernable changes in aggrecan staining over the 6 weeks. Scale 
bars are 200 µm.  
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Figure 7.1: Implantation of Hydrogel Pastes in a Human Cadaver Elbow 
 
A hydrogel paste, consisting of methacrylated hyaluronic acid and decellularized cartilage 
microparticles, was implanted in an articular cartilage defect created in a human cadaver 
elbow joint. The paste was able to be implanted and shaped by the surgeon. The paste was 
retained within the defect site prior to UV crosslinking. After crosslinking, the joint was 






Figure 7.2: Stress-Strain Curves of Native Porcine Cartilage Compared to Select 
Hydrogels 
 
The stress strain profiles of native porcine cartilage were compared to that of 20% 
MeSDCC, 20% MeSDVC acellular, 20% GelMA acellular, and 3% MeHA gels, where 
20% MeSDCC was the only hydrogel that fell within the 95% confidence interval of native 
porcine cartilage until they began to fracture at 7.5% strain on average. The next closest 
hydrogel matching the stress-strain profile of native cartilage was 20% MeSDVC, which 






Figure 7.3 Relative Gene Expression of Select Gels from Aims 2-3. 
 
Relative gene expression observed for A) aggrecan, B) collagen II, C) Sox-9, and D) 
collagen I. The 10% MeSDCC gels had significantly higher aggrecan and Sox-9 expression 
at day 1 compared to the other groups, but high levels of collagen II gene expression were 
only observed for the DVC-containing groups. Data reported as mean + standard deviation 
(n=5); *Significantly different from 3% MeHA at same time point (p<0.05), #significantly 
different from 3% MeHA 10% DVC at same time point (p<0.05), %significantly different 
from 10% GelMA at same time point (p<0.05), &significantly different from 10% 
MeSDCC at same time point (p<0.05), +significantly different from 10% MeSDVC at 
same time point (p<0.05), !significantly different from same group at first time point 
(p<0.05), @significantly different from same group at previous time point (p<0.05), 
^below detectable limit. 
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APPENDIX B: Tables 
CHAPTER 1: Tables 1.1-1.2 
CHAPTER 2: No Tables 
CHAPTER 3: No Tables 
CHAPTER 4: No Tables  
CHAPTER 5: No Tables 
CHAPTER 6: No Tables 















Table 2.2 Applications of Nanomaterials in Bone-Tendon and Bone-Ligament 
Interfaces 
 
 
